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ABSTRACT 
The nutritional deficiency of chromium has been linked with 
impaired glucose tolerance, and more recently has been implicated in 
cardiovascular disease. It was believed that a biologically potent 
'form of chromium existed as a coordination complex with nicotinic acid 
and various amino acids. The biologically active chromium complex was 
termed glucose tolerance factor (GTE) due to the curative effect on rats 
raised on a chromium deficient diet resulting in impaired glucose 
tolerance. The most studied source of GTE has been brewers' yeast 
although little has been learnt regarding the structure of GTE. The 
aim of this thesis was to isolate and characterize GTF. 
An existing in vitro assay system for GTE has been developed 
and is reported in this thesis. The assay was based on the anaerobic 
oxidation of 14 C-glucose by yeast (Saccharomyces cerevisiae) and its 
stimulation by GTE. 
Brewers' yeast was used as a starting material for the isolation 
of GTE. A defined synthetic Medium was eventually used for yeast culture, 
in order to establish that GTE was produced by yeast and not derived from 
culture medium components. GTE was isolated from yeast grown in synthetic 
medium and in higher yield when chromium was present. Low levels of 
chromium were found to inhibit yeast growth. 
A biologically active cationic fraction extracted from yeast 
was purified by chromatography. Nuclear Magnetic Resonance spectroscopy 
and other instrumental techniques indicated that the isolated material 
was a small lysine peptide devoid of chromium which could be likened to 
a class of basic hypoglycemic, agents. 
It was concluded that, as recent clinical trials reported 
in the literature indicated a division between the effect of chromium 
supplementation, and supplementation with high chromium yeast, GTF 
isolated from yeast grown in presence of chromium represents an interesting 
hypoglycemic agent. 
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CHAPTER 1 
INTRODUCTION  
1.1 PROLOGUE  
Many enzymes, particularly those involved in oxidation-
reduction reactions, contain certain metal ions of the first and 
second transition series as prosthetic groups. Chromium, a transition 
metal in subgroup VI B of the periodic table,was first implicated as 
being an essential nutrient in the 1950's. In humans, chromium 
deficiency has been linked with impaired glucose metabolism (Mertz 
1981), raised cholesterol levels and cardiovascular disease (Newman 
et al 1978). As well as human studies, chromium supplementation studies 
have been conducted on rats (Schwarz and Mertz 1959), rabbits 
(Abraham et al 1982), turkeys (Steele and Rosebrough 1978), swine 
(Steele et al 1977), trout (Tacon and Beveridge 1982), hens (Jensen et a/ 
1978), squirrel monkeys (Davidson et al 1967) and microorganisms 
(Gutierez et al 1974, Burkeholder and Mertz 1966). 
Supplementation with brewers' yeast was reported first in 1927 
by Glaser and Halpern, when it was found that yeast extract potentiated 
insulin action. The protective factor in yeast extract was later 
described as glucose tolerance factor (GTE) by Mertz and Schwarz (1957), 
the activity of which was attributed to the chromium content of the yeast. 
McCarty (1980) has speculated on the possible therapeutic 
applications of GTF derived from yeast. As the action of insulin was 
reported to be enhanced by GTE, the predictions were made by considering 
the wide range of physiological effects attributed to insulin. The most 
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obvious application was s'een to be the treatment of either maturity 
onset diabetes or juvenile diabetes mellitus as some studies have 
indicated therapeutic results with yeast or yeast extract (Liu et al 1977). 
GTE was seen to have a role in cancer therapy as insulin injections, 
anti-glycolytic and anti-gluconeogenic agents have been found to retard 
tumour growth. GTE administration was seen as a possible alternative, 
with less likelihood of toxicity posing a problem. High doses of GTE 
were proposed as a possible hunger suppressant during low calorie 
dieting as insulin has been found to stimulate the hypothalamic 
satiety centre. The anabolic effect of insulin on muscle was seen as 
indicating that GTF supplementation may havevalue in the management of 
anorexia nervosa, neoplastic cachexia, cystic fibrosis and protein 
malabsorption. Tryptophan (or tyrosine) therapy of depression was 
proposed as another area in which GTE supplementation could be 
beneficial along with migraine and insomnia treatment. As insulin 
enhances brain dopa uptake, increased GTE levels were expected to 
produce a similar effect and may thus be useful in the dopa treatment 
of Parkinsonism. The reduction in total serum cholesterol and 
triglyceride levels, accompanied by an enhancement of HDL levels 
with yeast supplements was seen as having value in preventative health 
measures and special value in the therapy of various hyperlipidemias. 
It can be seen that GTE has been implicated in the treatment 
of many disorders, yet little is known of the nature of the material. 
1.2 THE INITIAL ESTABLISHMENT OF CHROMIUM AS .A MICRONUTRIENT  
Mertz and Schwarz (1954) reported severe hypoglycemia and 
inability to utilize injected glucose in rats dying from necrotic 
liver degeneration when raised on a torula yeast based diet. 
Supplementation of the diet with debittered brewers' yeast or defatted 
pork kidney powder protected against death from necrotic liver 
degeneration, a syndrome later described as being caused by a combined 
vitamin E-selenium deficiency. Brewers' yeast and pork kidney powder 
supplementation was found to correct the impaired glucose tolerance 
detected in rats raised on the torula yeast diet several weeks before 
the onset of the terminal phase. 
• The prophylactic factor was termed factor 3 (Mertz and 
Schwarz 1955). Crude extracts of brewers' yeast and acid hydrolysates 
of defatted pork kidney powder were also found to be effective, 
- 
however, with progressive purification the factor protecting against 
necrotic liver degeneration was clearly separated from a factor that 
prevented the defect in glucose metabolism which was designated as 
glucose tolerance factor (GTE) (Mertz and Schwarz 1957). Ashing of 
active preparations did not destroy the protective ability of GTE 
although the activity was reduced, indicating a mineral content. 
Chromium was implicated as being the active ingredient by a spot test 
of the ashed sample. In order to establish the identity of the active 
element, complexes of forty different elements were given by stomach 
tube to rats fed on a diet containing 30% torula yeast (Mertz and 
Schwarz 1959). Only chromium III complexes were found to consistently 
improve glucose tolerance, thus chromium was regarded as the essential 
element of GTE. 
Commercial pelletized diets as well as semi-purified torula 
yeast based diets were compared with natural diets (Mertz and Schwarz 
1959). Rats fed the commercial diets developed impaired glucose 
tolerance whereas the rats fed on a natural diet did not. Impaired 
glucose tolerance was corrected within 18hours by giving GTE containing 
fractions from brewers' yeast or from pork kidney powder. 
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Yeastamin, an enzymatic digest of brewers' yeast, was also 
found to be a source of GTF as dietary supplementation prevented the 
development of low glucose removal rates. GTE concentrates were 
successfully applied by stomach tube; purified GTF was also satis-
factorily administered intraperitoneally and intravenously (Mertz and 
Schwarz 1959). 
As conversion to fat was regarded as the major metabolic 
pathway for excess sugar, Mertz, Roginski and Schwarz (1961) 
investigated glucose uptake by peripheral tissue - specifically, 
epididymal fat pads - in order to define the site of action of GTE. 
Various chromium salts were found to stimulate the oxidation of glucose 
in vitro by fat pad pieces as did those of manganese although to a 
lesser degree. The effect was found only in presence of exogenous 
insulin and observed best with sub-optimal insulin levels. 
Mertz and Roginski (1963) investigated the effect of inorganic 
chromium on galactose uptake of epididymal fat pads from chromium 
deficient rats. Galactose is poorly metabolised by peripheral tissue 
in vitro with entry into the cell being insulin regulated. Significant 
increases in the rate of entry of galactose were found with low levels 
of chromium (0.01-0.1pg). The increase was only found with tissue 
from chromium deficient rats. It was concluded that the site of sugar 
entry into the cell was effected by chromium III and that chromium may 
be an essential cofactor for insulin action, although other sites were 
known to be effected by higher chromium levels (Curran 1954 - 
cholesterol synthesis). 
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1.3 , CHROMIUM-INSULIN INTERACTION  
The inhibition of the effect of insulin on sugar transport 
by a thiol blocking agent (Cadenas et al 1961) and later the release 
of bound insulin from epididymal tissue (Fong et al 1962) suggested 
that a disulphide bridge may bind insulin to its receptor. Polarographic 
studies of chromium-insulin-mitochondria interactions undertaken in 
specific and non-physiological conditions found that a polarographic 
wave, appearing to originate from the mitochondrial membrane, was 
shifted to a more positive potential when insulin was added, suggesting 
an interaction between the mitochondrial sulphydryl group and insulin 
(Christian et al 1963). A similar effect was produced by chromium. 
Insulin and chromium together produced an effect threefold greater 
than the sum of the individual shifts. The results were interpreted 
as demonstrating that chromium initiates the formation of the new 
disulphide links between the intrachain of insulin and membrane 
sulphydryls by participating in a ternary complex in which chromium 
would coordinate to four sulphur atoms. The result of the possible 
coordination was thought to be a weakening of the original intrachain 
disulphide of the A chain of insulin, leading to the formation of a 
new insulin-membrane disulphide bridge. Mertz et al (1974) published 
a diagram illustrating the hypothetical ternary complex (Figure 1.1). 
Membrane 
 
SH rSH SH SH  . 
t 	 \ 
	
• 	 / 
f % 
I % 
t 
S 	t 
% 	i 	 S s , 
s , 
/ *,, / 
/ 	s 	 / 	s 
/ % / 
s' 	• S 	S' 
A - Chain 
Insulin 
FIGURE 1.1 Hypothetical ternary complex of chromium at 
site of action (Mertz et al 1974). 
Excessive non-physiological quantities of insulin as used 
in the early binding experiments can bind nonfunctionally and insulin 
can be re-extracted intact as would seem to have been the case with 
Fong et a/ (1962). Campbell and Mertz (1963) isolated liver mito-
chondria and measured the swelling of 'the mitochondria by the change 
in absorbance at 520nm in the presence of small quantities of insulin 
and chromium. Swelling was found to occur at concentrations of 
• chromium and insulin at which each were ineffective, further implicating 
a chromium-insulin-receptor effect. 
Mertz (1969) reviewed aspects against the sulphydryl ternary 
complex model at the receptor and pointed out that carboxyl groups 
have a high affinity as ligands for chromium compared to the thiol group 
and would thus seem to discount the ternary complex model. In view 
of more recent findings, a chromium-insulin interaction rather than one 
involving the structure of the receptor, which is not known, would seem to 
be more likely. Despite extensive investigations, the coupling 
system between the insulin receptor complex and the influence of the 
hormone on enzymes and membranes has not been identified (Walaas and 
Horn 1981). 
Belusko (1977) has demonstrated by circular dichroism and 
front gel chromatography,a dissociative effect of chromium III on 
zinc added to insulin, preventing aggregation that would otherwise 
occur. Anderson (1978) reports that synthetic labelled chromium complexes 
bind tightly to insulin in vitro thus some chromium-insulin interactions 
would seem to exist. Anderson (1979) later demonstrated that a chromium-
nicotinic acid-glutathione complex (Section 1.9.3) had a minimal 
effect on glucose transport in isolated adipocytes and implied a primary 
effect after entry of glucose into the cell, whereas, the chromium-
insulin-receptor complex had been thought to favour increased glucose 
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transport. The binding of chromium to insulin and the effect of 
chromium on glucose oxidation may thus be unrelated. 
1.4 BODY STORES OF CHROMIUM  
Chromium is present in large amounts in the brain and liver 
(Nath et aZ 1979) and high levels of chromium have been associated 
with inhibition of insulin secretion from the pancreas of the rat•
(Ghafghazi et al 1979). Studies of chromium exchange in animals 
using 51 chromium, show that chromium is rapidly cleared by urinary 
excretion and tissue uptake (Hopkins 1965, Mertz et al 1965, Onkelinx 
1977). 
Jain et al (1981), using 51 chromium of high specific 
activity, studied tissue chromium exchange in both chromium deficient 
and supplemented rats. Chromium deprivation of a moderate degree 
reduced serum chromium and tissue-exchangeable chromium pools but did 
not change total tissue chromium, 
51
chromium distribution or glucose 
tolerance. Chromium supplementation and chromium overload increased 
serum chromium and total, exchangeable and non-exchangeable tissue 
chromium pools but not 51chromium distribution. A simplified flameless 
atomic absorption technique was developed by Jain et al and used in 
conjunction with the isotope technique but has yet to be published. 
1.5 HUMAN STUDIES  
1.5.1 Inorganic chromium in clinical trials and recommended  
dietary chromium  
Chromium deficiency in human subjects cannot yet be reliably 
diagnosed by chromium analysis of body fluids or tissues (Mertz 1981). 
Difficulties in obtaining true chromium levels in biological material has 
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invalidated earlier work on determining chromium balances, body 
chromium pools and chromium status of individuals (Section 1.10). 
It has been implied that the recognition of chromium 
deficiency depends on diagnosis of impaired glucose tolerance in the 
presence of normal levels of insulin (Mertz 1976). Recent work 
by Nath et al (1979) and Riales (1979) has demonstrated that dietary 
chromium may affect not only glucose homeostasis but also lipid 
metabolism. 
Jeejeebhoy (1977) and Freund (1979) reported independently 
that patients sustained by administration of intravenous fluids 
developed glucose intolerance and insulin resistance. The disorders 
were normalized after administration of chromium chloride for seven 
days but not by the administration of insulin. 20pg per day of chromium 
was found to be sufficient to maintain the well being of the patient. 
Sherman (1968) treated normal subjects and diabetes mellitus sufferers 
with placebos and 150pg per day of chromium chloride in a double blind 
investigation of glucose tolerance and hyperglycemia. It was concluded 
that chromium had not improved glucose tolerance after sixteen weeks 
treatment and that chromium is not essential for normal glucose tolerance 
in man. Mertz (1977) responded to the findings of Sherman by indicating 
that a number of factors affect glucose removal rates and •thus chromium 
deficiency should not be construed as the sole criterion for impaired 
glucose tolerance. 
As a result of clinical trials, a recommended daily allowance 
(RDA) of 50-200pg per day of trivalent chromium was proposed (Mertz 1980). 
An average chromium intake for healthy males in the United States, for 
comparison, was reported to be 78±43pg per day by Kumpulainen et al (1979). 
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Regional variations resulted in some diets being reported as marginal 
i.e. less that 50pg per day. Kumpulainen (1980) later reported that 
the mean chromium intake per capita for Finnish people is the lowest 
known being 29pg per day. 
It would thus seem that adequate chromium intake is not 
always supplied by common diets in the United States or in countries 
with low chromium soils such as Finland or where basic malnutrition 
problems exist. Until it becomes possible to test for chromium 
deficiency in humans, the extent of chromium deficiency cannot be 
appreciated (Mertz 1969). 
1.5.2 The case for biologically active chromium 
Mertz (1977) suggested that with advancing age the ability 
to convert inorganic chromium to a biologically active form decreases 
and that some insulin requiring diabetics may also have this defect 
(Anderson and Mertz 1977). 
Carbohydrate abnormalities in malnourished children were 
found to respond to inorganic chromium within sixteen hours (Hopkins 1965). 
Improvement of glucose tolerance was also reported in marasmic 
Turkish children fed 250pg of inorganic chromium sixteen hours before 
testing (Gurson 1971). Elderly subjects however, fed up to 100pg per day, 
required one to three months to respond. One third to one half of 
the elderly subjects failed to respond (Mertz 1977, Glinsmann 1966). 
Due to the disappointing response of the elderly people to inorganic 
chromium, investigations with brewers' yeast were pursued. 
Doisy et al (1976) studied the effect of brewers' yeast 
extract on subjects over the age of sixty five with impaired glucose 
tolerance. Half of the subjects showed improved glucose tolerance. 
Liu et al (1977) also reported improved tolerance to glucose in 
women with hyperglycemia after supplementation with yeast extract. 
A recent controlled study by Offenbacher and Pi-Sunyer (1980) of a 
group of subjects with a mean age of 78 years and including some mild 
diabetics, were fed chromium rich brewers' yeast with other members 
of the group being fed low chromium torula yeast. The group receiving 
brewers' yeast had improved glucose tolerance, insulin sensitivity 
and cholesterol levels thus establishing the effectiveness of brewers' 
yeast supplementation. 
Differences in absorption rates between inorganic chromium 
and chromium in yeast GTF, imply that chromium may be more nutritionally 
important as the GTE complex. Chromic chloride was found to be poorly 
absorbed in the gut with 0.5-1.5% absorption being reported in animals 
and man (Donaldson 1966, Anderson 1980,Levine1968). This is 
presumed to be because of the tendency of chromium to olate at 
physiological pH (Mertz 1969). In animals, 10-25% of the organically 
complexed chromium in brewers' yeast was absorbed and appeared to be 
immediately available since the treatment led to the rapid improvement 
in glucose tolerance (Mertz 1969, Mertz and Roginski 1971). 
In conclusion, Anderson (1981), reviewing the nutritional role 
of chromium in light of improved analytical techniques, points out 
that the form of dietary chromium does not appear to be as important 
as had been postulated previously and that it is total chromium intake 
that is important for normal individuals. 
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1.6 CHROMIUM, GTF AND YEAST METABOLISM  
1.6.1 Inorganic chromium and yeast metabolism 
Burkeholder and Mertz (1966) investigated the effects of 
chromium on yeast metabolism using radio-chromium ( 51Cr) and the 
yeast strain Saccharomyces carZsbergensis (brewers' yeast, now 
Sacch. cerevisiae) in Sabouraud's liquid medium. 51chromium 
incorporation was found to be independent of cell growth but was 
stimulated by the addition of glucose. Glucose oxidation was 
stimulated by low levels of chromium (0.1ppm) relative to chromium- 
free cells while higher levels (lOppm) were found to depress fermentation. 
Generally, a lag time of several hours was found before increased 
oxidation, and this was attributed to the tissue required to form a 
chromium complex (GTF) which could then exert its influence on glucose 
metabolism. 
Polansky and Anderson (1977), while investigating extractive 
techniques for GTF, found a slow chromium uptake followed by rapid 
increase in uptake after eight days culture of Sacch. carZsbergensis 
in synthetic medium. Glucose additions at five and nine days growth 
decreased the amount of incorporated chromium label contrary to the 
findings of Burkeholder and Mertz (1966) using peptone based medium 
(Sabouraud's Liquid Medium). Anderson et al (1978), using 51chromium, 
found incorporation to be lower in the synthetic culture medium of 
Toepfer et al (1970) compared with a peptone based medium. An extract 
of yeast grown on the synthetic medium had comparatively little 
biological activity and may indicate that the GTE originated from 
the crude medium. 
Kumpulainen et al (1978) found that the incorporation of 
chromium from Sabouraud's medium correlated directly with the 
metabolic activity of the yeast and that the incorporation was highest 
with anaerobic conditions. A slight reduction in growth occurred 
with 1.0ppm chromium, the effect being more marked at 4.0ppm. 
Haylock et al (1982) reported that chromium exerted a slight inhibitory 
effect on fermentation rate in phosphate buffer and a defined 
synthetic medium, but not on cell growth. These findings are similar 
to those reported by.Mirsky, Weiss and Dori (1980). Haylock et al (1982) 
concluded from preincubation experiments with simple chromium III salts, 
that there was no evidence that brewers' yeast can synthesize a 
biologically potent chromium complex. Furthermore, response to GTE 
fractions was found regardless of whether the yeast was replete or 
depleted of chromium. 
Burkeholder and Mertz (1966) found no difference in chromium 
uptake over the concentration range of 0.001-1.0ppm contrary to the 
findings of Kumpulainen (1978). As the chromium content of the 
cells was always less than the medium and correlated positively with 
the concentration of the medium, Kumpulainen et al (1978) attributed 
chromium uptake to diffusion and ionic concentration balance. The 
nature of the ligands of added chromium complexes was found to have 
little influence on the rate and extent of chromium absorption in yeast 
(Anderson et aZ 1977). 
1.6.2 Toxicity of chromium 
Hartelius (1956) found chromium to be toxic at 200ppm and 
that toxicity is related to the nature of the medium. High levels of 
chromium in malt wort had no effect on cell growth, whereas the same 
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concentration in defined synthetic medium, inhibited totally. Ono and 
Weng (1982) have found that the structure gene for hoMocitrate dehydrase 
is involved in the detoxification of chromium in the wild type strains 
of yeast. 
The accumulation or metabolism of a metal does not establish 
physiological need but may be a detoxification mechanism (Harrison, 
Hoare, 1980). It may be that low levels of chromium diffusing into 
. the yeast cells are toxic, resulting in the slight reduction in ferment-
ation rates previously noted. 
In media containing peptone, it may also be added that 
chromium is bound by polypeptides and thus not able to diffuse into the 
yeast cell. Defined synthetic medium lacking peptone could not provide 
the same protective mechanism. Part of this thesis will examine the 
possibility that GTE is produced in response to chromium III. 
1.6.3 Yeast as an assay system for GTE  
Burkholder and Mertz (1966) found that the response to GTF 
by brewers' yeast was immediate and dependant on glucose utilization, 
thus the yeast system was proposed as a biological test for GTF. 
Mirsky et a/ (1980) were not able to produce an immediate response to 
GTF unless the cells were preincubated with glucose before the addition 
of GTF, however, after preincubation, significant increases in carbon 
dioxide production resulted in response to fractions derived from 
yeast extract. The yeast assay system was utilized successfully by 
Haylock et a/ (1982) for rapid screening for GTE activity in yeast and 
fractions from other sources. No separate preincubation period was used, 
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however, the fermentation time of 300minutes allowed sufficient time 
to overcome a lag phase of 100minutes. 
Burkeholder and Mertz (1967) report that yeast fractions 
active by the criteria of the yeast assay system were tested and found 
to affect glucose oxidation of epididymal fat tissue in presence of 
insulin only, thus establishing a link between the yeast assay system 
and the fat pad assay system. The effect of GTE in both systems was 
thought to involve a common effect on transport, however, Anderson (1979) 
subsequently demonstrated that the action of GTE in adipocytes was after 
the transport step. 
1.6.4 Yeast Metabolism and GTE  
Burkeholder and Mertz (1966) have reported enhanced glucose 
utilization by yeast in presence of GTE and that the repsonse is 
dose dependent. Mirsky et al (1981) reported the same effect for 
Sacch. carlsbergensis, Sacch. cerevisiae and Sacch. ellipsoideus and 
for not only glucose but fructose and mannose. GTE enhanced galactose 
metabolism, suggesting that GTE may influence the transport of sugar 
into the cell since the steps preceding fructose 1,6 diphosphate in 
the intracellular metabolism of galactose differ from that of glucose 
(Jaspers et al 1976). Further evidence for the transport hypothesis 
was found in the lack of stimulation of GTE on cell free extract and 
thus the hypothesis that GTE enhances fermentation rates by increasing 
the reaction velocity, was put forward by Mirsky et al (1980). 
Mirsky et aZ reasoned that the rate-determining step in the utilization 
of sugar was its transport, thus increased reaction velocity is due to 
increased transport. Uptake of deoxyglucose was found to be greatest 
when the cells were preincubated with GTE and glucose, thus Mirsky et al 
concluded that metabolic activity is required for triggering the action 
of GTE. 
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1.7 CRITERIA FOR GTE ACTIVITY  
1.7.1 Peripheral tissue  
Improvement in glucose tolerance of torula yeast fed rats 
after supplementation with GTE was the original criterion for GTE 
deficiency. Extrapolating to the site of glucose removal, the action 
of GTE was investigated in vitro in peripheral tissue. 
Fat tissue from animals supplemented with chromium chloride 
was found to have a 67% higher glucose uptake in vitro as compared 
to unsupplemented control animals. Increases of approximately 90% 
of glucose oxidation in vitro by fat tissue from deficient animals 
were observed when chromium complexes (chrome alum neutralized) were 
added to the tissue in presence of small quantities of insulin (Mertz 
et al 1961). Of thirteen elements tested, only manganese in addition 
to chromium III stimulated glucose oxidation. Roginski (1974) reports 
that nicotinic acid also stimulated glucose oxidation by fat pad pieces. 
The use of fat pad pieces thus became an assay system for GTE until 
it was demonstrated that an adipocyte preparation allowed more samples 
to be tested per animal with less interference from compounds such 
as nicotinic acid. 
Anderson (1978) reported that adipocytes isolated from 
epididymal fat tissue of chromium deficient rats can be used as a 
rapid and sensitive technique to detect and quantitate biologically 
active chromium. The method, an adaptation of the Robdell (1964) 
adipocyte preparation, is similar to the fat pad assay in that increased 
glucose oxidation with GTE added is only observed in presence of 
sup-optimal levels of insulin. The effects of inorganic chromium and 
nicotinic acid were insignificant on isolated adipocytes although 
sulphydryl compounds produced a GTE type of response (Anderson 1979). 
As a number of compounds are known to mimic insulin (Czeck 1977) 
and divalent ions (Cu 2 , Co 2 , M 2 , N.2 1 	) have been reported to 
mimic the effect of insulin on isolated fat cells (Saggerson et al 1976), 
care should be taken in establishing the presence of GTE. Copper 
deficiency in rats results in impaired glucose tolerance (Hassel 1982) 
and copper in presence of thiols can mimic insulin effects (May and 
Contoreggi 1982). 
The main advantage of the adipocyte assay is that a larger 
number of samples can be screened per animal (Anderson and Bratner 1978). 
 
1.7.2 Absorption  
Mertz and Roginski (1971) have demonstrated that chromium in 
its biologically active form is absorbed and retained in rats to a • 
much greater degree than chromium chloride. As absorption of radio-
chromium poses less problems experimentally, various workers have 
chosen to use absorption or bioavailability in preference to glucose 
tolerance tests for in vivo evaluation of GTF (Votava 1973, Huffman 
et aZ 1973). Anderson et al (1980) reports, however, that a compound 
well absorbed from the gastrointestinal tracts of animals, had 
previously been found to be inactive in the fat pad assay (Mertz 1969) 
and thus bioavailability may not necessarily imply bioactivity. 
1.7.3 Other indicators  
Yeast as an assay system has been discussed (Section 1.6.3). 
Gutierrez et aZ (1974) report the use of navobacterium rhenanum as a 
microbiological assay for GTF. The microorganism, a contaminant of a 
wild yeast culture, gave an increased dose response on addition of 
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GTE-containing fractions to the growth medium. A linear correlation 
between the response of F. rhenanum and the rat epididymal fat 
bioassay was reported. Anderson (1981) comments that the assay was 
discarded as it was not specific but does not elaborate further. 
Placental transport of 'chromium and 51chromium labelled 
GTE extracted from brewers' yeast provided a means of distinguishing 
the effect of GTF from that of chromium in vivo (Mertz 1969), and 
has later been suggested by Mertz (1974) as a definitive metabolic 
property of GTF but was not developed as an assay system. 
Nath and Sidhu (1979) compared the effect of GTF preparations 
on insulin sensitive diaphram tissue with hepatic tissue, as a means 
of establishing GTE activity. Unfortunately, the complex was not 
entirely separated from free glutathione or nicotinic acid. There was 
little difference in the incorporation of glucose into glycogen in 
liver or diaphram in the control rats and rats receiving insulin alone or 
a chromium-glutathione-nicotinic acid preparation alone. No glutathione 
or nicotinic acid controls were reported. The test group receiving 
both insulin and the chromium preparation showed a 24-fold increase 
in glycogen synthesis in diaphram but no effect on liver glycogen. 
Glycogen synthesis in liver is not sensitive to insulin and, as it was 
found to be unaffected by a chromium-containing preparation, it would 
seem that the assay system of Nath et al implicates the site of action 
in vitro to be glucose transport. The use of diaphram tissue had 
originally been reported (abstract only) by Mertz and Thurman (1968) 
as an assay system for GTE. 
In summary, the most commonly used bioassays for GTE reported 
in the literature are: 
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Epididymal fat pad assay, 
Adipocyte assay 
iii) Glucose tolerance tests on deficient animals 
iv) Absorptivity 
v) Microbiological assay 
vi) Diaphram tissue 
1.8 THE EXTRACTION AND STRUCTURE OF GTF  
1.8.1 Sources of GTE  
The first reported sources of GTE were defatted pork kidney 
powder and brewers' yeast (Mertz and Schwarz 1957). Toepfer et al 
(1973) in surveying the potential GTE content of various foods, found 
no correlation between total chromium and biological activity as 
determined by the fat pad assay but were able to correlate the 
chromium content of ethanol extracts with activity. Brewers' yeast 
was found to have the highest biological activity followed by black 
pepper, calfs' liver, cheese and wheat germ. 
Anderson (1982) determined the chromium levels in selected 
beers and found a range of 0.48 to 56ppb. He reported that the chromium 
was absorbed by humans similarly to chromium occurring endogenously in 
goods and thus it may be significant nutritionally. Chromium extracted 
from beer was found to be low in in vitro insulin potentiating activity. 
Mirsky et al (1980) and Haylock et al (1982) used commercially 
available yeast extract powder as a source of GTE. Haylock et al (1982) 
also extracted active material from sage, black peppercorns, molasses, 
wheat bran and pork kidney powder. Sage was found to be a poor source 
of GTE activity in agreement with the general observation that leafy 
vegetables were devoid of insulin potentiating activity in vitro (Mertz 
et al 1974). 
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1.8.2 GTE from higher plants  
Blincoe (1974) separated a 'chromium containing anionic 
material with a molecular weight of 2900 daltons from lucerne. 
Stanch and Blincoe (1982) report a chromium complex isolated from 
alfalfa, also anionic, had a high affinity for gel column packing giving 
false estimates of molecular weight. The complex was similar to 
other chromium containing complexes isolated from beans and wheat 
(Huffman and Allaway 1973). The absorption of the complex was compared 
with the absorption of inorganic chromium in marginally chromium 
deficient rats and it was found that less than 0.5% was absorbed in 
either case. Studies on the uptake of 51 chromium by plants demonstrated 
that most of the chromium was retained in the roots and was thus 
unavailable to grazing animals. 
1.8.3 . Extraction and structure of GTE  
Schwarz and Mertz (1959) found that extracts containing GTE, 
from brewers' yeast or hydrolyzates of pork kidney powder lost their 
activity on storage at 4°C and that the loss in activity was generally 
associated with the formation of a brown precipitate. They identified 
chromium III as the active ingredient by glucose tolerance tests on 
rats raised on a torula yeast based diet and dosed by stomach tube 
with salts of forty different elements. Only chromium III improved 
glucose tolerance. GTF was reported to be water soluble, extractable 
with phenol and isobutanol and absorbable on cation exchange resin 
and charcoal. Burkeholder and Mertz (1966) disintegrated yeast cells 
to yield two low molecular weight intracellular fractions containing 
chromium, and which were active in the yeast assay system. Chromium 
was found to be present as an organic complex that was dialyzable. 
Thurman and Mertz (1969) batchwise extracted yeast grown 
on 10-100ppm chromium and used ethanol and trichloroacetic acid to 
extract GTE. Mertz deduced that not all of the chromium extracted 
was associated with biological activity as some was retained by the 
ion exchange resin (presumably the Dowex 50W cation exchange resin 
reported earlier) and was thus free chromium (Schwarz and Mertz 1959). 
Alcoholic extracts of brewers' yeast labelled with 51chromium were 
fractionated by gel filtration (details not given) and the resultant 
fractions were monitored by chromium content and stimulation of glucose 
oxidation in the fat pad assay. Although biological activity and 
chromium content were found to be closely associated, non-chromium 
containing material eluted from the column was found to have activity. 
The nature of the active material not associated with chromium was not 
further investigated. The molecular weight of the isolated chromium 
complex was later reported to be 300-500 daltons (Mertz 1974). The 
optimal dose reported by Mertz (1969) in the fat pad assay was 200pg 
GTF containing 0.2ng of chromium. Assuming a molecular weight of 
400 daltons, the chromium content can be calculated to be 0.4ng of 
chromium per mole of GTE. The amount of chromium would thus seem 
to be inadequate if chromium is the central coordinated atom in the 
GTE complex. 
Votava, Hahn and Evans (1973) extracted yeast cultures grown • 
on Sabouraud's medium containing low levels of 51chromium (4pg/z) with 
high specific activity. They were able to extract 100% of the label with 
butanol and water; 90% of the chromium remained in the aqueous phase. 
Fractionation by ion exchange chromatography and gel filtration yielded 
an anionic fraction with molecular weight 400-600 daltons. Purification 
on unbuffered Sephadex G25, resulted in a higher molecular weight and 
this was attributed to reversible aggregation. The isolated material 
was found to be a chromium-binding peptide consisting of leucine, 
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isoleucine, proline, valine, alanine, serine and either glutamic or 
aspartic acid. The biological activity of the material was implied 
by its greater absorption in the rat, as determined by whole body 
counting, in comparison to the absorption of inorganic 'chromium. 
Mertz (1974) reported the extraction of dry brewers' yeast 
with 50% ethanol. The extract was absorbed on charcoal and eluted with 
ammonia and ether. Further purification was by ion exchange chroma-
tography and gel filtration. Paper chromatography yielded material 
with a similar Rf to nicotinic acid. Mass spectrometry demonstrated 
the presence of nicotinic acid but not chromium. Chromium was said 
to have been determined to be present by infra red and atomic absorption 
spectrometry, however, the results have yet to be published. The 
insulin potentiating activity was measured in the fat pad assay. Free 
nicotinic acid which would almost certainly have been present from the 
spectral data presented, also stimulates glucose oxidation by the fat 
pad (Roginski 1974). The material was reported to be a glutamic acid, 
glycine, a sulphur containing amino acid and nicotinic acid complex 
(Toepfer 1974, Mertz 1974) on the basis of mass spectrometry and amino 
acid analysis. No chromium levels were reported although more than 
half of the total chromium was lost during purification. 
Toepfer et al (1977) after extracting brewers' yeast with 
ethanol (50%) and eluting from charcoal, hydrolyzed the product for 
18hours with 5N hydrochloric acid. No explanation is given for this 
step which would surely dissociate peptides. Tuman et al (1978) 
found hydrolysis reactivated samples of GTE which had lost activity 
through storage although, in this instance, the hydrolysis was less 
severe. Mertz (personal communication 1981) confirms that mild 
hydrolysis reactivates GTF containing fractions. During fractionation 
on Dowex and other ion exchange materials (details not available), 
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the ratio of chromium to dry weight of material increased, but the 
biological activity did not, an unexpected result if chromium is an 
essential component. A number of chromium complexes present in the 
original extract were reported to have less or no biological activity 
while the biologically active fraction comprised 11% of the total 
chromium in the starting material. The published ultra violet absorption 
spectra indicated, assuming a molecular weight of 400 daltons, that 
the yeast concentrate contained approximately 98% free nicotinic acid. 
The authors argue that the "shoulders" either side of the 262nm 
maximum (8 band) are reduced in magnitude and indicate complexation, 
however, the side bands are pH dependent and are not observed at low 
pH (less than 4.5). 
Polansky and Anderson (1977) extracted 80% of labelled chromium 
with boiling water from yeast grown on a synthetic medium. Less chromium 
was extracted by ethanol :water, butanol:water or extended sonication. 
Purification by liquid chromatography included high performance 
liquid chromatography (HPLC) on a C18 column, yielding at least three 
chromium containing compounds. The biological activities were not 
reported. After comparing the rate of chromium uptake from synthetic 
(hydrolyzed casein) and peptone based medium and finding considerably 
higher uptake in the peptone medium, Anderson (1978) examined various 
means of extracting the incorporated "-chromium. Approximately 80% 
of the label could be extracted at a pH greater than 8.0 with little 
being extracted at pH 4.5 (similar pH to culture medium). Ethanol 
(50%) extracted considerably less chromium but a high proportion of 
the active material was extracted. Teichozyme Y and sonication 
released 80% of the label but inhibitory material was also released as 
biological activity was low and decreased even further with increased dose. 
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Kumpulainen et al (1978) isolated both cationic and anionic 
chromium complexes from yeast and from the spent medium. An anionic 
fraction not found in fresh medium was isolated. As Evans et a/ (1973) 
has reported that GTE binds to insulin, Kumpulainen concluded that none 
of the materials isolated were GTE as they would not bind to insulin. 
It was unfortunate that they used this criteria for GTE since the 
binding studies of Evans et al (1973) are somewhat ambiguous as only 
labelled insulin was used and no attempt was made to establish where 
chromium eluted from the gel column. The estimated molecular weights 
for cationic fractions from yeast were from 200-500 dal tons with the 
material from the spent medium being 700-1100 daltons. The polarity 
of all of the complexes was found to be greater than most amino acids. 
Mirsky et al (1980) obtained crude GTE containfng fractions 
from yeast extract by dialysis and ion exchange chromatography. 
Haylock et at, initially using yeast extract as a source of GTE, devised 
a system for isolating the various chromium compounds occurring -in the 
extract by elution from a series of ion exchange resins using phosphate 
gradients. Eleven distinct chromium containing complexes were isolated 
with varying biological activity in the yeast assay, all of the cationic 
fractions being active. A cationic fraction from pork kidney powder 
was found to have a different elution profile to those from yeast. 
Cationic fractions from peppercorns, molasses, wheat bran, sage and 
split peas were all found to elute at different pH and are thus of 
different chemical forms. Extraction was with distilled water at 70°C. 
Haylock et al (1982) report that anionic chromium containing compounds 
constitute the bulk of isolated chromium containing compounds and also 
give evidence for the formation of an octahedral chromium-glucose 
complex which would be expected to be anionic. Most of the complexes 
were a result of direct reaction between chromium and medium components. 
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They concluded that material with GTE activity in the yeast assay 
was not a chromium complex. 
Gonzalez-Vergera et a/(1982) report recently that they have 
isolated a fraction from brewers' yeast containing all of the chromium 
originally present in the yeast. The chromium was not associated with 
nicotinic acid, glycine, cysteine or glutamate, however, a tryptophan-
like compound was reported to be associated on the basis of spectral 
evidence. No details are available at present as to the extraction 
technique or biological activity. 
In summary, a wide variety of chromium containing complexes 
have been isolated from both yeast and from the medium in which it is 
grown. There is a general consensus that the material having biological 
activity is cationic, is of low molecular weight and binds strongly 
to the cation exchange resin Dowex 50W. Aqueous extraction is 
generally favoured. 
1.9 PREPARATION OF SYNTHETIC GTF  
1.9.1 Chromium  
Chromium has been found to occur in biological material in 
the trivalent state (Feldman 1968), the most stable oxidation state for 
chromium. Chromium III complexes, like those of cobalt III have low 
rates of ligand interchange and, in fact, many analogous complexes 
are known. The complexes of chromium III in aqueous solution are 
susceptible to hydrolysis and formation of polynuclear complexes by 
olation, more so than those of cobalt III (Rollinson 1973). As 
chromium III is not subject to high spin, low spin transitions and has 
a low rate of ligand exchange, chromium III complexes would seem 
unsuitable as a metal cofactor for the active site of an enzyme. 
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Mertz (1969) suggests that the relative inertness of the chromium 
ligand bond would be compatible with a structural function. 
1.9.2 Simple complexes  
Chromium chloride and chromium acetate were found by 
Anderson et al (1978) to inhibit glucose oxidation in isolated 
adipocytes. Mertz (1969) reports that neutralized chrome alum and 
chromium chloride were active in the fat pad assay. Further contra- 
diction between the assay systems lies in the observation by Mertz (1969) 
that very stable chromium containing complexes, specifically the 
acetylacetonate or bis-ethylenediamine complexes,did not improve the 
impaired glucose tolerance of chromium deficient rats whereas a range 
of anionic, cationic and neutral compounds with varying degrees of 
hydrolysis (chrome alum, chromium perchlorate) were effective. 
Anderson (1980) compared the rate of absorption of chromium chloride 
with chromium acetylacetonate and found the chromium chloride, in 
agreement with other investigators, was absorbed by only 1% whereas 
the acetylacetonate was 40% absorbed. The acetylacetonate was also 
effective in improving the blood glucose levels of diabetic mice and 
hence was biologically active, contrary to the findings of Mertz. 
Riley (1980) continued investigating complexes that would not olate 
in the intestinal tract and successfully synthesized a range of labelled 
chromium III porphyrin complexes, however, results of biological testing 
are not yet available. 
Chen (1973) measured chromium transport in rat intestine in 
both in vivo and in vitro and compared the effect of four chelating 
agents. Oxalate significantly increased transport while phytate caused 
a decrease. Citrate and EDTA did not affect transport. Interestingly, 
"-chromium EDTA has also been used as a soluble rumen marker due to 
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its lack of absorption (Downes and McDonald 1964). Gonzalez-Vergera 
et al (1981) found whole body retention of chromium EDTA to be 0.88% 
in normal rats, less than chromium III hydrate (1.96%) but higher than 
attempts to prepare GTE analogues containing nicotinic acid (0.19%). 
1.9.3 Chromium GTF  
Toepfer (1974) and Mertz et al (1974) having found a close 
correlation between absorption due to nicotinic acid at 262nm and 
biological activity, reacted nicotinic acid with chromic chloride 
at low pH. A fraction was obtained from fractionation of the reaction 
mixture on Dowex cation exchange resin that was reasonably stable and 
potentiated the effect of insulin on fat tissue from chromium deficient 
rats (Roginski 1974). The product was described as a tetraaquodinico-
tinatochromium complex (Figure 1.2) purely by analogy with a cobalt II-
nicotinate tetrahydrate, the structure of which has been determined 
crystallographically (Anagostopoulos et al 1969). 
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FIGURE 1.2 Proposed coordination of nicotinic acid to 
chromium (Mertz et al 1974). 
Gonzalez-Vergera et at(1980) have prepared a Ryridoxylidene-
glycylglycine-chromium III-dinicotinate complex and proposed an axial 
nicotinic acid configuration. They concluded that coordination 
through the heterocyclic nitrogen confers stability on the complex 
but-there was no compelling evidence that nicotinic acid is an essential 
feature of GTE. A trinuclear chromium III nicotinic acid complex 
•coordinated through the carboxyl groups rather than the nitrogen was 
crystallized by Gonzalez-Vergera et al (1982). The complex was virtually 
insoluble at neutral pH thus precluding its testing in biological 
systems. The complex characterized by crystallography, was found to 
be vastly different from the structure proposed by Mertz. 
Mertz et al (1974) prepared the chromium nicotinate in the 
presence of ethanol and amino acid ligands to compete with hydroxyl 
ions . in order to reduce the tendency to olate. Although glycine, 
glutamic acid and cysteine were added to the reaction mixture, glutamic 
acid did not occur in the purified complex. The complex was found to 
be active in the fat pad assay despite the absence of glutamate which 
was thought to be present in yeast GTE. Molar ratios of 2 nicotinic 
acid:2 glycine:1 cysteine per mole of chromium were reported. 
Anderson and Brantner (1977) and Anderson, Polansky, 
Brantner and Roginski (1977) claimed to have synthesised a chromium-
glutathione-nicotinic acid complex which was found after fractionation 
by HPLC to be active in vitro. Anderson and Mertz (1977) report later 
that the use of HPLC was of limited success because of the instability 
of the complexes and peculiar binding properties with column packing 
materials. The compounds have not be isolated as yet because of 
dissociation during purification (Anderson 1981). 
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Anderson (1977) incubated labelled chromium-glutathione-
nicotinate with labelled insulin and fractionated the solution by gel 
chromatography. A fraction of the complex was found to bind to insulin, 
however, it was ambiguous as no control with inorganic chromium and 
insulin was presented and free chromium (or dissociated) has been shown 
to bind to insulin (McDonald and Belusko 1976). 
Toepfer et al (1977) compared the absorption spectra of a 
complex with molar ratios of 2 nicotinic acid:2 glycine:1 glutamic 
acid:1 cysteine per mole of chromium with material isolated from 
brewers' yeast and concluded that the axial nicotinic acid configuration 
may be the essential GTE configuration with the amino acid moities 
conferring solubility and being of lesser importance for biological 
activity. 
Anderson et o4 (1978) compared the in vitro activity of a 
chromium-nicotinic acid complex with a chromium-nicotinic acid-
glutathione complex and a yeast preparation. The two synthetic 
complexes had comparable activity but high levels of chromium (50pg/m1) 
were required to produce a response in comparison with 0.06n9/m1 of 
chromium as yeast GTE. The activity of a chromium-nicotinic acid-
glycine complex prepared (no details published) implies that the thiol 
moiety of cysteine is not necessary to form a biologically active complex. 
Kienle et al (1979), having followed the synthesis of Toepfer, 
attempted to purify the active material from the reaction mixture 
by thin layer chromatography. They found appreciable amounts of 
unreacted components, diverse compounds that could not be separated 
and chromium containing compounds that could not be eluted from columns 
without destruction of the complexes. Nath et al (1979) using the 
method of Toepfer with glutathione rather than individual amino acids, 
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used an anion exchange resin followed by a Sephadex G25 gel column 
to purify active material. A molar ratio for the purified complex of 
2 nicotinic acid:1 glutathione per mole of chromium was reported. 
Biological testing by the adipocyte assay was unsuccessful because 
of a poor response to basal insulin stimulation, however, increased 
glycogen synthesis was reported in rat diaphram tissue. The control 
rats were not dosed with an equivalent amount of a simple chromium 
salt, nicotinic acid or glutathione. Nath claims that the complex 
has an identical composition to GTE from brewers' yeast. 
In summarizing the preparation of synthetic GTE, it would 
seem that a large number of by-products are produced by the method 
published by Toepfer (1977) and that elucidation of structure has 
been prevented by instability of the chromium complexes. Much higher 
levels of chromium are required to produce a response in biological 
systems both in vitro and in vivo compared to the chromium levels in 
brewers' yeast fractions and this might imply that the yeast GTE 
may not contain Chromium and thus comparison may not be necessary. 
Tuman et at (1978), using non-deficient diabetic mice, found a small 
effect on nonfasting plasma glucose concentration with synthetic GTE, 
and Anderson reports activity in the adipocyte assay. 
1.9.4 Cobalt GTE  
Bertrand and Macheborf (1926, 1934) reported the hypoglycemic 
action of cobalt salts and their accumulation in the pancreas. 
Silio (1977) examined the evidence that GTE from pig kidney was 
chromium containing and, on finding inadequate evidence, he hypothesized 
that cobalt would be more likely to be the active principle of GTE in 
higher animals. 
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• Silio (1980) prepared a cobalt-dinicotinamide-glutathione 
complex via a cobalt II intermediate (Figure 1.3), the crystal 
structure of which has been determined (Vegas et al 1981). Reaction 
of the intermediate with reduced glutathione resulted in a brown water 
FIGURE 1.3 Trans-tetraaqua-bis-(nicotinamide)-cobalt II-
dichloride dihydrate (Vegas et al 1981). 
• soluble complex having a molecular weight of 1500 daltons. The 
complex was active in the adipocyte assay at a concentration of 
5 x 10 -7M (0.03pg/m1), considerably lower than equivalent chromium 
complexes, and was only active in the presence of insulin. Silio 
(personal communication 1982) attributes the action of high levels of 
chromium complexes in the adipocyte assay to the inhibition of oyruvate 
carboxyl ase. 
1.9.5 Conclusion  
The status of synthetic analogues is made difficult to assess 
since different methods have been used to test biological activity. 
Andersonet a/(1978) have shown that thiol groups are not necessary for 
activity; Gonzalez-Vergera(1981) disputes the necessity for the axial 
nicotinic acid structure. Glutathione-nicotinic acid-chromium complexes, 
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prepared for their stability rather than the amino acid mixture of 
Toepfer (1977), were found to precipitate from aqueous solution 
(Nath et al 1979). Silio (1980) has prepared active material containing 
cobalt and not chromium. Underlying the differences in the active 
complexes is the fact that yeast preparations, active in the 
biological assay, may have low or no chromium and raises the question . 
of the importance of chromium. 
Haylock et al (1982) report that chromium is present as 
an impurity in GTF containing fractions derived from yeast. From the 
data presented by Tuman et al (1978) and Mertz (1969), the low chromium 
levels in purified GTE would seem to indicate that chromium is not 
part of the GTE complex (Section 1.8.3). It may be that the purified 
product was still grossly impure, however, the material reportedly 
had high biological activity indicating a degree of purification. 
1.10 ANALYSIS OF CHROMIUM IN BIOLOGICAL MATERIAL  
Urinary chromium levels, blood and hair chromium levels 
have been used as criteria for chromium deficiency hence, the analysis 
of chromium in biological material has become important. Anderson (1981) 
has reviewed the variety of techniques available for determining the 
concentration of chromium in biological material and the expectations 
of each method. Chromium levels in certain matrices have changed 
radically with improved methodology. Figure 1.4 depicts the change 
in reported chromium levels in blood as a function of time (Horwitz 1982), 
showing a dramatic decrease in chromium levels with the introduction of 
the graphite furnace in the 1970's and reference materials for chromium. 
Almost every paper reviewed by Horwitz provided a linear calibration 
curve and good recovery values for added chromium and even for "-chromium 
yet, immense variability of several orders of magnitude exists. Much 
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variability has resulted from contamination, particularly from sampling 
devices such as syringes and stainless steel needles (Guthrie 1981). 
1950 1960 1970 1980 
Year 
FIGURE 1.4 Chromium concentration in blood as a function 
of reporting date (Horwitz 1982). 
As the level of chromium reported appeared dependent on the 
nature of the matrix (Kayne 1979), the US National Bureau of Standards 
issued a range of materials certified for chromium, including brewers' 
yeast, liver and orchard leaves. Shapcott et at (1977), Versieck 
(1978), Koirtyohann (1976), Kumpulainen (1977) and Tuman et at (1978) 
report losses of chromium during the ashing cycle of flameless atomic 
absorption atomizers which would appear to reflect the difficulties 
experienced generally with background correction. Thompson (1980) 
found that by comparing with a uranium line at 358.5nm, 0.6nm from the 
chromium line most commonly used, substantially improved background 
33 
correction was obtained. Kumpulainen et al (1982), using a tungsten 
iodide lamp, were also able to improve on the deuterium continuum due 
to increased intensity at 359nm. Guthrie, Wolf and Veillon (1978) 
stress the problems in determining chromium levels in urine and 
conclude that deuterium background correction is inadequate. 
The purge gas and pyrolitic coating of carbon tube furnaces 
also considerably influenced the final result. Routh (1980) was able 
to reduce the non-specific absorption to an acceptable level by using 
a hydrogen diffusion flame as a supplement to the inert gas sheathing 
the graphite furnace. Veillon et al (1981) report direct urine 
analysis with added standards prepared in 1M hydrochloric acid, 
however, Matsusaki (1980) reports chloride interference in determination 
of chromium. •Shapcott (1977) found contaminating chromium in acid used 
to digest samples which was not reported by Davidson (1972). 
Dry heating at greater than 500°C resulted in losses of 
"volatile chromium". Tuman (1978) reports that digestion with nitric acid 
and peroxide converts chromium to a non-volatile form and hence, by 
adopting the following formula, was able to measure volatile chromium 
which was equated to biological activity. 
Total Cr (acid pretreated) - Non-volatile Cr (no pretreatment) 
= volatile Cr 
Although corrections were made for chromium contamination in acid used 
for digestion, there is a change in matrix which would account for 
the differences (Kayne 1979). Seeling (1979), using the procedure 
of Tuman but with a tantalum cup, found no differences or indications 
of volatile chromium. 
Gorsuch (1959) and McClendon (1978) report losses associated 
with wet ashing of material with perchloric acid. This is almost 
certainly due to the formation of chloroxy-chromium compounds which 
would sublime, resulting in losses (Kumpulainen 1979). Kumpulainen 
experienced difficulty with NBS brewers' yeast SRM-1569 due to acid 
insoluble silicates strongly absorbing the analyte from the digestion 
but found no volatility during dry ashing. 
Kumpulainen (1980) stresses the importance of avoiding 
contamination during sampling of urine and human milk. As doubts 
have been raised concerning the significance of the trace element 
content of hair as an indicator of nutritional status (Bradfield and 
Hambridge 1980, Assarian and Oberleas 1977, Spivey-Fox and Tao 1981), 
Kumpulainen et aZ (1982) and Salmela et al (1981) used a variety of 
solvents and detergents to remove contaminating chromium from samples 
prior to analysis. Success with washing with lauryl sulphate may 
lead to further attempts to determine hair chromium with a view to 
establishing chromium deficiency.. Mild cleaning procedures before 
chromium determination by neutron activation analysis, resulted in 
a small difference being found in the chromium content of scalp hair 
from normal and diabetic individuals (Tiefenbach 1979). 
Concluding this section, Iyengar et al (1982) find that 
there are still serious methodological problems in the determination 
of chromium in biological materials. The measure of volatile chromium 
has been shown to be an artefact of the methods employed. 
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1.11 CONCLUSION  
Although chromium supplementation in humans may not fulfill 
the rather optimistic hypothesis of McCarty (1980), there appears 
to be correlation between chromium and carbohydrate metabolism 
(Anderson 1981) and cardiovascular disease (Newman et al 1978). 
Mertz (1979) has stated that, "Although we have de-emphasised the 
nutritional importance of GTE, we are still convinced of the biochemical 
importance of GTE whatever it may be within the organism. So I think 
this will be one major key for the solution of our problems". 
The aim of this thesis is to investigate the chemical nature 
of GTE as it occurs in brewers' yeast and in active chromium coordination 
compounds. A yeast assay system has been developed for detecting GTE 
in fractions, however, when possible, the fractions have been submitted 
to Ms J. Sherriff to determine activity in the adipocyte assay. 
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CHAPTER -IO 
ANALYTICAL NETHODS  
2.1 INTRODUCTION  
2.1.1 Chromium determination and chromium deficiency  
Chromium deficient rats were raised by Ms J. Sherriff to 
provide tissue for the adipocyte assay for GTE activity (Chapter 5). 
As glucose tolerance tests to establish the chromium deficiency of 
the animals were unsuccessful (Sherriff, M.Sc. Thesis, 1983), the 
collection and analysis of rat urine for chromium determination was 
attempted. In a further attempt to establish chromium deficiency, 
whole body chromium determinations were carried out on the carcasses 
of rats killed after glucose tolerance tests. Although Jain et al (1981) 
found no difference in total tissue chromium (Chapter 1.4), it was hoped 
that the whole body determination may indicate some degree of deficiency 
when compared with chromium replete rats. The chromium levels in two 
batches of "16w chromium" food were determined and compared with the 
food supplied to normal colony rats. 
The problems associated with the determination of chromium 
by flameless atomic absorption spectrometry (AAS) has been discussed 
in Chapter 1.10. Samples requiring preconcentration, such as yeast 
medium, or desalting, were solvent extracted by an extraction procedure 
adapted from effluent techniques (Varian, 1975). As chromium does not 
readily form chelates suitable for solvent extraction (Stary, 1964), 
samples and standards were heated with the chelation agent prior to 
extraction. 
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The instrumentation and principles of operation of AAS has 
been well documented and will not be described (e.g. Lvov, 1970). 
2.1.2 Chemiluminescence  
Seitz et al (1972) and Chang et al (1980) report the 
determination of chromium III by chemiluminescence with a detection 
limit of 0.2ppb. The method was sensitive and specific for chromium III. 
The catalysis by metal ions of the oxidation of luminol by hydrogen 
peroxide is utilized by the method. In presence of excess reagents, 
the intensity of light emission is proportional to the metal 
concentration. The method reported by Seitz et al (1972) utilizes the 
kinetically slow rate of formation of Cr (EDTA) to remove interference 
by the metal ions which are rapidly complexed and hence not available 
as catalysts. 
2.2 METHODS  
2.2.1 Atomic absorption spectrophotometer  
The atomic absorption spectrophotometer (AAS) used for 
chromium determination was a single beam Varian Techtron Model 1000. 
A carbon rod atomizer (CRA 63) workhead had been incorporated beside 
the flame workhead in the instrument to facilitate changeover from 
one technique to the other. A deuterium square wave modulated 
background corrector (made by J. Jordan) was used with both flame 
and furnace atomization. The limit of correction was 0.9 absorbance 
units (AU). The hollow cathode lamp used for chromium determination 
was a multi-element lamp (Varian) and was generally operated at 
8-10mA. The chromium line at 357.9nm was used in preference to the 
more sensitive line at 425.4nm to improve background correction and 
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reduce incandescent noise (Section 2.2.1.1). A CRA mask was used 
along with aluminium foil placed in front of the photomultiplier in 
an attempt to further reduce incandescent noise. A larger than normal 
spectral bandwidth was necessary to permit the adjustment of the 
background corrector (SBW 1.0nm). 
The tube furnaces used in the CRA were coated with pyrolitic 
graphite. The tubes were plain thus restricting the maximum sample 
volume to lOpl. Frequent replacement of the tube furnaces was 
necessary due to the high atomization temperatures used (2 500°C). 
"High Purity" nitrogen with a flow rate of 1.0p//min was used as the 
sheath gas. Sample injection was achieved manually with a SGE micro-
syringe (0-15l) having disposable plastic capillary tips. 
• The original nebulizer in the instrument had been replaced 
by a Varian "adjustable tantalum nebulizer". Maximum sensitivity 
with an air/acetylene flame -was achieved by adjusting the flame so 
that it was rich in acetylene. Aspiration rates were adjusted to suit 
the chromium level and volume of the sample being analysed. 
The signal from the MS was recorded by a fast response 
Hitachi chart recorder (QPD 33) and a peak height detector (made by 
J. Jordan). The limits of detection using flame atomization were 
0.05 to 10.0 ppm for aqueous standards. Detection limits of 1.25 x 10 -10 
to 2.5 x 10 -9 g for chromium were found using the CRA furnace. 
The operating temperatures of the furnace were determined by reference 
to standard curves supplied by the manufacturer. 
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2.2.1.1 Technical problems associated with deuterium background  
correction and incandescent noise  
Continuous background correction is the preferred method 
for elements with analytical lines below 350nm. The hydrogen lamp 
intensity at greater than 350nm is low (Figure 2.1) thus a high 
gain was required resulting in increased noise. In order to zero 
the instrument with the corrector operating, a large spectral band 
width (SBW) was used to compensate for the low intensity of the 
hydrogen lamp. The use of high gain and large SBW is not conducive 
to maintaining a high signal ratio to unmodulated light originating 
from the furnace walls when operating at the high temperatures required 
for refractory elements. The overall result was increased baseline 
noise when using correction and a troublesome spike due to incandescent 
noise. 
2.2.1.2 Preparation of standards and glassware  
'grade volumetric flasks and bulb pipettes were used for 
preparation of standards and samples. The glassware was acid soaked 
in 10% nitric acid (AR, Univar), rinsed with deionized water three 
times and finally rinsed with two washings of deionized distilled water. 
All solutions were prepared with distilled deionized water and standard 
solutions were prepared by serial dilution of BDH chromium nitrate 
standard for AAS (1mg/m1). 
2.2.2 Digestion of samples  
A 101 yeast culture was grown in liquid yeast medium containing 
4.0ppm chromium (Chapter 4.2.2) and 2.5mCi of 51chromium (New England 
Nuclear). The yeast was harvested by centrifugation, air dried and 
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FIGURE 2.1 The hydrogen lamp spectrum and wavelength of the 
chromium line used. (a), (b) are examples of 
typical recorded outputs for chromium determination 
in an organic matrix by CRA-AAS with and without 
continuous correction. 
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ground to a powder. The yeast was then used toassessthe efficiency 
of wet digestion as compared to dry ashing at 500°C with sulphuric 
acid and hydrogen peroxide as described by Kumpulainen et al (1979). 
 
2.2.2.1 Dry ashing  
3 samples of 51Cr yeast of approximately 0.5 and 1.0g were 
weighed to the nearest 0.1mg into vitreosil crucibles. The crucibles 
(with lids) were heated to 500°C overnight in a clean muffle furnace 
(Analite Pty. Ltd.). 25p/ of concentrated sulphuric acid (Aristar, BDH) 
and 25pZ of hydrogen peroxide (Merck) were added to the ash which was 
then taken to dryness on a hot plate before returning the crucibles 
to the furnace for a further 2hrs. The ash was rinsed from the 
crucibles with 1.0N nitric acid (Aristar, BDH) into polyethylene 
y-counting tubes so that the final total volume was 2.0m1. The number 
of counts per minute (cpm) arising from the " -Cr were determined 
in a NaI well y-counter (Kontron MR 252). The results are presented 
in Table 2.3. 
2.2.2.2 Wet ashing  
Triplicate samples of 0.07 to 0.5g of "-Cr yeast were 
weighed to the nearest 0.1mg into acid washed 10m1 Kjeldahl flasks. 
1.0m1 of concentrated nitric acid was added to each flask along with 
acid washed boiling chips. The flasks were allowed to stand 
overnight at room temperature with the tops covered. The flasks were 
heated in a Kjeldahl digestor (Electrothermal) in a clean fume hood 
with a small filter funnel sitting in the neck of each flask to prevent 
loss of contents and contamination. An extra 1.0m1 of nitric acid 
was added to each flask and digestion continued until the evolution 
of fumes of nitrogen dioxide ceased and the volume of the contents 
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was reduced by half. The contents of the flask were diluted to 5.0m1 and 
2.0m1 aliquots were counted. The results are presented in Table 2.1. 
2.2.2.3 1-counting of digested samples  
In order to determine the % recovery of the isotope after 
digestion, equivalent amounts of the dry " -Cr yeast were weighed 
into 1-counting vials and a linear calibration curve of cpm vs grams 
of yeast was plotted. To determine the extent of self absorption, 
1001.1/ of 51Cr (30 000cpm) was pipetted onto 0.5g of dry yeast 
(without isotope) in a counting vial and the cpm compared with 
100111 of aqueous "-Cr. The vials were prepared in triplicate. 
2.2.3 Chromium determination in rat urine  
Rat urine was collected over a period of 24hrs from both 
"chromium deficient" and replete rats housed in plastic lined 
metabolic cages. Contamination of the urine with faeces and food 
were problems that were not overcome. 
51A aliquots of urine were injected into the CRA tube furnace 
with the following settings: 
Cycle Duration Temperature ( ° C)  
dry 35 sec 80 
ash 50 sec 900 
atomize 2 sec 2500 
The non-atomic absorption was determined using the deuterium lamp 
only and was found to be greater than could be corrected for (0.9AU) 
by the instrument. 
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2.0m1 aliquots of rat urine were digested with 2.0m1 of 
nitric acid (Aristar, BDH). The digestions were diluted to 5.0m1 
and chromium determined by standard addition using the CRA furnace. 
Reduction of non-atomic absorption was achieved but a high reagent 
blank (0.048g/m1) was found due to the chromium content of the BDH 
nitric acid. The analysis of chromium in urine was abandoned due 
to the collection problems and, for further analysis, Merck "suprapur" 
nitric acid was obtained (0.002ppm Cr). 
2.2.4 Whole body chromium determination  
The total body chromium of "chromium deficient" and replete 
rats was determined on eight rat carcasses provided by Ms J. Sherriff 
in a double blind study. The rats had been killed and intestinal 
tract removed. The bodies were dried in vitreosil evaporating dishes 
in a clean vented oven at 90°C over two days. The dried bodies were 
then ashed at 500°C in a clean muffle furnace (Analite Pty. Ltd.). 
The ash was finely ground and the total weight determined to the 
nearest 0.1g. The ashes were stored in polyethylene containers. As 
salt levels of digested ash were high, the following extraction and 
preconcentration was used. 
Duplicate homogeneous samples of ash (0.6g to nearest 0.1mg) 
from each ashed rat were taken and digested into 10m1 of nitric acid 
(Merck). The digest was diluted to approximately 10m1. 2.5m1 of 
freshly prepared 1% ammonium Ryrrolidine dithiocarbamate (APDC) was 
added and the pH adjusted to 6.0 with 1N ammonium hydroxide (AR, Univar). 
Chromium standards were treated in the same manner. The samples and 
standards were heated at 80 ° C for 2hrs to aid complexation. After 
cooling the flasks, 2.5m1 of water saturated methyl-isobutylketone, 
Merck (MIBK) was added and shaken for lmin before withdrawing the solvent. 
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The MIBK was aspirated into a pre-mix air/acetylene flame and the 
corrected signal recorded. The total chromium was calculated from 
the linear calibration curve (Table 2.2). 
 
2.2.5 Determination of chromium in rat food  
The chromium levels in two batches of Teklad "low chromium" 
rat food and pelletized rat food (supplied by Gibsons) were determined 
with NBS brewers' yeast SRM 1569 as reference material. The finely 
ground samples were air dried at 80°C. Triplicate samples of 
approximately 0.8g (to the nearest 0.1mg) were wet ashed in 
acid washed Kjeldahl flasks. On completion of digestion, the flask 
contents were diluted to 2.0m1. Standards and samples were aspirated 
and total chromium content calculated on a dry weight basis (Table 2.3). 
2.2.6 Determination of chromium in yeast medium  
The chromium level of freshly prepared liquid yeast medium•
and synthetic medium (Chapter 4.2) was determined by chelation with 
APDC and solvent extraction before the addition of chromium salts. 
The chromium levels of yeast culture medium after addition of chromium 
were sufficiently high (1.0-4.0ppM) to allow direct reading by AAS. 
The pH of 50m1 of medium was adjusted to 6.0 with 1N ammonium 
hydroxide (AR, Univar). 2.5ml of freshly prepared 1% APDC was added. 
Chromium standards were prepared and treated in the same manner. 
The samples and standards were heated at 80°C for 2hrs and, on cooling, 
were extracted with 5.0m1 of water saturated MIBK. 1011/ of the MIBK 
extract was injected slowly into the CRA with the drying cycle operating 
in order to prevent losses due to solvent creep. The following settings 
were used. 
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Cycle Duration Temperature (°C)  
dry 50 sec 50 
ash 20 sec 900 
atomize 2 sec 2500 
The results were calculated from the calibration curve (Table 2.4). 
 
2.2.7 Determination of chromium in GTE fractions  
The chromium content of concentrated fractions from yeast 
was determined by injection of 2-10111 directly into the CRA furnace. 
The samples were not pretreated and were diluted so that the chromium 
level was within the detection limits given in Section 2.2.1. Generally, 
two different dilutions were analyzed. Continuous background 
correction was used and was found to be adequate. The operating 
conditions were as follows. 
Cycle Duration . Temperature (°C)  
dry 50 sec 90 
ash 50 sec 900 
atomize 2 sec 2500 
2.2.8 The luminescence biometer and chromium determination  
A DuPont 760 luminescence biometer specifically designed 
for the measurement of ATP (adenosine triphosphate) by the firefly 
reaction was used in the determination of chromium III by chemilumin-
escence. The maximum light output of the sample over three seconds 
was displayed as a digital readout. The maximum volume of the 
reactants was restricted to 8001A. Activation of the instrument was 
automatic on injection of a reactant through a septum into the 
reaction vial. 
 
2.2.8.1 Reagents  
(i) 0.2M EDTA (ethylenediaminetetraacetic acid, AR, 
Univar) as stock solution. 
(ii) 0.1M KOH-H 3 B0 3 buffer. 6.189 of H 3 80 3 (Merck) 
was dissolved in 500m1 of distilled water and the pH adjusted to 10.6 
with 1.0N KOH (AK, Univar). 100m1 of stock EDTA was added to the 
buffer and the total volume adjusted to 1.01. 
(iii) Luminol. 18.0g of crystalline luminol (5-amino-
2,3-dihydro-1,4-phthalazinedione, Sigma) was dissolved in 100m1 of 
buffer. 
(iv) Peroxide. To 0.34m1 of 30% 4ydrogen peroxide (Merck) 
was added 1.0m1 of stock EDTA solution and the final volume adjusted 
to 10.0m1 with distilled water. 
2.2.8.2 Chemiluminescence assay 
500 11Z of luminol solution, 101.l of EDTA and 25011Z of sample 
were pipetted (Oxford automatic pipettes) into acid washed reaction 
vials. A vial was placed in the biometer and 441 of peroxide was 
injected with the syringe supplied with the instrument. 
Duplicate standards were pipetted into vials containing 
lOpl of EDTA. The vials were heated in a convection oven at 80°C 
for 60min and cooled before adding 500 11 Z of luminol reagent. The 
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bioluminescence was determined as described above (Figure 2.2). 
2.2.9 Determination of radioisotope activity  
2.2.9.1 "-chromium and 'carbon  
The preparation of individual counting standards will be 
described in sections of the thesis where the isotopes were used. 
Samples were generally counted for 10.0min and standards as well as 
blank vials, containing ACS II scintillation cocktail (Amersham) 
in the case of (3-counting, were routinely determined with the samples. 
The final concentration was determined by ratio. 15m1 of scintillation 
cocktail was routinely used so that the counting efficiency was the 
same for all samples. 
Samples and standards were prepared so that the upper limits 
of each counter were not exceeded over a period of 10.0min. 
(i) y-counter 
Kontron MR 252 with 1.75" NaI crystal 
Window preset for "'chromium 
Maximum counts 0.8 x 10 6 
% efficiency for y-radiation = 10.6 
(ii) (3-counter 
Beckman liquid scintillation system 
Maximum counts 1 x 10 6 
% efficiency for (3-radiation = 87 
Determination of the amount of label in dual isotope 
preparations was by the method of Olson (1977). The samples were 
recounted after a known period of time in excess of 7 days. 
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2.2.9.2 Detection of isotopes on chromatograms  
(i) Spark chamber 
Both 51 Cr and PT were detected on chromatograms using a 
Birchover Instruments spark chamber. 10% methane in argon was used 
as the counting gas and a high voltage of 1900V was applied to the 
coiled wires. The sparks were photographed by exposure to Polaroid 
film. At least 1 400dpm were required for the radioactivity to be 
detected. To aid in orientation of the photograph, 5pl spots of l 'C 
in benzoic acid were made on the corners of the chromatograms. 
(ii) X-Ray film 
Chromatograms which had been dried and not treated with 
visualization reagents (e.g. ninhydrin) were sandwiched with Kodak 
Medical X-Ray film (30 x 38cm) in X-Ray cassettes. Exposure time was 
varied according to the activity of the material on the chromatogram. 
The film was developed according to the manufacturers' instructions. 
2.3 RESULTS  
2.3.1 Ashing technique  
Dry wt. sample 
(mg) 
Total cpm 
51Cr 
% Response 
 
± standard error 
of estimate 
Wet ash - nitric 1 
I. 
.. 
i. 
Dry ash - 500°C 2 
.. 
70 
140 
370 
450 
500 
1000 
39 600 
70 250 
191 700 
233 270 
235 870 
455 390 
102 ± 3% 
102 ± 2.5% 
102 ± 2% 
103 ± 2% 
91 ± 2% 
80 ± 2% 
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1 2.0m1 of nitric acid. 2 500°C for 18hr before addition of sulphuric acid. 
TABLE 2.1 The recovery of 51 Cr after ashing of labelled brewers' yeast. 
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2.3.2 Self absorption  
100p1 aqueous standard siCr = 30 236cpm ± 4% 
100p/ standard + 0.5g dry yeast = 31 041cpm ± 4% 
2.3.3 Whole body chromium determination and rat food  
Sample No. 
Cr Replete 
Total Cr (pg) Sample No. 
Cr Deficient 
Total Cr (pg) 
14.3 
3
  
X
 >
-  N
I 
21.4 
C.-)  31.5 , 11.0 
1.5 10.8 
2.3 3.0 
TABLE 2.2 The determination of whole body chromium in rats 
fed Teklad "low chromium" diet and the diet + 
chromium acetate. B, C, W, X had been 
cannulated; the cannula plug was stainless steel. 
Sample g Cr/g dry wt. 
Teklad batch 1 0.46 ± 0.05 
Teklad batch 2 0.78 ± 0.05 
Gibsons 0.82± 0.05 
NBS yeast SRM 1569 2.10 ± 0.05 
TABLE 2.3 Chromium determination of Teklad "low chromium" 
diet and a normal colony rat diet (Gibsons). 
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2.3.4 Chromium levels in yeast medium 
Culture medium Cr (jig/m1) 
100m1 synthetic 0.002 
5.01" 0.001 
100m1 liquid yeast medium 0.020 
10.01 .. 0.020 
TABLE 2.4 The chromium concentration in synthetic 
yeast medium (Table 4.4 & 4.7) and 
liquid yeast medium (Table 4.3). 
2.3.5 Chemiluminescence standard curve for chromium III  
determination  
0 0.01 0.05 0.10 
Chromium III Concentration ( ppm ) 
Chromium/luminol 
1,— Chromium/EDTA/luminol 
FIGURE 2.2 The chemiluminescence assay for chromium III. 
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2.4 DISCUSSION  
2.4.1 Digestion of samples  
The results of wet and dry ashing are presented in Table 2.1. 
Losses of siCr occurred with the dry ashing technique due to the 
sulphuric acid "creeping" out of the crucible rather than drying. No 
losses were found on wet ashing of "-Cr yeast with nitric acid, thus 
wet ashing was used routinely. No significant counting errors due to 
self absorption of the isotope were found (Section 2.3.2). The practice 
of allowing the samples to stand overnight with acid before digestion, 
considerably reduced the viscosity of the samples and reduced charring 
and sputtering. Nitric acid was diluted by 50% for digestion of the 
Teklad "low chromium" diet as the high sugar content caused excessive 
foaming. 
It became apparent during an attempt to analyze rat urine, 
that low chromium acids should be used and the volume kept to a 
minimum for all digestions to avoid contamination. 
National Bureau of Standards reference material SRM 1569 
(a kind gift from the Cenovis Health Food Company) was analyzed in 
conjunction with rat food (Table 2.3). The mean result of three 
analyses was marginally less than the NBS certified value. Kumpulainen et al 
(1978) also reports values lower than the certified value for NBS 
brewers' yeast and attributed the problem to chromium being strongly 
bound to insoluble silicates not digested. 
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2.4.2 Chromium deficiency  
The analysis of rat urine was abandoned as a measure of 
chromium deficiency due to insurmountable difficulties in collecting 
urine without contamination from food or faeces (Section 2.2.3). 
Direct injection of urine into the CRA furnace was not an appropriate 
method for the AAS unit used since background correction was 
insufficient (Section 2.2.3) (Veillon et al 1981, Guthrie et al 1978). 
Had sufficient sample been available, digestion followed by desalting 
and concentration may have been successful. 
The analysis of the "low chromium" rat food revealed a 
higher level of chromium than calculated by the manufacturers (0.12ppm) 
and was actually little different to the diet supplied to normal 
colony rats, thus casting doubt on the chromium deficiency of the 
animals. Whole body chromium determination of replete rats (50ppm 
chromium added to Teklad diet) was found to be no different to that 
of deficient rats (Table 2.3.3), however, within the eight rat 
carcasses ashed, four had been cannulated and showed significantly 
higher body chromium levels, most likely due to contamination from 
the stainless steel cannula plug. 
2.4.3 Chromium in yeast culture medium 
The extraction procedure described in Section 2.2.6 using 
APDC and MIBK was successful as a preconcentration step in the analysis 
of freshly prepared culture medium. The chromium levels in the 
synthetic yeast medium were found to be 2ppb, thus the yeast 
subcultured in synthetic medium could be regarded as being chromium 
deficient. Chromium levels in the liquid yeast medium were found to be 
0.02ppm or 2Ong/ml. 
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2.4.4 Chromium determination by chemiluminescence  
The initial results obtained with the DuPont biometer 
(Figure 2.2) appeared promising with aqueous chromium III standards. 
Unfortunately, the instrument was not available for further work thus 
no data on samples was obtained. The method is reported as an 
alternative analytical method to MS and is potentially interesting 
for GTF studies as it is specific for chromium III. The adaption of 
the method of Seitz et al (1972) was successful, however, the detection 
limit was not as low as was expected. Recrystallization of the 
luminol as reported by Chang - et al(1980) and the replacement of EDTA 
by DTPA (diethylenetriaminepentaacetic acid) were considered as 
possible improvements to the method reported in Section 2.2.8. 
CHAPTER THREE 
CHROMATOGRAPHY  
3.1 INTRODUCTION  
Ion exchange chromatography (separation by charge) was 
first reported as a means of purifying GTE by Schwarz and Mertz (1959). 
The cation exchange resin was neutralized with ammonia to displace the 
active material. Mirsky et al (1980) report the fractionation of GTE 
by using an'anion exchange cellulose and then proceeding with cation 
exchange chromatography. Haylock et a/ (1982) report the use of a 
phosphate pH gradient to improve the separation of fractions from cation 
exchange chromatography. 
As multiple column chromatography involves concentration of 
the column eluant, volatile solvent systems were used throughout to 
prevent the concentration of large amounts of.salts which would have 
affected analysis, biological activity and been difficult to remove, as 
desalting by dialysis was not possible due to the low reported molecular 
weight of GTE (300-500 daltons, Saner, 1980). A range of volatile 
buffer systems has been reviewed by Dawson et al (1969). 
The use of gel filtration chromatography has been reported in 
the fractionation of GTE and the determination of molecular weight 
(Kumpulainen et al 1978, Toepfer et al 1977, Polansky et al 1977). 
Votava et al (1973) reported an aggregation process for GTE on the basis 
of the change in elution volume from Sephadex (dextran) with buffers of 
different ionic strength. 
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The use of high performance liquid chromatography (HPLC) 
as a means of fractionating GTE has been reported by Polansky and 
Anderson (1977) using a reverse phase system (C-18) but no details 
have been published. An evaluation of the reverse phase chromatography 
of peptides by HPLC has been published recently by Wehr et al (1982) 
and the use of the ion pairing reagent trifluoroacetate in the 
separation of peptides has been reported by Bishop et al (1981) and 
Isied et al (1982). The technique and theory of HPLC has been well 
documented (Snyder et al 1974). 
The use of paper chromatography and associated techniques 
has been well documented by Smith (1969). Paper chromatography was 
used by Toepfer et al (1977) to qualitatively compare fractions. The 
use of paper chromatography in this chapter includes the use of prepar-
ative chromatography for the purification of GTE. 
3.2 METHODS  
3.2.1 Column chromatography - detection and fraction collection  
The column eluate was passed through the 5mm absorbance 
cell of a LKB Uvicord II scanner (253nm) which was routinely adjusted 
to give 100% transmittance with the buffer used. 10m1 samples were 
collected by a LKB Ultrorac fraction collector. The transmittance was 
recorded with a Heathkit chart recorder. 
Detection of "'chromium was achieved by collecting fractions 
in y-counting vials and then transferring the vials to the Kontron 
MR 252 y-counter. Where chromium concentration was high (chromium 
complex preparation), a small portion of each fraction was aspirated 
into an atomic absorption spectrophotometer and the relative chromium 
content plotted. 
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3.2.2 Ion exchange chromatography  
(i) Dowex 50W-X8 (e): a cross linked polystyrene with 
sulphonyl functional groups (100-200 mesh, Bio Rad) was used batchwise, 
as described in Chapter 5.2.4, as it has been demonstrated that active 
material is sorbed by Dowex and can be displaced at high pH. When 
used for column chromatography, the resin was pre-swollen in distilled 
water before pouring into the column taking care to exclude air bubbles. 
The column was equilibrated at 4°C by eluting with three column volumes 
of water (gravity feed) before loading the sample at a pH of 3.9. 
Th'e active material was eluted with either ammonia or triethylamine/ 
acetate buffer (TEA). Where a linear gradient is reported, the gradient 
was generated by a Gradipore gradient mixer. Dowex resin was 
regenerated after use with 10% hydrochloric acid according to the 
manufacturer's instructions. 
(ii) Dowex 50W-X2 formate: was prepared by the technique 
reviewed by Smith (1969) for quantitation of todoamino acids. The 
resin (100-200 mesh) was washed with 1.0N ammonia (Univar) and then 
equilibrated with 0.2M ammonium formate buffer, pH 3.9. Elution by 
increasing ionic strength was unsuccessful but . a gradient from 1.0N 
formate to 0.5N ammonia, resulted in fractionation (Figure 5.5.1). 
The ammonium formate was removed from fractions by lypholization. 
(iii) Anion exchange cellulose DEAE 22 (Whatman) was 
thoroughly washed with 0.1N ammonia and 0.1N hydrochloric acid. The 
column was transferred to 4°C and washed with distilled water until 
no further absorbance at 253nm was detected. The column size was 
50mm x 400ram. A sample was loaded onto the DEAE 22 cellulose and eluted 
with water. The water eluant was passed directly onto a Dowex 50W-X8 (H
+
) 
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column which was connected in series with the DEAE cellulose column. 
The two columns were then disconnected and the strongly sorbed material 
was eluted from the DEAE cellulose with 1N hydrochloric acid and the 
eluant lypholized. The now separate Dowex column was eluted with 
ammonia as described in Chapter 5.2.4. 
Amphoteric material was fractionated with DEAE Sephadex 
(Pharmacia), a beaded ion exchange cellulose. The cellulose was 
supplied pre-swollen. The column was poured taking care to exclude 
air bubbles and was then equilibrated at 4°C with 0.25N ammonia before 
loading the sample. The fractions were eluted with a linear gradient 
from 0.25N ammonia to 1M acetic acid. Tightly sorbed material was 
displaced by 0.1N hydrochloric acid. 
3.2.3 Gel filtration  
Bio-Gel P, porous acrylamide beads (100 - 200 wet mesh, 
Bio Rad) columns were prepared, with different exclusion limit gels 
•and different column sizes being prepared in the same manner. The 
sample volume used was generally 5% of the total volume of the column. 
The gel was suspended in buffer (generally, 50mM ammonia), swirled and 
allowed to stand at room temperature for four hours. The swollen gel 
was then deaerated by aspiration and poured into a glass column 
which contained 25% of the total column volume of buffer. A plunger 
with filter was inserted into the column so that the filter was touching 
the gel. The column was then transferred to a 4°C room where it was 
equilibrated under operating conditions (gravity feed, head height 900mm) 
and stored to discourage bacterial growth. 
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Bio-Gel P6 (25mm x 400mm) was used in initial investigations 
for molecular weight determination. The void volume was determined with 
cytochrome c (2mg) and the column was calibrated with glucagon (5mg), 
vitamin B I 2 (lmg) and glutathione(5mg)which was detected by the addition 
of 5 drops of 2% sodium nitroprusside (Merck). The calibration was 
satisfactory using 50mM ammonia which also ensured that the samples 
which were ammonia soluble did not precipitate. 
A Bio-Gel P4 column (25mm x 900mm) was packed in an attempt 
to increase resolution and the amount of material which could be loaded. 
When volumes of material exceeded 5% of the column volume, the sample 
was divided and duplicate column runs were made. Calibration for 
molecular weight determination was only achieved at high triethylamine 
acetate (TEA) buffer concentrations (Table 3.1) and, as 50mM ammonia 
produced good resolution and was easily removed by lypholization 
compared with TEA, ammonia was used routinely and molecular weight 
determination discontinued. 
The use of Bio-Gel P2 was considered as a possible replacement 
for P4 but band spread was excessive (Table 3.2). Phenyl Sepharose 
C1-48 was considered,as separation by hydrophobic interaction may have 
been possible. The use of 0.05N ammonia and later, 1.0M TEA pH 6.3 
gradient to 0.05N ammonia, were both unsuccessful with little sample 
retention occurring. 
3.2.4 Paper chromatography  
Descending paper chromatography was used as a technique to 
qualitatively assess the purity of fractions after column chromatography. 
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The chromatography tanks used were glass 210mm x 550mm and 
550m high with tightly fitting ground glass lids. The solvent 
reservoirs (200m1) were supported in the top of the tank. 50m1 of 
solvent was poured into the bottom of the tank and allowed to equilibrate 
for several hours before suspending the paper from the reservoir and 
allowing the paper to equilibrate prior to filling the reservoir. 
The chromatography paper used was Whatman 3 MM medium flow, 0.3mm thick 
and 455 x 570mm in area. 
The paper was prepared for development by placing 5111 spots of 
sample every 20mm 'across the paper 100mm from the bottom edge (reservoir 
edge). The edge to which the solvent travels was trimmed with pinking 
shears to encourage even solvent flow. Paper for preparative chromato-
graphy was thoroughly washed with 0.2N ammonia and air dried before 
applying 0.5m1 of sample across the origin as a streak (100mm from the 
reservoir edge) and drying. 
The chromatograms were removed from the tanks after elution 
for 18hrs and suspended in a vented oven at 40°C. 
When the papers were dry, they were examined for absorption 
or fluorescence with UV light (254nm, 360nm) or radioactivity (Chapter 
2.2.9.2). Detection with ninhydrin (0.2% in acetone applied as a spray) 
was satisfactory and used routinely. Spray reagents were used on a 
thin strip cut from each edge of preparative chromatograms. 
The preparative chromatograms were cut into strips, each strip 
containing a separated compound. The strips were placed into a descending 
chromatography tank and eluted with 0.1N ammonia. The eluant was 
collected directly into freeze drying pots and the samples then lypholized. 
Solvent systems  
(i) n-butanol 200m1 
glacial acetic acid 50m1 
distilled water 250m1 
The two phase system was prepared by shaking the solvents 
in a separating funnel and allowing the layers to equilibrate and 
separate over one hour before discarding the aqueous phase. 
(ii) iso-propanol 140m1 
ammonia 40m1 
water 10m1 
3.2.5 High performance liquid chromatography  
Chromatography was performed on a system consisting of two 
Water Associates M-6000 A solvent delivery pumps with Model 660 solvent 
programmer and U6K injector. The column used was a radially compressed 
reverse phase column - 51dm C-18 packing in a RCM 100 compression unit. 
Detection was at 260nm and 220nm with a Model 440 absorbance detector 
and a variable wavelength detector made by Mr J. Jordan of the 
Biochemistry Department. Refractive index was also recorded after 
optical measurement with a Waters differential refractometer. 
Initial investigation using relatively impure fractions 
from a 101 culture indicated that a 10pm reverse phase column with a 
70:30 methanol/water mobile phase (isocratic) may be satisfactory. 
Nicotinic acid and nicotinamide were used as model substances to 
develop the system. 
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With purification of sample 2 e (Figure 5.5.3) it became 
apparent that no pyridine ring structure was present (lack of UV 
absorbance) and the model was changed to that of the separation of 
peptides as 2 e was ninhydrin positive. Glu-gly, cys-gly (Serva), 
glutathione (Sigma) and oxidized glutathione were prepared (1mg/m1) 
and 11a of each mixed in a syringe (10111, pressure Lok) and injected. 
The mixture was resolved with a radially compressed 5pm C-18 column 
with an aqueous phase containing 0.3% trifluoroacetate (BDH) ion-
pairing reagent. Fraction 2 e when injected into the system, was 
not retained and was eluted at the void volume. Manipulation of the 
mobile phase by addition of methanol, acetonitrile, acetic acid and 
ammonia did not improve retention. 
3.3 RESULTS  
The molecular weights of active fractions 3 and 4 (Figure 5.3) 
were found to be 1180 and 960 daltons respectively by using a Bio-Gel P4 
column and 50mM ammonia. The initial use of HPLC with a reverse phase 
C-18 packing and 70:30 methanol/water mobile phase indicated a high 
degree of impurity with at least eight different peaks being detected. 
Calibration 
compound 
MW 
V e 
50mM NH 
V e 
260mM TEA 7.5 
Vo ' pH V o 
flavin mononucleotide 478 0.95 - 
NAD 663 1.11 2.58 
riboflavin 375 1.65 - 
vitamin 8 12 1 355 2.42 2.20 
nicotinamide 122 3.62 3.42 
TABLE 3.1 The ratio of elution volume to void volume of compounds used 
as calibration markers on Bio-Gel P4 (25mm x 900mm) in 
buffers of differing ionic strength. Flow rate = 30m1/hr. 
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Bio-Gel 
No. of theoretical 
plates 
Column volume 
(ml) )
Exclusion limit 
(daltons) 
P2 
P4 
P6 
105 
657 
573 
470 
375 
177 
1 800 
. 3 600 
4 600 
TABLE 3.2 The number of theoretical plates calculated from the 
bandspread of lmg of vitamin B12 in 50mM ammonia. 
Results of column chromatography and paper chromatography 
as used in the separation of GTE are presented along with extraction 
data in Chapter 5. The Rf values of various substances in the systems 
finally used are presented in Table 3.3. 
Solvent system Compound Rf 
butanol/acetic glycine 0.23 
I, 
n 
tyramine 
nicotinic acid 
0.64 
0.75 
u glu-gly 0.26 
.. (ox.) cys-gly 0.10 
iso-propanol/NH 3 glycine 0.15 
II nicotinic acid 
_ 
0.47 
ti n-methyl-adenosine 0.58 
TABLE 3.3 The Rf values of known compounds on paper 
chromatograms in the solvent systems 
indicated. 
The use of absorption and fluorescence under UV light and the 
use of ninhydrin was found to be satisfactory for visualization of 
developed chromatograms. Spraying with o-phthalaldehyde followed by 
inspection at 254nm (Benson et al 1975), for the detection of primary 
amines, yielded no additional information although the method was found 
to be more sensitive than ninhydrin. The use of p-anisidine/phthalic 
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acid (sugar detection), Ehrlichs' reagent (indoles) and benzidine 
reagent (sugars) did not give a positive result with active material. 
Compounds on chromatograms were detected non-specifically by heating 
the paper to 230°C, insufficient to char the paper, and then examining 
at 360nm (Alperin, 1982). No additional compounds were found by this 
method which proved to be sensitive. An example of a developed chromato-
gram is given in Figure 3.1. 
3.4 DISCUSSION  
The use of an ammonium formate pH gradient was found to 
increase the number of fractions eluted from yeast extract sorbed to 
cation exchange resin (Figure 5.5.1). Active material was strongly 
sorbed to cation exchange resin in agreement with Mertz and Schwarz (1959) 
and difficult to displace, implying that GTE is a highly charged cationic 
complex. 
Bonilla (1969) and Khym (1974) reported excellent separation 
of basic proteins, ribonucleotides, ribonucleosides and purine and 
pyrimidine bases with low exclusion limit polyacrylamide gels when 
a low ionic strength alkaline buffer was used. Separation was by 
sorption rather than difference in migration rate. Schwartz et al (1965) 
report the use of Bio-Gel P2 for the separation of yeast ribonucletc 
acid. The same phenomena was observed using Bio-Gel P4 for fractionation 
of yeast extract. High concentrations of triethylamine acetate were 
necessary to obtain a linear calibration plot of Ve/Vo vs logi o MW. 
As the active complex appeared to be highly charged, it was uncertain 
that the buffer concentration was high enough to suppress the sorption 
effect. Dilute ammonia was used, thus utilizing the sorption effect for 
fractionation rather than trying to suppress it. 
0000 
Rf 
0.75 
0.55 
0.48 
Ninhydrin positive 
UV absorbing 
UV fluorescent 
0.13 
Origin 
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FIGURE 3.1 An example of a quantitative paper chromatogram developed 
in butanol/acetic acid. Samples 1-6 were from Bio-Gel P4, 
3 and 4 were biologically active. Free nicotinic acid 
with an Rf of 0.75 was detected by absorbance and presence 
of radioactivity. 
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The aggregation effect reported by Votava et a/ (1973) would 
seem to be a sorption effect and not "reversible aggregation" as 
reported, since Khym (1974) has reported similar sorption effects with 
modified dextrans such as the Sephadex used. Stanch and Blincoe (1982) 
report an anionic chromium containing complex with a high affinity 
for column packings (Chapter 1.8.2). 
Fractionation by HPLC was unsuccessful as no retention of 
the active material on the C-18 column was achieved, even with high 
concentrations of ion-pairing reagent. Close examination of the results 
reported by Bishop et al (1981), who used a similar system, revealed 
that, of the peptides reported, gly-gly-lys tri-peptide eluted at 
2.3ml which appeared to be the void volume of the system. The basic 
amino acid, lysine, would seem to have been responsible for the loss of 
retention as all other peptides reported were either neutral or acidic. 
Another mechanism other than hydrophobicity may be involved as 
Iseid (1982) reports the separation of positively charged cobalt III 
peptide complexes using trifluoroacetate counter ions. 
Preparative chromatography was used for the final fractionation 
of yeast extract due to the lack of success with high performance 
liquid chromatography and was found to be satisfactory. The Rf value of 
nicotinic acid was found to be 0.75 in butanol/acetic acid and was well 
separated from other components. The active material of Toepfer et a/ 
(1977), common to both the synthetic preparation and the yeast preparation 
would almost certainly be free nicotinic acid with a reported Rf of 0.78 
and activity in the adipocyte assay (Sherriff, MSc thesis, 1983). 
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3.5 CONCLUSION  
GTF was fractionated by column and paper chromatography. 
The methods are reported in this chapter with the fractionation of 
yeast extract being reported in Chapter 5. 
CHAPTER FOUR 
YEAST MAINTENANCE AND GTF ASSAY  
4.1 INTRODUCTION  
4.1.1 Taxonomy  
Various yeasts were referred to in Chapter 1 as brewers' 
yeast. Torula yeast was found by Schwarz (1951) not to contain the 
prophylactic factor 3 present in debittered brewers' yeast. Mirsky 
et al (1980) report the response of Saccharomyces cerevisiae, 
Sacch. ellipsoideus, and Sacch. carlsbergensis to GTE. Recent changes 
in taxonomy have occured due to advances in the knowledge of microfungi 
and a brief discussion is warranted to clarify the different names 
used in the literature. 
Torula yeast used as rat feed in GTE deficient diets was 
most likely to be ToruZopis utilis, now Candida utilis (Ladder 1970). 
C. utilis has been used as a foodstuff on a commercial scale as it is 
undiscriminating in its nutritional demands and grows rapidly. 
Although C. utilis has a fermatative ability, it is not as strong as 
genus Saccharomyces (Cook 1954). 
Until the end of the 19th century, surplus brewers' yeast 
was used to leaven bread dough. Sacch. cerevisiae and Sacch. 
carZsbergensis have long been recognized as two brewing species where 
the former includes top fermenting or ale producing strains and the 
latter are bottom fermenting or lager producing strains. Sacch. uvarum 
became the correct name for all strains previously known as Sacch. 
carlsbergensis and Sacch. uvarum. Recently, all strains of Sacch. 
uvarum are now strains of Sacch. cerevisiae (Barnett 1979). 
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Metabolic differences between genera Candida and Saccharomyces 
are most pronounced in glucose metabolism with 0-30% glucose 
metabolized aerobically via the hexose monophosphate pathway by 
Sacch. cerevisiae and 30-50% by C. utilis Chang and Peterson (1949) 
showed that C. utilis neither required or accumulated biotin whereas, 
Sacch. cerevisiae accumulated biotin and would not grow unless 0.2ppm 
was present in the medium. 
For purposes of the yeast assay system discussed in this 
chapter, a pure strain of Sacch. uvarum catalogue number NCYC 529 
was subcultured, the original slope was kindly provided by the 
Australian Brewers' Association. Large cultures grown for extraction 
were inoculated with wort freshly obtained from Cascade Breweries. 
A pure strain of Sacch. cerevisiae (formerly Sacch. ellipsoideus) 
was a kind gift from Dr' L. Blackwell (Massey University, Palmerston 
North, New Zealand). To avoid confusion, yeast strains referred to from 
the literature will be named as reported by the authors. 
4.1.2 Fermentation  
The anaerobic metabolism of hexoses by living yeast can 
be expressed by the Gay-Lussac equation first put forward in 1815 and 
accounts for approximately 95% of glucose metabolised. 
C6H12 06 
 
2 C 2 H 5OH + 2 CO 2 
 
The remaining 5% is converted mainly into cell carbohydrates and 
succinic acid. Most efficient conversion to carbon dioxide takes place 
at pH 5.8 to 6.0 (Cook 1958). If the pH is raised into the alkaline 
region, ethanol, acetic acid, glycerol and carbon dioxide are produced. 
The steps of glycolysis in yeast leading to pyruvate, are the same 
as those in muscle, however, yeast contains pyruvate decarboxylase 
and alcohol dehydrogenase but lacks lactate dehydrogenase. 
It was been observed in fermentation experiments, that the 
yield of carbon dioxide can be appreciably less than theoretical. 
Liener and Buchanan (1951) have shown by isotopic techniques that 
growing cells can obtain up to 5% of their carbon requirements by 
assimilating carbon dioxide. Yeast can also grow aerobically in 
media containing ethanol or acetate as the sole carbon source. 
4.1.3 Yeast Assay  
The yeast assay to be described is derived from the observa-
tions of Burkeholder and Mertz (1966) and Mirsky, Weiss and Dori (1980). 
Burkeholder and Mertz report a doubling of carbon dioxide production 
after four fours in presence of 10Ong chromium III per ml but depressed 
fermentation with 10 000ng. Chromium deficient cells (Sacch. 
carlsbergensis) were used in fresh medium. A nitrogen atmosphere was 
used with 1 x 10 8 cells in 2m1 of phosphate butter at 25°C and pH 3.5. 
Glucose in the Warburg flask was 2.8mM. Little difference was seen 
between the control and chromium containing flasks without a 16hour 
incubation prior to the experiment. GTE containing fractions produced 
a response in the first 10-20minutes without preincubation, the greatest 
effect reported being 46% increase in carbon dioxide production. 
Mirsky et al (1980) used 3 x 10 8 cells/ml, a nitrogen 
atmosphere and 0.1M phosphate buffer at pH 5.7 and 30°C, with 20mM 
glucose. The cells were preincubated at room temperature before each 
fermentation experiment for 30min to ensure consumption of endogenous 
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substrates. Anaerobic preincubation of the cells with glucose was 
found to be required to produce an immediate effect of GTE. GTF 
stimulated the production of carbon dioxide. Vitamins that may have 
been present in GTF containing fractions, had no effect on fermentation. 
Simple chromium salts were also found to be ineffective. At 120min 
fermentation, a 111% increase over control was reported for Sacch. 
carlsbergensis being a total production of 11.4pM carbon dioxide/3 x 10' 
cells with 20.2pM/3 x 10 7 cells being produced by Sacch. ellipsoideus. 
Haylock et al (1982), when optimizing the standard yeast 
assay for screening fractions for GTE activity, found cell number, 
conductivity, pH and glucose concentration could be varied to increase 
the response to GTE. Furthermore, Mirsky et al (1980) presented data 
showing different responses of various strains of yeast to yeast GTE 
fractions. A summary of published conditions is tabulated below 
(Table 4.1). 
Author Strain 
Cell No. 
(cells in 
test vol.) 
Temp. 
(°C) pH 
Glucose 
(pmoles in 
test vol.) 
CO 2/2hr 
Control 
(moles) 
Burkeholder & 
Mertz (1966) S. carlsbergensis 1 x 10 8 25 3.5 11.1 33 
Mirsky et al 
(1980) S. carlsbergensis 3 x 10 8 30 5.7 50 5.4 
It S. cerevisiae 6 x 10 8 30 5.7 50 21.8 
II S. eZlipsoideus 3 x 10 7 30 5.7 12.5 9.76 
Haylock et al 
(1982) S. cerevisiae 1.5 x 10' 30 5.75 55.6 2.2 
TABLE 4.1 Yeast fermentation conditions for detection of GTE active 
fractions (all anaerobic). 
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Based on these previously published assays, it was decided to use 
U-"C labelled glucose as the substrate to measure "CO 2 produced 
radiometrically and also to see whether stoichometric amounts of ethanol 
(measured enzymatically) were produced. The development of such an 
assay is the subject of Section 4.3. 
4.2 METHODS  
4.2.1 Yeast culture  
A pure strain of Saccharomyces cerevisiae (Sacch. carlsbergensis) 
catalogue No. NCYC 529, provided by the Australian Brewers' Association, 
was maintained on a solid yeast morphology medium (Table 4.2). For 
purposes of the yeast assay, the pure strain was serial subcultured 
aseptically in 100m1 of sterile chromium-free medium (Table 4.4). 
Where possible, all chemicals were analytical grade. Cultures were 
inoculated with 6 x 10' cells per 100m1 culture and grown aerobically 
at 18°C. Two days growth were sufficient to provide cells for the 
GTE assay. The strain Sacch. ellipsoideus was maintained in the same way. 
Yeast for growth of a large culture (2007.) was obtained from 
Cascade Breweries as three day old wort. The wort was centrifuged 
(2 000xg - MSE Mistral 6L) and the supernatant discarded. The remaining 
yeast was washed twice with distilled water and centrifuged (500xg) 
to remove hop residues, then at 2 000xg for 10min. The washed cells 
were resuspended and used to inoculate preparative cultures (Section 
4.2.3). Cascade yeast was also serial subcultured in liquid yeast 
medium (Table 4.3). 
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Malt Extract (Difco) 1.0g 
Yeast Extract Powder (Oxoid) 0.2g 
Bactopeptone (Difco) 1.0g 
Maltose (Difco) 1.0g 
Glycerol (Sigma) 0.2g 
Potassium dihydrogenphosphate 
(Univar, AR) 50mg 
Ammonium sulphate (Univar, AR) 50mg 
The above dissolved in 100m1 distilled water 
pH adjusted to 5.0, then 
Agar (Difco) 1.5g 
Sterilized by heat. 
TABLE 4.2 Solid medium for maintenance. 
Bactopeptone (Difco) 5.0g 
Yeast Extract (Oxoid) 2.0g 
Glucose (Ajax, AR - anhydrous) 40.0g 
Potassium dihydrogenphosphate 
(May & Baker, AR) 0.2g 
Ammonium sulphate (Univar, AR) 1.0g 
Final pH adjusted to 5.5 after dissolving in 
1.01 deionized water. 
TABLE 4.3 Liquid yeast medium. 
5.0g Asparagine (anhydrous, Sigma) 
Casamino acids (Difco, acid hydrolysed 
casein) 
Glucose (anhydrous, Ajax, AR) 
Magnesium sulphate (Univar, AR) 
Ammonium phosphate (Univar, AR) 
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Potassium dihydrogenphosphate 
(May & Baker, AR) 0.5g 
Calcium chloride (Univar, AR) 0.2g 
The above dissolved in 1.01 of distilled 
water, pH adjusted to 5.5 and autoclaved. 
Then, 
Sterile Vitamin Mix (Table 4.5) 1.0m1 
Iron citrate (0.9% w/v) 0. 1m 1 
Trace metal mix when required 
(Table 4.6) 1.0m1 
TABLE 4.4 Chromium deficient synthetic medium 
(based on Difco morphological 
medium). 
Inositol (meso, BDH) 10mg 
Calcium pantothenate (Kock-Light) 10mg 
Biotin (D-cryst., Kock-Light) 2mg 
Thiamine hydrochloride (Kock-Light) 10mg 
Pyridoxine hydrochloride (BDH) 10mg 
Nicotinamide (Sigma) 10mg 
The above dissolved in 100m1 and sterilized 
by autoclave. 
TABLE 4.5 Vitamin mix. 
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Copper sulphate hydrate (Univar, AR) 19.6mg 
Zinc sulphate hydrate (Univar, AR) 1570.0mg 
Cobaltous chloride hydrate (Sigma) 20.0mg 
Manganous chloride hydrate 
(Univar, AR) 360.0mg 
Sodium molybdate (BDH) 12.6mg 
The above dissolved in 1.01 and sterilized by 
autoclave. lml of trace metal mix was added 
to 1.01 of chromium deficient synthetic medium 
and, where indicated, 0.1m1 was added to 100m1 
of phosphate buffer. 
TABLE 4.6 Trace metal mix 
(A) Ammonium sulphate (Univar, AR) 
Asparagine (anhydrous, Sigma) 
Glucose (anhydrous, Ajax, AR) 
Casamino acids (acid hydrolysed 
casein, Difco) 
Cysteine hydrochloride (Ajax) 
Potassium chloride (BDH, AR) 
Sodium chloride (BDH, AR) 
Magnesium sulphate (Univar, AR) 
Calcium chloride (Univar, AR) 
Potassium dihydrogenphosphate 
(May & Baker, AR) 
75 
90.0g 
5.0g 
200.0g 
1.0g 
0.1g 
2.0g 
2.09 
10.0g 
0.2g 
20.0g 
The above made to approximately 151 and pH 
adjusted to 5.5 and sterilized by autoclave. 
(B) Trace elements 
Boric acid (Univar, AR) 100mg 
Copper sulphate hydrate (Univar, AR) 8mg 
Ferric chloride 40mg 
Manganous sulphate hydrate (Univar, AR) 80mg 
*Sodium molybdate (BDH) 40mg 
Zinc sulphate (Univar, AR) 80mg 
*Potassium iodide (Univar, AR) 20mg 
*added separately, the remaining salts were 
dissolved in 100m1 and added to (A). 
(C) Vitamins (autoclaved separately) 
Biotin (D-cryst., Kock-Light) lmg 
Calcium pantothenate (Kock-Light) 80mg 
Inositol (meso, BDH) 400mg 
Thiamine hydrochloride (Kock-Light) 80mg 
Pyridoxine hydrochloride (BDH) 80mg 
Riboflavin (BDH) 40mg 
Folic acid (BDH) lmg 
The above are dissolved in 500m1, sterilized 
by autoclave and added to (A) aseptically. 
The total volume of the culture medium is 201. 
TABLE 4.7 Synthetic medium for large scale 
yeast cultures (5-2000. 
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4.2.2 Growth of Cascade brewers' yeast in liquid yeast medium  
The growth of only one culture will be reported as the 
method was essentially the same for all grown on the bactopeptone 
based liquid yeast medium. Where differences exist between cultures 
extracted, the differences will be indicated in Chapter 5. 
9.01 of liquid yeast medium (Table 4.3) were prepared and 
sterilized by autoclave in a 101 flat bottomed pyrex flask containing 
a 75mm stirring bar. When the flask had cooled, it was fitted with 
a sterilized brewers' air trap. The flask was placed on top of a 
"Magnetic 9x9" stirrer (Coleman Industries) and the stirring rate 
adjusted to approximately 200rpm. A three day old culture of chromium 
deficient yeast grown in liquid yeast medium (3.8 x 10' cells) was used 
to . inoculate the 9.0Z of medium. The culture was grown at 18°C in a 
constant temperature cabinet. 
'chromium acetate was prepared by dissolving 44.0mg of 
chromium acetate (Hopkin and Williams) in 10.0m1 of water containing 
10mCi of carrier free "chromium (New England Nuclear). 9.0m1 of the 
preparation was added to the growing culture. The chromium concentration 
in the medium was calculated to be lmg/Z and the activity of the isotope 
was 1pCi/11g chromium. "chromium acetate standard for y-counting was 
prepared by diluting 100pZ to 100m1 with 0.3N acetic acid. A 100pZ 
aliquot of the dilution was sealed in a polycarbonate counting tube 
(Disposable Products Australia) and was used as a standard. 
After three days growth, 100g of anhydrous glucose (Univar, 
AR) and 100mg each of cysteine hydrochloride (Ajax) and reduced 
glutathione (crystalline, Sigma) were added to the culture. The same 
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additions were made on day 5. The culture was harvested when the 
cell number reached 2.20 x 10 7 cells/ml. The culture was harvested 
by pouring the culture into 1.51 polyethylene centrifuge pots and 
separating the cells by centrifugation at 2000xg (MSE Mistral 60. 
The wet weight of the yeast pellet was determined by difference. 
4.2.3 The growth of a 2001 culture  
2001 of synthetic culture medium was prepared as shown in 
Table 4.7 omitting sterilization, as the volume was too great. The 
medium was contained in a fibreglass container (400mm dia. x 930mm) 
with a close fitting lid having a brewers' air trap. The vessel was 
sterilized by irradiation with a "Germicide" UV light for 16hrs and 
the salts were dissolved in deionized water sterilized by filtration 
through a 0.2m Millipore filter. The container was supported over a 
"Magnetic 9x9" stirrer (Coleman Industries). The preparation of the 
yeast that was used to inoculate the culture has been described in 
Section 4.2. The culture was grown at room temperature (20-25°C). 
The cell concentration after inoculation was 0.7 x 10' cells/ml. The 
stirring rate was adjusted so that the cells were evenly suspended in 
the medium. 
Both 51 chromium and 14C-nicotinic acid were added to the 
culture. 880.0mg of chromium acetate was dissolved in 20.0m1 of 
distilled water containing 0.4m1 of 51 chromium (1000pCi, carrier free, 
New England Nuclear). 0.1m1 of the 51 chromium acetate was reserved as 
a standard for y-counting. The final 51 chromium concentration of the 
culture was 1.0mg/Z with the activity of the isotope being 0.005pCi/pg Cr. 
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The 14C-nicotinic acid, labelled in the carboxyl group, was 
prepared as follows. 400.0mg of nicotinic acid (anhydrous, Sigma) 
were dissolved in 20.0m1 of water containing 250pCi of carrier free 
14C-nicotinic acid (New England Nuclear) and pH adjusted to 5.5 with 
1M TRIS (Ultrol). A 8-counting standard was prepared by diluting 
25p1 of the 20.0m1 solution to 5.0m1. The remainder of the solution 
was added to the culture. 
Samples were withdrawn during the growth of the culture and 
extra glucose additions were made when required as determined by 
testing the supernatant with Labstix (Ames, lower limit of detection 0.25%). 
The results of cell determinations and the additions to the culture 
are tabulated in Section 4:4.1. 
Prior to harvesting (8 days growth), stirring was stopped and 
the cells were allowed to settle. Cells still in suspension were removed 
from the supernatant by centrifugation at 6000xg with a continuous flow 
head fitted to a Sorvall SS40 centrifuge. The supernatant was pumped 
through the centrifuge head with a peristaltic pump at approximately 
11/min. 201 of the spent medium was set aside for extraction with 
activated charcoal (Chapter 5). The cell slurry remaining in the bottom 
of the tank was harvested by centrifugation in 1.51 pots at 2000xg 
(MSE Mistral 60. The wet weight of the pellet was determined by 
difference. 
4.3 YEAST ASSAY  
Two day old chromium deficient yeast grown as described in 
Section 4.2 were centrifuged at 2000xg (GS 200 bench centrifuge, 
Clements) for 5min, the medium discarded and the cells resuspended in 
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an equivalent volume of 0.05M potassium phosphate buffer, pH 5.5. 
The cells were shaken overnight at room temperature (aerobic), at 
100rpm by a reciprocating shaker (Paton Industries) to deplete the 
cells of endogenous substrates. The yeast cells were evenly suspended 
and an aliquot taken and diluted lml in 200m1 of saline (0.9% sodium 
chloride, AR). The cell number in the dilution was determined by 
counting 0.5ml by Coulter Counter (Coulter Electronics) having an 
aperture of 100pm and impedance matched to the saline used (20kV) 
The particle count due to the saline was subtracted from the cell count 
and the total number of cells calculated. The cells were centrifuged 
(2000xg for 5min) and resuspended in a volume of phosphate buffer 
(0.05M, pH 5.5) such that the cell concentration was 2 x 10 cells/ml. 
The cells were continually stirred with a magnetic stirrer while 1.0m1 
aliquots were pipetted (Excalibur 0.2-1.0m1) into 25m1 glass scintillation 
vials (Australian Pharmaglass). 
Fractions to be tested were pipetted (Oxford Sampler 101'0 
into the vials containing the yeast and allowed to stand at room 
temperature for a preincubation period of lhour before adding labelled 
glucose. Duplicates of all test vials were prepared along with control 
vials without sample. During the preincubation, the vials were fitted 
with Clinbritic rubbers having a plastic centre well, a 1.10 x 38mm 
disposable hypodermic needle to introduce nitrogen, and a 1.23 x 13mm 
needle serving both-as an outlet for nitrogen and access for the syringe 
needle used to introduce glucose (Figure 4.1). A 15 x 15mm square of 
Whatman 3MM chromatography paper was placed in each centre well with 
1041 of 5.0N sodium hydroxide to absorb carbon dioxide produced during 
fermentation. 
Plastic centre well 
1.10 x 38 mm needle for N 2 
1.23 x 13m needle 
for glucose addition 
15 x 15 mm paper + 
sodium hydroxide 
Clinbritic rubber 
Glass scintillation vial 
1.0 ml of cell suspension 
introduction 
FIGURE 4.1 A fermentation vial for collection of carbon 
dioxide generated during the yeast assay. 
The vials were placed in a Metabolyte water bath/shaker 
(New Brunswick Scientific) at 30°C and shaken at 100rpm. "High Purity" 
nitrogen, water saturated by bubbling through a 250m1 drechsel bottle, 
was distributed to the vials via a manifold fitted with 250mm lengths 
of silicone tubing fitted with polyethylene connectors. Approximately 
100m1/min/vial of nitrogen was introduced for 10min to purge oxygen 
from the vial and displace dissolved oxygen in the cell suspension. 
To each vial, 10011/ of universally labelled ' LT-glucose 
(100pmoles, 0.3pCi/100pl, New England Nuclear) was introduced with a 
1041 SGE syringe taking care to avoid the centre well. The 13mm needle 
was withdrawn from the stopper and then the 38mm needle. The fermenta-
tion was stopped after 120min by introducing 0.2m1 of 3.0N sulphuric 
acid to the cell suspension by injecting through the stopper with 
a 1.23 x 13mm needle and 1.0m1 glass syringe. As approximately 80% of 
carbon dioxide evolved during fermentation was absorbed, the cells 
were shaken for a further hour to allow complete absorption. 
The vials were opened and the paper removed from the wells 
with forceps, and placed into plastic scintillation vials (Packard) 
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containing 1.0m1 of distilled water. A further 0.5m1 of water was 
used to rinse the wells, the washings being transferred to the scin-
tillation vials by pasteur pipette. The papers were allowed to stand 
for approximately lhour before adding 15m1 of ACS II aqueous 
scintillation cocktail (Amersham). The scintillation vials were shaken 
well before measuring 3-radiation in a Beckman Liquid Scintillation 
counter. Generally, 48hours were required for the phosphorescence of 
the blank vial (paper, 100111 5.0N NaOH, 1.5m1 water, 15ml scintillation 
fluid) to fall to background levels. 
To determine glucose and ethanol levels in the supernatant, 
the cell suspension was transferred to 15m1 conical centrifuge tubes, 
the vials were rinsed with 1.0m1 of phosphate buffer, and the cells 
were centrifuged at 2000xg for 5min. The supernatant was poured off 
and neutralized with 0.8m1 of 1M IRIS (Ultrol, Calbiochem). The 
final volume of supernatant was adjusted to 3.0m1. Aliquots were 
taken for ethanol determination by alcohol dehydrogenase assay 
(Boehringer 1970) and glucose determination by glucose oxidase method 
(Boehringer 1970). 
• l'Carbon fixed in the cells was determined after washing 
twice with phosphate buffer by resuspending the yeast pellets in 5.0m1 
of ACS II scintillation fluid and transferring into plastic 
scintillation vials with a further 10.0m1 of ACS II. 
4.3.1 Calculation of results from the yeast assay 
To enable the comparison of activities of different fractions, 
the results from each fraction were expressed as a percentage of a 
known active fraction which was used as a GTE control along with the 
control vials containing cells and glucose. The following formula 
was used to calculate the % of GTE control. 
average sample cpm - average control cpm 
x 100 
average GTE control cpm - average control cpm 
A short program was written to calculate the results. and 
present them in such a way that the printout was a record of the 
experiment when attached to a work sheet detailing the fractions 
tested in each vial. The computer system used was a Kontron PSI 80 
system interfaced with a Star DP8480 printer. 
Percentage response of a sample in relation to the control 
vials was calculated when required by the following formula: 
average sample cpm - average control cpm 
x100 
average control cpm - background cpm 
Calculation of carbon dioxide collected in terms of pmoles 
per 2 x 10 cells was by the ratio of cpm with background subtracted, 
with the ratio of glucose cpm having known concentration. It was 
assumed that the 14 C-carbon dioxide represented all of the carbon 
dioxide derived from the "C-glucose as the cells had been starved 
to deplete them of endogenous substrates. 
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:LIST 
10 PRINT CHR$(17);"DID YOU ACTIVATE $MX80 #3'-'"gCHR$(17) 
20 N1=3 
70 T=0 
40 INPUT "The date of assay"gA$ 
50 PRINT #3: TAB (30);"YEAST ASSAY ";A$ 
60 INPUT "CO2 blank value";B 
70 INPUT "Control values"gC , D 
80 E=((C+D)/2)-B 
90 INPUT "GTE controls"gC , D 
100 G=((C+D)/2)-B 
110 PRINT #3:"CONTROL="gE 
120 PRINT #7:"GTF CONTROL="gG 
125 PRINT #3: 
130 PRINT #3: "MEAN CPM-BG","% OF GTE CONTROL" , "RANGE","TEST NO." 
140 F=(1/(G-E))*100 
150 INPUT "Sample results";C , D 
160 P=((C+D)/2)-B 
170 P1=(P-E)+F 
180 S=((C-D)/2)*(1/P)4100 
190 PRINT #7:P, 
200 PRINT #3:USING"###.#" , PI , 
210 PRINT #3:USING"###.#",S, 
220 N1=N1+2 
230 N2=N1*1 
240 PRINT #3: TAB (60):N1g",":N2 
250 INPUT "ERROR (if error type 1)"gT 
260 IF T=1 THEN 270 ELSE 150 
270 N1=N1-2 
280 N2=N2-2 
290 GOTO 150 
300 END 
Ready 
YEAST ASSAY 10/12/82 
CONTROL= 14839 
GIF CONTROL= 24537 
MEAN CPM-BG % OF GTE CONTROL RANGE TEST NO. 
21714 70.9 0.2 5 , 6 
35757 211.6 0.0 7, 8 
15878 10.3 0.6 9 , 10 
21000 63.5 0.2 11, 12 
SECTION 4.3.1 The program used to calculate yeast assay results 
and an example of the final results presentation. 
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4.4 RESULTS  
4.4.1 Geometry of the assay system  
The final geometry of the yeast assay evolved from a series 
of prototypes. The needles selected allow unrestricted flow of 
nitrogen. Blockages resulting in vials not being purged of oxygen 
had previously been a problem in pilot systems. The size of the paper 
in the centre well was such that lOOi.iZ. of sodium hydroxide was absorbed 
and would not splash out of the well. Agitation sufficient to keep 
the cells suspended, and cell numbers were kept constant to enable 
the comparison of day to day results. The Clinbritic rubbers were 
found to self heal sufficiently well to allow reuse several times 
before discarding. Vials and centre wells were soaked in a solution 
of Pyroneg (Diversy) and rinsed with deionized water prior to use. 
4.4.2 Collection of carbon dioxide  
In order to assess the efficiency of the collection of 
carbon dioxide, vials were set up for a yeast assay but containing 
1.0m1 of water instead of yeast suspension and 100pmoles and 200pmoles 
of 14 C-sodium bicarbonate in place of glucose, -and the assay proceeded 
with as described in Section 4.3. 
pmoles HCO 3 - cpm added mean cpm recovered No. of vials 
100 
200 
138 
277 
596 
100 
+ 0.3% 
+ 0.2% 
138 
276 
034 
712 
+0.2% 
+ 0.2% 
4 , 
4 
TABLE 4.3 Recovery of 14 C-carbon dioxide generated during the yeast 
assay. 
Sodium hydroxide was found to be most suitable for 
absorbing carbon dioxide. Hyamine absorber (Sigma) containing 
methanol had been used in early experiments, however, the vapour was 
adversely affecting the yeast cells. The results indicate no losses 
of carbon dioxide (Table 4.8). 
4.4.3 Temperature  
Results at different temperatures for the control vials 
and vials containing the active fraction Y10 Seph. 7-23 (Chapter 5) 
were compiled and show that the greatest difference and hence greatest 
sensitivity was at 30°C (Figure 4.2). As condensation around the 
necks of the vials occurred at higher temperature, to avoid losses of 
''C-ethanol or contamination of the sodium hydroxide, temperatures 
higher than 30°C were not considered. 30°C was used routinely. 
50.0 
40.0 
30.0 
20.0 
10.0 
20 25 30°C 
Temperature 
o 2 x 10 7 cells + 40mM glucose. 
• 2 x 10 7 cells + 40mM glucose + GTE 
FIGURE 4.2 The effect of temperature on anaerobic 
fermentation. 
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4.4.4 Preincubation  
Chromium deficient yeasts were depleted and then incubated 
with and without glucose for 0-60min to determine the effect of 
preincubation on fermentation. The results are presented in Table 4.9. 
As the best response to the active fraction with preincubation 
was without glucose, and for 60min, the preincubation was used 
routinely. 
Time 
Preincubation 
without glucose 
Preincubation 
with 8pmoles glucose 
(min) pmoles ethanol % increase pmoles ethanol % increase 
Control 
0 
30 
60 
4.46 
5.42 
8.66 
14.00 
- 
21.5 
48.5 
213.9 
3.53 
7.16 
7.59 
9.38 
- 
03 
115 
166 
TABLE 4.9 The effect of preincubation on fermentation at 25°C , 
lOpmoles U-'C-glucose added to vials at the end of 
preincubation. 
4.4.5 Decline in yeast assay response and trace metal addition  
The glucose concentration had initially been 40mM for the 
yeast assay, hence the following results were not obtained using 100mM 
glucose as outlined in Section 4.3. A gradual decline in response to 
control GTF containing fractions over a period of more than a month 
was found from accumulated results (Figure 4.3). The loss of response 
did not correlate with the basal fermentation rate of control cells. 
As it had been reported that active fractions lose activity on storage 
(Chapter 1.8.3), the decline in response was attributed to loss of sample 
activity. The amount of GTE control (Sephacel 7-23) routinely used was 
100 
90 
80 
70 
60 
51) 
0 50 
40 
30 
20 
1 0 
5 10 
Weeks 
15 
FIGURE 4.3 The decline in the yeast assay response 
(40mM glucose, 25°C) to the GTE control 
fraction with time. 
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Dilution of GTE Control 
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considerably more than required to produce a maximum effect (Figure 4.4). 
It seemed that if the fraction was deteriorating, the concentration 
of GTE was being diminished and thus the saturation effect would not be 
observed. A 1 in 2 diultion was found to produce the same effect as 
the concentrate when the overall response of the yeast assay was 
reduced to 50% of the original after eight weeks, implying that the 
activity of the fraction had not diminished. It was thus thought that 
the yeast may have become insensitive to GTE due to a deficiency in 
the medium, and that the fractions were not deteriorating. 
FIGURE 4.4 The dose response of the yeast assay to the 
GTE control fraction. 1.0 = 101a of fraction. 
As zinc is known to be an essential cofactor of many enzymes 
involved in yeast metabolism (e.g. pyruvate carboxylase, alcohol 
dehydrogenase) and, as it was absent from the synthetic medium, a trace 
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metal mix was prepared and added to the synthetic medium (Table 4.6). 
Yeast from a slope rather than serial subcultured yeast, were used 
to innoculate the trace metal replete medium. An increase of 20% in 
response to the control GTE fraction resulted (Table 4.10). 
Temp. 
(°C) 
Trace metal 
addition 
Glucose 
(mM) % Response 
Duration 
of assay 
CO ' control 
vials 
(pmoles) 
30 
30 
- 
added 
40 
40 
61.2 
79.7 
2hr 
2hr 
30.9 
33.2 
25 
25 
' i 
ii 
40 
100 
64.5 
98.0 
2hr 
2hr 
33.8 
56.5 
TABLE 4.10 Enhancement of carbon dioxide production by GTE with 
variations in glucose concentration and trace metal 
addition. 
Although it was not conclusive that the trace metal mix 
was responsible for the increased response, and as no loss of sensitivity 
had occurred, the use of the trace metal mix was continued, providing 
the yeast with a more comprehensive medium. A beneficial result of 
trace metal addition was an increase in the total yield of cells per 
culture. 
4.4.6 Glucose concentration  
A glucose concentration of 40mM had been selected after pilot 
studies (with 8mM) had indicated that no glucose remained in the 
supernatant when an active sample was assayed. 40mM glucose was found 
to result in low supernatant glucose levels (4mM) in vials containing 
GTE after the response of the assay was increased by altering parameters 
which have been discussed. 
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The increase in glucose to 100mM resulted in an increased 
response (Table 4.10). When glucose levels remained high during the 
assay, no imbalances were found between the glucose used and carbon 
dioxide produced, and no indication was found that fermentable substrates 
that might be present in samples were interferring since, in the 
absence of U- 1 'C-glucose, the samples produced negligible 14 CO2. 
4.4.7 Specificity of the assay for GTE  
In order to establish that the fractions found to be active 
by the yeast assay did not contain an established compound that would 
cause a response, a range of compounds were tested for GTE activity 
(Table 4.11), including the vitamin mix used in the growth of large 
scale cultures. Of the compounds tested, ammonium chloride produced 
a small response. Ammonia produced a large response due to the 
increased pH of the cell suspension. It was thus apparent that care 
should be taken to ensure that all residual ammonia has been removed 
from ammonia eluted fractions concentrated by lypholization. 
Compound Concentration 
% Response 
over control 
Ammonia* 7.0mM 60 
Glycine 5.8mM nil 
Thiamine hydrochloride 0.1mM inhibitory 
Ammonium chloride 1.0mM 18 
poly-L-lysine 0.05mM inhibitory 
poly-DL-lysine 0.05mM inhibitory 
DL-Carnitine 0.06mM nil 
N-methyladenosine 0.2mM slightly inhibitory 
Vitamin mix 
t
10p/ nil 
Nicotinic acid 0.1mM nil 
Chromium 60mg/m1 nil 
* increase in pH of cell suspension to 6.75. 
The composition of the vitamin mix is presented in Tabel 4.7 (C). 
TABLE 4.11 The response of the yeast assay to various compounds 
that may have been present in fractions tested. 
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4.4.8 Sacch. ellipsoideus and yeast assay response  
The variety of yeast donated by Dr L. Blackwell was compared 
with the named strain described in Section 4.2. To avoid confusion, 
the variety will be referred to as Sacch. ellipsoideus. 
Coulter counting The sizing display on the Coulter Counter 
(Coulter Electronics) showed that Sacch. ellipsoideus had a narrow size 
distribution compared to the yeast used for the yeast assay. 
Microscope examination The cells were seen to be spheroidal 
in contrast to the Sacch. uvarum which were generally irregular and 
elliptical in shape with a broader size distribution. 
Mean diameter of Sacch. ellipsoideus = 5.0 x 10 -3 mm ± 0.8 x 10 -3 , n = 40 
Mean diameter of Sacch. uvarum 	= 6.7 x 10 -3 mm ± 1.1 x 10 -3 , n = 30 
Yeast 
Control 
(j.00les CO 2 ) 
GTE Control 
(pmoles CO 2 ) % Response 
Week 1 
Sacch. uvarum 
Sacch. ellipsoideus 
45.7 
14.0 
70.2 
24.4 
53.6 
74.3 
• 
Week 2 
Sacch. uvarum 
Sacch. ellipsoideus 
57.9 
19.7 
82.9 
32.8 
43.2 
66.5 
TABLE 4.12 The fermentation of the two varieties of yeast in 
consecutive assay. Both cultures were trace metal 
replete and chromium free. 
The greater response of the different strain to the control 
GTE fraction (Table 4.12) may be due to the fact that the cells had 
not been serial subcultured to the same extent as the cells with which 
they were compared. Bearing this in mind, it would seem that the 
Sacch. ellipsoideus responds to the same extent as the yeast usually 
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used in the assay. The most apparent difference was the lower rate of 
fermentation with basal fermentation being one third of the standard 
yeast fermentation. A contributing factor to low fermentation rates 
may have been the tendancy of the strain to clump together during the 
yeast assay. Tight clumping may have reduced the availability of 
glucose to the cell. 
4.5 DISCUSSION  
Yeast assay systems for GTE previously described (Section 4.1.3) 
relied on manometric techniques to measure the response of yeast to GTE 
In such systems, appreciable quantities of carbon dioxide would remain 
dissolved in the medium. The GTE assay reported in this thesis 
(Section 4.3) utilises the quantitative collection of 'carbon dioxide 
produced as a result of the oxidation of U-'C-glucose, a previously ' 
unpublished approach. The addition of acid to stop fermentation 
ensured the release of dissolved carbon dioxide from the buffer, which 
was then efficiently collected by absorption (Section 4.4.2). The 
response obtained to GTE after 2hrs fermentation is comparable to 
that obtained by Mirsky et al (1980) and Haylock et al (1982) over 
the same time interval. 
The concentration of ethanol produced in the medium was also 
found to reflect GTE activity (Table 4.9) and hence the use of labelled 
glucose could, if required, be dispensed with by determining the ethanol 
concentration in the medium. As results obtained from the collection 
of 'carbon dioxide alone were found to be adequate and reproducible, 
the oxidation of labelled glucose was routinely used without ethanol 
determination. 
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The stoichiometric increase in carbon dioxide and ethanol 
production from an exogenous labelled source of glucose proves that 
GTE effects the anaerobic metabolism of glucose by yeast. The previously 
reported manometric techniques measured endogenous as well as exogenous 
carbon dioxide. The use of variously labelled glucoses has been further 
investigated by Appleby and Holdsworth (to be published) in order to 
determine the site of action of GTE. 
The most effective preincubation (Section 4.4.4) was found 
to be without glucose, contrary to the findings of Mirsky et al (1980) 
where they added a small amount of glucose to their anaerobic preincuba-
tion, which would, in any case, have all been consumed over the 
preincubation period. 
• In agreement with Mirsky et al (1980), no response was found 
to vitamins that may be extracted from yeast. In agreement with 
Haylock et al (1982), Mirsky et al (1980) and contrary to the finding 
of Burkeholder and Mertz (1966), no response was found to low levels 
of.chromium, even though the cells were grown in deficient medium 
(2ppb Cr, Chapter 2). 
The apparent lack of difference in the % enhancement of 
carbon dioxide produced in response to GTF by different yeasts was 
contrary to the differences reported by Mirsky et al (1980), (Section 
4.4.8). The lack of difference may reflect some difficulties with 
yeast taxonomy, i.e. Sacch. uvarum routinely used in this thesis, may 
not have been identical to the Sacch. carZsbergensis reported. The 
differences in carbon dioxide production of control cells would seem 
to support this but differences in % enhancement due to GTE may have 
been associated with the manometric technique, as vastly different 
quantities of carbon dioxide were produced. 
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4.6 CONCLUSION  
A rapid and reproducible assay for GTE activity has been 
developed based on the oxidation of labelled glucose by yeast cells 
under defined conditions. 
Conditions are described for the growth of yeast labelled 
with "-Cr and ''C-nicotinic acid, and the processing of this yeast is 
described in Chapter 5. 
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CHAPTER FIVE 
THE ISOLATION OF GTF 
5.1 INTRODUCTION  
A review of the extraction of GTF has been discussed in 
Chapter 1.8.3. The extraction of GTE for the purpose of this thesis 
was initially based on the extraction of 51chromium from whole brewers' 
yeast. Based on this information, the assumption was made that 
extracted chromium represented extractable GTE. The extraction technique 
of Anderson et al (1978) was used as they had demonstrated that 70-87% 
of 51chromium in brewers' yeast could be extracted at high pH with 
correspondingly high "relative bio-activity". 
A cationic chromium co-ordination complex was sought that 
would stimulate anaerobic glucose oxidation by yeast cells (Chapter 4.3)- 
and would potentiate the effect of insulin on glucose oxidation by adipo-
cytes in the assay developed by Anderson (1978). When possible, samples 
were assayed for biological activity in the adipocyte assay by 
Ms J. Sherriff (MSc thesis, 1983). The adipocytes were isolated from 
the fat pads of Hooded Wistar rats that had been raised on Teklad 
torula yeast, Plow chromium diet" (Chapter 2.4.2). The adipocytes were 
prepared, essentially by the method of Robdell (1964), using modifications 
described by Ms Sherriff. The effect of samples on glucose oxidation 
by adipocytes to carbon dioxide was measured in the presence of sub-
optimal levels of insulin. The basal level activity of samples was 
determined in the assay without exogenous insulin to establish that 
the effect produced was not an insulin mimicing effect such as produced 
by oxidized glutathione, kinetin riboside or hydrogen peroxide generated 
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by divalent ions such as CO + (May and Contoreggi 1982). 
It should be stressed that the availability of the adipocyte 
assay for testing yeast extract fractions was dependent on the avail-
ability of 150-1809 rats raised on Teklad diet. Delays in obtaining 
the diet resulted in many weeks interruption in the husbandry of the 
animals and thus lack of data for some fractions. Crude fractions were 
found to contain inhibitory material thus obscuring the response of 
the adipocytes. For this reason, testing by the adipocyte assay was 
reserved for samples with a higher degree of purity. 
The question of the amount of sample required for activity 
in both assay systems became difficult as the importance of chromium 
in yeast fractions diminished. Initially, sample volumes resulting 
in -60ng/m1 Cr in the assay system was thought to be adequate however, 
decreasing chromium levels resulted in testing on a dry weight basis. 
5.2 • RESULTS  
5.2.1 Extraction of "-Cr  
The extraction of yeast using dilute ammonia generally 
resulted in the extraction of 70% of incorporated "-chromium, slightly 
less than reported by Anderson et a/ (1978). The accumulated results 
of pilot studies of extraction of "-Cr (Table 5.1) were typical of all 
ten cultures grown. Butanol was added to the extraction to increase 
the proportion of ruptured cells. 
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Wet weight of 
cells (g) 
Medium Cr 
(ppm) 
Total Cr 
in yeast 
Extraction 
(0.1N NH 3 ) 
% Cr 
in 1st 
extraction 
Total 
% Cr 
extracted 
108 
220 
105 
1.0 
1.5 
4.0 
0.28 
1 : 47 
4.31 
3 x 200m1 
2 x 500m1 
3 x 200m1 
35 
60 
49 
55* 
71 
70 
* A fourth extraction with 200m1 NH 3 and 50m1 n-butanol yielded a 
further 3% of extracted chromium with 90% of cells being disrupted. 
TABLE 5.1 The extraction efficiency of 51 chromium from yeast cells 
grown in liquid yeast medium. 
5.2.2 The extraction of yeast grown with and without chromium  
Two 51 cultures of Sacch. cerevisiae were grown in synthetic 
medium (Table 4.7) under identical conditions except that 2.0ppm Cr was 
added to one flask, and were inoculated with 4 x 10' cells from the 
same subculture. The growth rate of the two cultures was vastly 
different. The chromium deficient culture grew vigorously and was 
harvested after 5 days growth to yield a 27.0g wet pellet of yeast. 
The slow growing chromium replete culture was harvested after 8 days 
growth yielding 18.59 of wet cells. Counting of the cells using a 
Coulter counter (Coulter Electronics) was inaccurate due to branching 
and clumping of the chromium replete cells. 
The two pellets were extracted twice with 0.1N ammonium 
hydroxide (8m1 NH 3 /9 wet cells), centrifuged (7 700xg, Sorval RC2-13), 
and the supernatants lypholised. The dry solids were resuspended in 
5.0m1 and loaded onto Dowex 50W-X8 (H + ) resin and eluted as shown in 
Figure 5.2. The water eluted and ammonia eluted materials were 
lypholised and resuspended so that the concentration was 5601119/10pl. 
The biological activity was determined by yeast assay (Table 5.2). 
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0) The elution of ammonia extract of chromium deficient 
yeast from Dowex 50W-X8, 15mm x 250mm. 
Water ---101 0.2N NH 3 
0— 
(ii) The elution of ammonia extract of chromium replete 
(1.80pm) from Dowex 50W-X8, 15mm x 250mm. 
FIGURE 5.1 The extraction of 5/ synthetic yeast cultures 
grown with and without chromium. 
Dowex 50W-X8 
Eluant 
Total wt. 
(mg) - 
Biological Activity 
Yeast Assay (%) 
(560pg) 
Cr+ 
Water 
Ammonia 
51.0 
20.9 
53.8 
18.6 
Cr- 
Water 
Ammonia 
44.0 
1.0 
89.0 
44.7 
, 
TABLE 5.2 The yield and biological activity of material 
eluted from Dowex in Figure 5.1. 
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-- 
l/D 
20 
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15 
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5.2.3 The extraction of a 101 yeast culture grown in liquid yeast  
medium  
The growth of yeast in liquid yeast medium has been described 
in Chapter 4.2 and the growth rate of the culture is depicted in 
Figure 5.2. The yield of wet cells was 108g. 
23 4 
No. Days Growth 
FIGURE 5.2 The growth of a 10Z culture of brewers' 
yeast in liquid yeast medium. 
The cells were extracted with 2 x 200m1 of 0.1N ammonia 
(AR, Univar) and the extract centrifuged at 7 700xg (Sorval RC2-8). 
The extract was lypholized and resuspended in 4750 of distilled water 
prior to ultrafiltration at 4°C under nitrogen (100mm membrane, 
10 000 MW cut off, Amicon). The ultrafiltrate was concentrated to 
20m1 and the pH adjusted to 3.9 before loading onto a Dowex 50W-X8 (H 4- ) 
column (25mm x 400mm). The active material (Table 5.3.1) was eluted 
with 0.2N ammonia, lypholized and resuspended in 6.0m1 of distilled 
water before loading onto a Bio Gel P6 column (Bio Rad) with dimensions 
25mm x 400mm. 
108g Yeast 
1 IAMMONIA EXTRACTIONI 
Cells Extract 
0.13mg Cr 0.14mg Cr 
ENZYME 
>10 0001 ULTRAFILTRATION 
MW 10 000 
<10 000 
Residue Soluble 0.04mg Cr 0.09mg Cr 
0.02mg Cr Material 
0.08mg Cr 
NH 3 
NH
3  
NH 3 
<0.001mg 0.016mg 0.001mg Cr 
[2] [4] 
I • 
I DOWEX 50W-X8 I 
IDowEx 50W-X81 
NH 3 , NH
3 
0.7pg 1.1pg 
[2] [3] 
Water 
24.6pg 
BIOGEL P6I 
BIOGEL P6 
1.0pg 2.0pg 8.0pg 2.0pg • 1.0pg Cr 
[1] [2] [3] [4] [5] 
I 	I 	I 
 
3.6pg 0.4pg 0.1pg Cr 
[2] [3] [4] HPLC HPLC 
FIGURE 5.3 The distribution of 51chromium after fractionation of 
yeast culture extract. The 101 culture was grown in 
liquid yeast medium ( Table 4.2.2 ) with 1.0ppm Cr. 
1 00 
ULTRAFILTRATION 
MW 10 000  Water 
I <10 000 
0.054mg 0.052mg 
[1] 
>10 000 
0.015mg 
NH 3 
5.9pg Cr 
 1[4] 
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2 I 3 4 
Dowex 50W-X8, 25mm x 420mm. Elution profile 
of NH extract ultrafiltrate from Figure 5.3. 
(ii) Bio Gel P6, 25mm x 420mm, eluted with 50mM NH 3 . 
Elution profile of active Dowex fraction [3] 
from above. 
FIGURE 5.3.1 The elution profiles of active material 
extracted from 108g of yeast. See flow 
chart Figure 5.3 and Table 5.1. 
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The residue remaining after extraction of the yeast was 
suspended in 160m1 of distilled water and digested at 30°C over two 
days by 250mg of "Zymase" and 50mg of DNA-ase at pH 7.4, releasing 60% 
of the chromium in the residue. The digestion was ultrafiltered as 
before and the ultrafiltrate treated in the same manner as the ammonia 
extract. 
Fraction 
(Figure 5.1) 
ng Cr 
in assay 
Biological Activity 
Yeast Adipocyte 
NH3 Extract, Dowex 1 65 18% - 
II II 	
2 <1 nil - 
II 	 II 3 47 76% - * 
4 <1 nil - 
. Bio Gel P6 1 56 25% - 
I. ,, 
2 71 24% 
. 
- 
3 44 111% nil 
i.  II
4 45 . 52% active 
I, I. 
5 45 33% - 
Enzyme Digest, Dowex 1 35 15% 
ii II 	 II 4 51 24% - 
Bio Gel P6 1 70 4% - 
I, ti ., 
2 94 11% - 
3 88 19% - 
,. H .. 
4 60 nil - 
* not tested until further fractionated on Bio Gel P6. 
TABLE 5.3.1 The biological activity of fractions from brewers' yeast 
shown in Figure 5.3 and 5.3.1. 
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5.2.4 . 2001 yeast culture - synthetic medium 
Details of the growth and harvesting of the 2001 culture 
are to be found in Chapter 4.2. To establish the presence or otherwise 
of active material in spent culture medium, a charcoal extract of 201 
of medium was purified to the stage where fractions could be assayed 
by the adipocyte assay. 
5.2.4.1 Spent medium  
201. of spent medium were stirred overnight with 500g of 
coarse activated charcoal (Norit) after adjusting the pH to less than 
3.0 with concentrated hydrochloric acid. The charcoal was filtered 
and washed with distilled water in a buchner funnel. The charcoal 
was twice extracted with 500m1 of 0.2N NH 3 /50% ethanol. The extract 
was reduced in vacuo at 40°C with a Rotavapour (Buchi) and then taken 
to dryness by lypholization (-70°C, 0.05 torr). The solids were 
resuspended in 5m1 of distilled water and the pH adjusted to 3.9 with 
0.1N HC1 before loading onto a Dowex 50W-X8 (e) column (25mm x 400mm) 
(See Figure 5.4 and Table 5.4). 
5.2.4.2 Extraction of the yeast cells  
The yeast pellet was extracted twice by shaking with 5.01 
of 0.2N NH 3 /14% butanol for 16hr. The cell residue was spun down in a 
MSE Mistral 6L centrifuge (2 000xg) and the supernatant lypholized. 
The solids were redissolved with distilled water and the insoluble 
residue removed by centrifugation at 10 000xg (Beckman L2-65). The 
supernatant was sorbed batchwise onto 1 000g of Dowex 50W-X8 (e). 
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Batchwise extraction was necessary as white solids precipitated from 
the supernatant on the lowering of pH to 3.9 by the resin, and would 
have blocked the flow if packed in a column. The resin was washed 
thoroughly with 5 equivalent volumes of distilled water before revising 
the pH of the resin suspension with 1.0N ammonia to displace the active 
material. The resin was washed again with two equivalent volumes of 
distilled water, and the washings and ammonia eluate were concentrated 
by lypholization before resuspending in 140m1 of distilled water. This 
material was loaded onto a DEAE Sephadex (C1 - ) (50mm x 400mm) and water-
eluted material passed-directly to a Dowex 50W-X8 (e) column connected 
in series (25mm x 400mm). The Dowex column was disconnected and then 
eluted with 0.2N ammonia. The eluant was lypholized and redissolved in 
175m1 of distilled water (fraction Cl, Figure 5.2). The remaining 
details of fractionation are presented in Figure 5.4, 5.5.1 - 5.5.3). 
 
5.2.4.3 Amphoteric material  
' A brown material had been retained by the anion exchange gel 
(DEAE Sephadex) which was eluted with 1.0N hydrochloric acid and 
repeatedly lypholized to reduce the acid concentration. The final volume 
of the material (Figure 5.4 [A]) was 22.0m1, a 2m1 portion of which was 
fractionated further (Figure 5.6) by both DEAE Sephacel and Dowex 50W-X8 
followed by preparative chromatography. The biological activities of 
some of the fractions is shown in Table 5.6.1. 
IDOWEX 50W-X8 I 	12.8pg 	3.5pg 	9.2.ig 
	
87pg 52pg llpg 
[5] 	[6] 	[7] 
9.7pg Cr 
9pg NA 
[8] NH 
2001 Culture 
Cells 	I 	Medium Centrifugation 
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4.1Kg Yeast 
NH 3 —pi 
I LYPHOLIZATION  
Water 	• I DOWEX 50W-X8 Batchwise Extraction 
ILYPHOLIZATION1 
660pg Cr 
40.6mg NA 
Medium + charcoal 
NH3/Et0H 
I DOWEX 0W-X8 I 
Water 	NH Gradient to 0.5N NH3  
I 	1 
13.9pg 	0.15pg 	<0.01pg 	35.3pg Cr - 39.5pg 	121.9pg 	42.2pg 	159.5pg NA 
[1] 12] 	[3] [4] 
	 HC1 
IDEAE 22 Cl - I 	• 204pg Cr 
11.5mg NA 
I BIOGEL P4 I 
Water'. [A] - see Fig. 5. 6 
50mM NH 3 
124pg Cr 
13.9mg NA 
[Cl] - see Fig. 5. 5 
FIGURE 5.4 The initial fractionation of a 2001 ( 1.0ppm Cr ) culture grown in synthetic medium and the fractionation 
of GTF extracted from 20Z of spent culture medium 
by absorption onto activated charcoal ( Section 5.2.3.2). 
Biogel P4 = 25mm x 900mm. 
Fraction 
(Figure 5.4) 
Levels of Cr, NA 
in assay 
Biological Activity 
% Yeast 
Assay 
Adipocyte 
Assay ng Cr ng NA 
Dowex 1 46 132 8 . inhibitory 
2 0.5 420 7 nil 
3 0.5 222 2 nil 
4 147 663 69 _ slight 
Bio Gel P4 5 44 300 2 active 
6 24 347 13 active 
7 61 75 16 nil 
8 61 58 12 active 
TABLE 5.4 The biological ac t ivity of fractions derived from 
201 of spent synthetic medium. The fractionation 
is outlined in Figure 5.4. 
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0.2M NH 4 Formate - 0.2N NH 3 ----0 0.2N NH  - 0.5N NH 3-44 
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3 Iii 	2 1 
The initial fractionation with Dowex 50W-X2 
50mm x 400mm equilibrated in 0.2N ammonium 
formate pH 3.9 of fraction Cl (Figure 5.4). 
0.2-1.0 NH41 1.0N NH 4 Formate pH3.9 - 0.5N NH 3 
Formate 
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4 1 51 6 1 7 1 8 1 9 110 1 11 1 12 13  1 
(ii) The active fraction (yeast assay) [3], from 
(i) above, eluted from Dowex 50W-X2/Formate. 
FIGURE 5.5.1 Elution profiles of cationic material 
from Dowex X2 formate (Figure 5.5). 
Fraction 
Biological Activity 
(%) Yeast Assay 
(400pg) 
Adipocyte Assay 
(80pg) 
Dowex X2 Formate 7 54 nil 
n 
8 51 nil 
9 38 slightly active 
10 33 active 
11 12 active 
12 0 most active 
13 28 active 
TABLE 5.5.1 Biological activity of the major fractions from 
Figure 5.5. 
( from Fig 5.4 ) 
[Cl] 
DOWEX X2 FORMATE, 
Gradient 0.214 Formate pH3.9 
to 0.5N NH 3 
	
I 	 I 
49Tig lOug 	5Oug Cr 
2. 47mg 	2. 21mg 3.2mg NA 
[ 1 ] [ 2 ] 	[3 ] 
1 
I 	4  
I DOWEX X2 FORMATE I 
Gradient 0.2 - 1.0N Formate 
pH 3.9 then to 0.5N NH 3 
I 	I 	I 	I 	1 	I 	I 	I 	I 
[ 4 ] 	[ 5 ] 	[ 6 ] [ 7 ] 	[ 8 ] 	[ 9 ] [ 10 ] [ 11 ] [ 12 ] [ 13 ] 
• • 	• 	t • 
l3. 4g Cr 
2. Omg NA 
 I 
I PHENYL SEPHAROSE I 
5.3ug 	8.1ug 	0.1ug Cr 
558pg 1365pg 23ug NA 
I 	0  
I BIOGEL P4 I 
I 	I• 	I 	I 	I 	I 	• 
[1 ] 	[2 ] [3 ] 	[4 ] [5 ] 	[6 ] 	7] 
• • 
I 	4 I 
I BIOGEL P41 
I 	 I 
8 ] 	9 ] 	[ 10 ] [ 11 ] [ 12 ] 	13 ] 
I PREPARATIVE PAPER CHROMATOGRAPHY  I ( see Fig.5.5. 3 
FIGURE 5.5 Fractionation of cationic material EC1] 
extracted from 4.1Kg of Yeast. 
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0 
0 
•1- 
E 
0 
= 
100 
I 1 1 2j 3 1 4 1 5 1 6 17 
(i) Bio Gel P4, 25mm x 900mm, eluant 50mM NH 3 . 
Initial gel fraction of fractions from phenyl 
sepharose (Figure 5.5). 
100 
1 8 1 9 1 10 1 11 1 12 1 13 
(ii) Elution of active fractions 5, 6 from (i) above. 
Same conditions as (i). Fraction [10] was then 
fractionated by paper chromatography (Figure 5.5.3). 
FIGURE 5.5.2 Elution profiles of cationic material from 
unbuffered Bio Gel P4 (See Figure 5.3). 
Fraction 
Biological Activity 
(%) Yeast Assay 
(400pg) 
• 
Fraction 
Biological Activity 
(%) Yeast Assay 
• (400pg) 
C•
J
 C
v
) 	
1.11  
(
.0
  
N
. 
inhibitory 8 22 
16 9 13 
13 10 71 
20 11 91 
64 12 22 
111 13 13 
42 
.. - 
FIGURE 5.5.2 Biological activity of fractions from 
Figure 5.3. 
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PREPARATIVE PAPER CHROMATOGRAPHY 
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( from Fig. 5.3 ) 
Biogel P4 DO] 
Rf is".".".""""nn Rf Is/s"","/•/■.","" 
(a) butanol/HAc 
Ninhydrin positive. 
(b) isopropanol/NR 3 
UV absorbing or 
fluorescing 
FIGURE 5.5.3 The final fractionation of cationic material by paper 
chromatography to yield the active fraction 2 e on 
which structural information was obtained. For paper 
chromatography details, see Chapter 3. 
Fraction 
Biological Activity 
% Yeast Assay 
(200pg tested) 
Adipocyte Assay 
(80wg) 
butanol/HAc 0 199 - 
1 99 - 
2 60 - 
3 67 inhibitory 4 
e 
63 - 
isopropanol/NH3 0e  - 
l e 81 slightly active 
2 e 53 active (max.) 
3
e 
44 active 
4: 23 inhibitory 
5 - nil basal activity 
TABLE 5.5.3 Biological activity of cationic material from 
Figure 5.5.3 above. 
[A] 	( 2m1 from Fig. 5.4 ) 
9.3pg Cr 
520pg NA 
I DEAE Sephacel I 
1M HAc 0.25N NH 3 Linear Gradient to 
[1] 	[2] 	[3] 
1—-1 IDEAE Sephace1 4 Mild Acid Hydrolysis 
1N HC1, 80 C 
I DOWEX 50W-X8 I 
0 5N TEA pH6.3 0.2N NH 3 
[2] 	[3] 
PREPARATIVE PAPER CHROMATOGRAPHY I 
• 
Butanol/HAc 
Ninhydrin positive. 
FIGURE 5.6 The fractionation of the amphoteric material [A] from 
brewers' let extract ( Figure 5.4 ) to yield active 
fraction 3 . For paper chromatography details see Chapter 3. 
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0.1N HC1 
Rf 
0.50 
0.45 
0.37 
0.22 
5AH 
4AH 
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1 0.25NH 3 1 Linear Gradient 0.25NH 3-1M HAc 	0.1N HC1 
I 	10.0 0 r7r—'■ 
             
8.0 
6.0 
4.0 PE 
2.0 
, 0 
             
             
             
             
             
             
             
100 
            
            
            
   
1 	2 	I 	3 	I 	41 	5 	161 
 
    
(i) The elution of 2m1 of [A](from Figure 5.4)from 
DEAE Sephacel, 15mm x 250mm. 
I  0 	Water—of 0.5N TEA pH6,1 0.2N NH 3 
          
        
        
100 0— 
1 
     
       
1 	2 	1 	3 	1• 
(ii) The elution of [6] from (i) above, after mild 
acid hydrolysis, from Dowex 50W-X8, 15mm x 250mm. 
(iii)The elution from DEAE Sephacel of [6] from (i) 
above, after mild acid hydrolysis, 15mm x 250mm. 
FIGURE 5.6.1 Elution profiles of fractions shown in 
Figure 5.6. 
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Fraction 
(Figure 5.6) 
ng Cr/ml 
in assay 
Biological Activity 
Yeast (%) Adipocyte 
DEAE Sephacel 
. 
Dowex 50W-X8 
Chromatogram 
1 
2 
3 
4 
5 
6 
1 
2 
3 
0
AH 
1AH 
2AH 
3AH 
4AH 
5AH 
100 
100 
10 
10 
10 
320 
200 
180 
160 
10 
10 
10 
5 
10 
10 
106 
97 
68 
72 
23 
80 
37 
111 
56 
46 
19 
76 
92 
60 
38 
nil 
- 
- 
- 
- 
- 
- 
• nil 
- 
inhibitory 
- 
- 
active 
- 
- 
FIGURE 5.6.1 The biological activity of fractions derived 
from amphoteric material as outlined by 
Figure 5.6. No entry for the adipocyte assay 
indicated that the assay was not available. 
113 
114 
5.3 DISCUSSION  
In order to determine the effect of chromium on the production 
of GTE, the chromium deplete and replete cultures described in Section 
5.2.2 were grown. Synthetic medium was used in preference to liquid 
yeast medium due to the considerably lower chromium content, thus ensuring 
that the deplete culture was actually deficient. Pilot studies had 
previously shown satisfactory growth of yeast in synthetic medium. 
Cultures grown as pilot studies with 4.0ppm Cr in liquid yeast medium 
containing peptone and yeast extract were apparently not affected by the 
chromium present,yet the yield of cells from the chromium deplete and 
replete (2.0ppm Cr) cultures demonstratesa toxic effect. Kumpulainen et al 
(1978) report a slight inhibition of growth at 1.0ppm Cr, yet Burkeholder 
and Mertz (1966) report no effect up to lOppm Cr. 
The result of GTF extraction from the two completely synthetic 
cultures indicates yeast can synthesize a biologically active cationic 
material in the absence of chromium (Table 5.2). The material was not 
tested in the adipocyte assay as, from previous experience, a higher 
degree of purification would have been required before a response could 
be observed and the yield of lmg , consumed by the yeast assay, was 
insufficient to allow further purification. As there was some suggestion 
that a higher total yield of GTE may result from the addition of chromium, 
1.0ppm Cr was added to the cultures grown for GTE extraction. 
Furthermore, GTE reported to be active in the adipocyte assay, has 
historically been extracted from chromium containing material. As the 
use of the adipocyte assay in conjunction with the yeast assay as 
criteria for GTE has only been reported in one other instance 
(Burkeholderand Mertz 1961) and GTE is reported to be a chromium containing 
material, the addition of chromium to the medium was a precaution in the 
event that chromium may be needed to produce material that was active in 
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the adipocyte assay. 
The enzyme digestion of cell residue (Figure 5.3) after ammonia 
extraction yielded very little material with biological activity 
(Table 5.3.1), thus the residue was discarded in later experiments. 
High molecular weight material (ultrafiltration retentate) was also 
discarded as GTE is reported to have a molecular weight of less than 
10 000 daltons, the exclusion limit of the membrane used. Chromium 
containing material eluted from Dowex cation exchange resin with water 
had little biological activity in relation to ammonia eluted material, 
thus only the ammonia eluted material was further fractionated in all 
cases. The water eluted material may have been equivalent to the anionic 
material reported by Votava et al (1973) which was called GTE on the 
basis of absorption from the gastrointestinal tract of rats (Chapter 1.7). 
Kumpulainen et al (1978) also report anionic material extracted from 
yeast as do Mirsky et al (1980) who report no activity with material 
eluted from anion exchange cellulose. 
The fractionation of the active ammonia eluate on Bio Gel P6 
(Figure 5.3.1) resulted in fraction 3 (ii) containing chromium and 
fraction 4 with no significant chromium. Fraction 3 was found to be 
active by the yeast assay but not by the adipocyte assay in which 
fraction 4 was active, casting doubt on the importance of chromium and 
confusion as to which fraction represented GTE. As an insulin 
potentiating compound was sought, the adipocyte assay was decided on as 
the final criteron for GTF. 
The yield of active material was low (less than 3mg) and still 
impure, hence a large culture was grown to provide more active material. 
As Mirsky et al (1980) and •Haylock et al (1982) had extracted GTE from 
116 
yeast extract, and as yeast extract and bactopeptone were components of 
the liquid yeast medium, we decided to grow a 2001 culture using 
synthetic medium in order to establish that GTF extracted from the cells 
was produced by the cells and not derived from the medium. A 101 pilot 
study indicated that growth in synthetic medium was feasible. The 
chromium concentration was 1.0ppm chromium to lessen growth inhibition 
observed with 2.0ppm Cr in the 5.01 cultures. The use of synthetic 
medium also allowed investigation of the possibility that GTE may diffuse 
from the cells into the medium. Kumpulainen et al (1978) reported the 
formation of anionic chromium containing material in spent yeast medium 
but was unable to establish its biological activity (Chapter 1.8.3). 
51chromium was added to the large culture to facilitate 
analysis in the early stages of extraction and,as nicotinic acid was 
deemed to be an essential component of GTE, 1 C-nicotinic acid was added 
to the culture. The labelled nicotinic acid was taken up by the yeast 
and was presented in the extracted material but, when present in 
detectable levels in active fractions, it was seen on chromatograms as 
free nicotinic acid (Rf 0.75, butanol/acetic acid, Chapter 3) and was not 
found incorporated in a complex. 
Amphoteric material arising from the yeast extract was tightly 
bound to anion exchange gel and could only be displaced by hydrochloric 
acid. It was found that active material was present after elution with 
hydrochloric acid and lypholization. Elution from DEAE Sephadex with acid 
followed by lypholization appears to have caused partial hydrolysis of 
the material to yield active material which would no longer sorb to 
anion exchange cellulose (fraction [1], Figure 5.6.1). Strongly sorbed 
active material was deliberately acid hydrolysed under mild conditions 
and was found to yie)d a range of fractions when reloaded onto 
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DEAE Sephacel and an active fraction which was sorbed by cation exchange 
resin. After further but incomplete purification on chromatography paper 
(Figure 5.6) by elution with butanol/acetic acid, a fraction was found (3) 
that was active in both the adipocyte assay (with some basal activity) 
and the yeast assay and contained negligible quantities of chromium. The 
Rf value in butanol/acetic acid of the 3
AH 
shows that it is not the same 
as the final cationic fraction 2 e . 
As a cationic Cr co-ordination complex was sought, most effort 
was concentrated on the cationic material Cl (Figure 5.5). After fraction-
ation on Dowex cation exchange resin with ammonium formate, a division of 
activity was found between the yeast assay and adipocyte assay and again 
after fractionation by preparative chromatography. The adipocyte assay 
with no basal activity (2 e , Table 5.5.3) had only slight activity in the 
yeast assay. The structure of this material which contained insignificant 
chromium was investigated due to its outstanding activity in the adipocyte 
assay when performed with isolated adipocytes from rats fed on Teklad diet, 
a torula yeast based diet generally used as chromium deficient food, but 
which was inactive with adipocytes from colony rats. 
Details of fraction 2 e are presented in Chapter 7 which deals 
with structure. 
5.4 CONCLUSION  
Fractions having GTE activity have been isolated from yeast and 
synthetic medium proving that GTE is produced by yeast and that GTE can 
diffuse into the medium. GTE active in the yeast assay can be isolated 
from yeast grown in the absence of chromium. The fractions •found by the 
adipocyte assay contained insignificant quantities of chromium thus 
chromium is not essential for activity and the structure of GTE. 
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CHAPTER SIX 
SYNTHETIC GTF  
6.1 INTRODUCTION  
The synthesis of the active chromium complex of Toepfer et al 
(1977) has been discussed in Chapter 1.9.3. Appreciable amounts of 
unreacted components and diverse compounds resulted from the technique 
(Kienle et al 1979). Anderson et al (1978) report an active chromium-
glycine-nicotinic acid complex but give no details - of the preparation or 
structure. As no sulphydryl groups would be present in such a preparation, 
unlike the Toepfer et al (1977) preparation, the investigation of the 
glycine complex seemed more appropriate as the adipocyte assay has been 
found to respond to sulphydryl groups.. 
The preparation of the chromium complexes reported was based 
on the method of TOepfer et al (1977) which was a preparation in solution 
rather than a solid state reaction (Oki et al 1976). The preparation of 
cobalt GTE was by the patented method of Silio (1980). The tendency of 
chromium to form polynuclear complexes, and examples of isolated and 
characterized complexes have been reported by Rollinson (1973). 
The purpose of this chapter was to gain some understanding of the 
nature of the chromium GTE complex and the very different cobalt GTE 
described in the literature (Chapter 1). 
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6.2 METHODS  
6.2.1 Preparation of cobalt GTF  
(i) Trans-tetraaquabis(nicotinamide)cobalt II dichloride 
dihydrate 
1.59 (5m moles) of cobalt II acetate hydrate (Sigma) were 
dissolved in 2.0m1 of distilled water at 35°C in a "Reactivial" conical 
vial with a teflon cap. 1.25g (10m moles) of nicotinamide (Sigma) were 
added to the solution. 2.0M potassium hydroxide (AR, Univar) was added 
to increase the pH to 6.5. The capped vial was heated to 80°C for two 
hours. On adjusting the pH to 4.4, large prismatic crystals formed. 
The crystals were filtered from the mother liquor and blotted dry. A 
saturated solution of the crystals was made at 80°C (pH 4.4) and allowed 
to cool slowly yielding a well crystallized product. The crystals were 
stored in air-tight containers. 
(ii) Cobalt-nicotinamide-glutathione 
A fresh solution of reduced glutathione (crystalline, Sigma) 
consisting of 0.66g (2m moles) in 2m1 of distilled water was prepared. 
The pH was adjusted to 4.7 after adding 1.0g (2m moles) of the cobalt 
nicotinamide crystals. The reactants were cooled to 4°C to slow the 
formation of an intense brown colour. After one hour, the solution was 
frozen and lypholized to produce an amorphous brown solid. 
6.2.2 Preparation of chromium acetylacetonate  
2.39 of chromium III acetate (10m moles, Hopkins and Williams) 
were dissolved in 3m1 of distilled water and 3.1m1 of acetylacetonate 
(30mM, Merck) were added. The pH was adjusted to 7.0 with 2N potassium 
hydroxide. A greenish precipitate was filtered from the solution before 
heating at 80 °C for four hours. On cooling, purple needle like crystals 
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formed slowly. The crystals were filtered from the mother liquor and 
blotted dry with filter paper. The crystals were stored in an air tight 
bottle. 
6.2.3 Reaction of 51chromium/ 14C-glycine/nicotinic acid/ethanol  
46mg of anhydrous chromium III nitrate (193pmoles) were 
dissolved in 2.0m1 of distilled water. 100pl of 51chromium chloride 
with an activity of imCi (carrier free, New England Nuclear) were added 
and allowed to equilibrate at room temperature for lhour before adding 
47.3mg (384pmoles) of nicotinic acid (Sigma). After heating at 80°C 
for 18hours, 57.7mg of glycine and 1.3mg of 2- 14C-glycine (785pmoles, 
0.1mCi, Amersham) were added and the volume adjusted to 2.00m1. 500pl 
were removed from the vial as a counting standard for the two isotopes. 
500pz of absolute ethanol (AR, Univar) were added to the remaining 1.5m1, 
capped, and heated for 18hrs at 80°C. The contents of the vial were 
allowed to evaporate to 1.0m1 after which an additional 1.0m1 of ethanol 
was added and the process repeated with 2.0m1 of ethanol. The pH was 
adjusted to 5.8 with 1N ammonia. The final volume was adjusted to 2.00m1. 
The solution was loaded onto a well washed Dowex 50W-X8 
100-200 mesh, Bio-Rad) column with dimensions 15mm x 270mm. The column 
was eluted with water and then with a 0.25M triethylamine acetate linear 
gradient from pH 7.5 to 10.5. y-radiation in the fractions was measured 
and plotted with the recorded % transmittance at 260-280nm. Portions of 
the pooled fractions were lypholized before suspending in scintillation 
fluid and counting at intervals of several weeks to enable the calculation 
of the amount of f3-radiation by the method of Olson (1977) based on the 
rapid decay of 51chromium in comparison with 14carbon. 
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6.2.4 Chromium-glycine preparation with and without ethanol reflux  
2.38mg (10pmoles) of chromium nitrate were dissolved in 1.0m1 
of distilled water. 3.00mg (40pmoles) of glycine (AR, Univar) were 
added to the vial containing the chromium solution. A duplicate vial 
was prepared and 1.0m1 of absolute ethanol (AR, Univar) was added. 
The pH of each vial was adjusted to 6.0 with 5N ammonia before capping 
and heating for 18hours at 80°C. The final volumes were accurately 
diluted to 2.0m1. A further vial was prepared containing ethanol, glycine 
and ammonia in the same concentrations. The contents of the vials were 
tested for biological activity in the adipocyte assay. 
6.2.5 Chromium-glycine- 11'C ethanol  
92mg (387pmoles) of chromium nitrate were dissolved in lml of 
distilled water and 122mg (1.63pmoles) of glycine were added and the 
solution heated at 80°C for four hours before adjusting the pH of the 
solution to 6.0 with 1N ammonium hydroxide. lml of 1-' 4 C-ethanol 
(0.1mCi/5.0m1 ethanol, New England Nuclear) was added, the vial capped 
and heated at 80°C for 18hours. The volume was allowed to evaporate to 
1.0m1 before adding a further 2m1 of labelled ethanol and repeating the 
process. 
The contents of the vial were loaded onto a well washed 
Dowex 50W-X2 (H + , 100-200 mesh, Bio-Rad) column and eluted with a linear 
gradient of water to 0.25N ammonia. Three distinct fractions were 
collected, lypholized and dry weights determined to the nearest 0.1mg. 
Portions of the extremely soluble solids were dissolved and analysed by 
atomic absorption spectroscopy for chromium. A known weight of each 
fraction was dissolved in a small amount of water in scintillation pots 
before adding scintillation fluid (ACS!!, Amersham) and counting the 
0-disintegrations. 
122 
6.3 RESULTS  
6.3.1 Cobalt  
(i) Orange crystalline intermediate 
Cobalt GTF was prepared according to the patented method of 
Silio (1980). The orange crystalline intermediate compound was found 
to lose water at relatively low temperature (90°C, with complete loss at 
120°C) to form an amorphous purple solid. Differential thermal gravimetric 
analysis (Stanton and Redcroft, TG750) with an argon atmosphere and a 
heating rate of 5°Cmin -1 to 970°C indicated a total of 6 molecules of 
water and .a molecular weight of 490daltons, arrived at by assuming the 
final product was Co 3 0 4 . The value compared closely with 482daltons 
calculated from the published crystal structure (Vegas et al 1981). 
Reflectance spectra of the orange crystals (Beckman DK2 spectrophotometer) 
and solution spectra (Cary 219, Varian) indicated that the complex was a 
cobalt II complex. The molar extinction coefficient (c510 = 5.7) 
indicated that the complex was most likely to be a trans-isomer with 
octahedral geometry in agreement with the published structure (Vegas et al 
1981). The structural evidence would seem to indicate that the intermediate 
of Silio (1980) had been successfully prepared. 
(ii) Cobalt GTE 
The change in colour and intensity reported in Section 6.3.1 
was accompanied by spectral shifts in the visible region from 510nm to 
485nm and 383nm and were consistent with a change in oxidation state to 
cobalt III. Furthermore, the material formed sorbed strongly to Dowex 
cation exchange resin indicating that it was not anionic as reported by 
Silio. No activity was found in the yeast assay at a concentration of 
5 x 10 -7M, 5 x 10 -5M or 5 x 10-5M. As the patent described a cobalt II 
nicotinamide-glutathione anionic complex, it was concluded that the complex 
prepared was not the same as the patented complex. 
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Silio later described (personal communication, 1982) the 
spontaneous oxidation of CO 2+ to CO 3+ during the preparation of the 
complex and cautions that the complex is light sensitive. A generous 
gift of cobalt GTE (Dr F. Silio, Instituto "G. Maranon, Madrid) was 
found to be inactive in the yeast assay (5 x 10 -7 , 5 x 10 -5M) but 
active when tested in the adipocyte assay (Sherriff, MSc thesis, 1983). 
at 5 x 10-7to 1 x 10-5 M. The solution spectrum of cobalt GTE (0.5pmoles/ 
2.9m1) was consistent with a cobalt III complex, absorbing at 455, 383 
and 257nm with a molar extinction coefficient of c 383 nm = 3 538 in 
contrast with the cobalt II intermediate with an absorption maximum at 
510nm and E510 = 5.7. The high extinction coefficent suggests a cis-isomer. 
In light of the additional information, it would appear that 
the attempt to prepare active cobalt GTE may have been successful but 
activity is only to be found with the adipocyte assay. 
6.3.2 Chromium acetylacetonate  
The complex was found to have a low solubility in water and 
had similar physical properties to those expected of the structure 
elucidated by Morosin (1965). An insoluble chromium hydroxide formed 
in the aqueous phase on increasing the pH during the preparation of the 
complex and was thought to arise from the use of what appeared to be 
a basic chromium acetate, rather than chromium acetate as described by 
the supplier. The basic chromium acetate was difficult to dissolve, 
thus anhydrous chromium nitrate was prepared from the acetate with hot 
nitric acid (AR, Univar) and the product dehydrated in vacuo. The 
anhydrous chromium nitrate was extremely water soluble and was used 
for subsequent synthesis. 
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Chromium acetylacetonate was found to be inactive when tested 
at 200ng Cr/ml in the yeast assay and 200 and 2Ong Cr/ml in the adipocyte 
assay in agreement with Mertz (1969). 
6.3.3 Active chromium glycine preparations  
The elution profile of a preparation consisting of 'IchromiuM, 
14  C-glycine, nicotinic acid and ethanol is shown in Figure 6.1. The 
molar ratio of glycine to chromium was found to be 3.7 glycine to 1 
chromium (Table 6.1). As there appeared to be a background level of 
glycine in fraction 4 of 0.4M, the value was subtracted giving a rounded 
value of 3 glycine/chromium. UV absorption spectra detected free 
nicotinic acid in the water eluted fractions 1-3 with most free nicotioic ac 
eluting in fraction 5. As nicotinic acid is active in the adipocyte 
assay and there was no evidence that nicotinic acid was coordinated to 
chromium, a pilot preparation similar to that of Section 6.2.3 was 
undertaken and initial results indicated that the presence of nicotinic 
acid in the preparation was not essential for activity in the adipocyte 
assay. Furthermore, no activity was found until the preparation had 
been refluxed with ethanol. As a result of these findings, two prepara- 
tions of chromium glycine complexes were made under identical conditions 
with the exception of the ethanol reflux step (Section 6.2.4). The 
• chromium glycine complex was inactive in the adipocyte assay (0.521g/m1 Cr) 
as •was the glycine, ethanol, ammonia control. Only the ethanol refluxed 
complex was found to be active. Fine purple crystals precipitating 
from the ethanol refluxed preparation were found to have no biological 
activity in the adipocyte assay (0.5pg/lml Cr). UV-visible solution 
spectra of the reaction mixtures showed an absorbance shift of 12nm from 
the 564nm absorbance maximum of aged chromium nitrate solution, to 552nm 
for chromium glycine and 540nm for the ethanol refluxed complex. 
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FIGURE 6.1 The elution of a 51chromium/nicotinic acid/ 
1 C glycine/ethanol preparation from Dowex 
50W-X8 resin (Section 6.2.3), column size 
15mm x 270mm, flow rate 90m1/hr. 
Fraction 
(From Figure 6.1) 
M glycine 
per 1M Cr 
 
Biological Activity 
(Adipocyte, 0.511g Cr) 
1--
1
 C \
 I
 C
O
 .:1-  IS
)  
L
O
  
0.56 nil 
0.66 nil 
7.8 nil 
0.4 nil 
3.7 active 
0.5 active 
TABLE 6.1 The biological activity and ratio of glycine to 
chromium determined for fractions eluted from 
cation exchange resin shown in Figure 6.1. 
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Further investigation of the role of ethanol in the complex 
involved the use of labelled ethanol (Section 6.2.5). The complex was 
eluted from Dowex as shown in Figure 6.2. Further attempts to purify 
fraction 3 (Figure 6.2) by preparative paper chromatography in a 
butanol/acetic acid solvent system (Toepfer et a/ 1977) resulted in 
dissociation of the complex. The final product (fraction 3) was 
lypholized to avoid the loss of activity due to precipitation 
(Nath et al 1979) and ensure the removal of free ''C-ethanol. The 
freeze dried solids were extremely water soluble. 
Differential thermal gravimetric analysis (DTA) of the active 
cationic fraction 3 from Dowex indicated a molecular weight of 524 if 
it assumed that the complex decomposes to Cr 20 3 . The sample was heated 
in argon at a rate of 3°C/min. The program was stopped at 700°C as 
the sample had reached 14% of its initial weight. The residue was 
found to be a green-black solid similar in appearance to Cr 20 3 . The 
decomposition of the complex is shown in Figure 6.3 with indicated 
possible decomposition products. If the complex is assumed to be mono-
nuclear, a MW of 524 can be calculated or if binuclear, a MW of 1 022. 
The results of micro-analysis by the Australian Analytical 
Services (AMDEL) were as follows: 
0/0 C 30.39 
16.48 
0/0H 6.20 
%Cr 9.92 
%0 by differ- 
ence 37.01 
The chromium analysis was by AAS as described in Section 6.2.5. 
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3 
FIGURE 6.2 The elution of a chromium/glycine/ 14C ethanol 
preparation from Dowex 50W-X8. The fractions 
indicated were lypholized. 
Fraction 
Yield 
Dry wt. (mg) M ethanol/1M Cr 
1 
2 
3 
40.3 
14.1 
102.4 
3.5 
5.6 
4.3 
TABLE 6.2 The chromium to 14C ethanol ratio of 
fractions eluted as shown above (Figure 
6.2). 
Fraction 
Biological Activity 
Yeast* 
(1.5pg Cr) 
Adipocyte 
(50pg of complex) 
1 
2 
3 
nil 
nil 
30% 
nil 
nil 
active 
* % enhancement 
TABLE 6.3 The in vitro activity of fractions eluted 
as shown in Figure 6.2. 
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The %Cr was found to be in agreement with the calculated value 
from the DTA curve shown in Figure 6.3. The micro-analytical results 
indicate approximately 13 two carbon molecules per 2 chromium atoms 
with 12 nitrogen atoms per 2 chromium atoms. As 14C ethanol counting 
indicated that there were 8.6 ethanol molecules per 2 chromium atoms 
(Table 6.2) and that 9 ethanol molecules could be assigned to the 
decomposition curve (Figure 6.3), the remaining imbalance of 6.atoms 
of nitrogen per 2 atoms of chromium may be attributed to associated 
ammonia. 
Infra red spectra were obtained on a Digilab FTS 20E' 
spectrometer by Mr J. Bignall of the Central Science Laboratory, 
University of Tasmania. The infra red spectrum of the cationic active 
complex was compared with that of free glycine. A potassium bromide 
pellet of the complex was prepared and the spectrum accumulated over 
100 scans. The resolution was 8 wavenumbers (Figure 6.4). 
A multiple combination and overtones region common to both 
glycine and the complex was discernible from 2 000 to 3 000cm -1 with a 
strongly absorbing band from 3 300 - 3 600cm -1 in the complex being due 
to water. A prominent line at 2 129cm -1 in glycine, the asymmetrical 
-N11 3 and torsional oscillation, was absent in the spectrum of the 
complex. Another prominent line at 698.2cm -1 , likely to be a torsional 
-NH 3 + oscillation was also found to be absent. If chromium was 
coordinated to glycine through the carboxylate ion, thus the -NH 3 + was 
now NH 2 , the loss of zwitterionic character would account for the change 
in the spectrum including the weakness of the 1 400cm -1 region compared 
with the 1 600cm -1 region in the complex. 
100 
3H 20/2Cr 
90 
80 1••• 
70 
9Et0H/2Cr 
60 
4-3 
..0 
CT) 50 
40 
6gly/2Cr 
30 
20 
i 
Cr 20 3 
0 1 I I 1 I I I 	4 	I 
0 100 200 300 400 500 600 700 800 
Temperature °C 
FIGURE 6.3 The thermal decomposition of the active chromium 
cationic complex and possible decomposition 
fragments. A molecular weight of 1 048 can be 
calculated from the final %Cr 2 0 3 if the starting 
product was a binuclear complex. 
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UV-visible solution spectra of an aqueous solution of 
fraction 3 (Table 6.4) showed visible region absorbance maxima of 
535nm and 396nm similar to many defined octahedral solution species of 
chromium III. 
6.4 DISCUSSION  
Chromium acetylacetonate (Cr(acac) 3 ) was found to be inactive 
in vitro with both yeast and adipocyte assay systems in agreement with 
Mertz (1969) even though the compound was reported to be absorbed in 
the gut of rats to the extent of 40% (Anderson et al 1980). The problems 
associated with the use of chromium acetate, as used by Toepfer et a/ 
(1977) were highlighted in the preparation of the Cr(acac)3 complex as 
olation products formed even in the presence of the strong acetylacetone 
ligand. As acetate ligands can act as bridges in the same way as 0H 
in olation (Rollinson 1973), chromium nitrate was substituted resulting 
in no olation products precipitating in the preparations described 
(Section 6.2) and in contrast to the preparation of Toepfer et al (1977). 
The reason for the addition of ethanol by Toepfer et a/ (1977) 
at an early stage of synthesis was not made apparent. The addition of 
alcohol at an early stage of the synthesis of a chromium glycine complex 
was found to increase olation problems by precipitating glycine and 
thus reducing the concentration of ligand available to compete with water. 
The addition of increasing concentrations of ethanol at a later stage of 
synthesis was found to be necessary for biological activity in the 
adipocyte assay, an aspect of the synthesis not previously reported. 
Biologically active material was also synthesized in the absence of 
nicotinic acid and although not outstandingly active in the yeast assay, 
was found to be active in the adipocyte assay. 
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Ammonia was used in all experiments to adjust the pH of 
the reaction mixture in accordance with the method of Toepfer et a/ (1977). 
As a small colour change was generally associated with the addition of 
ammonia and extra nitrogen was detected by the micro-analysis, the presence 
of ammonia in the active complex seems likely as glycine is not a 
completely effective chelating agent (Rollinson 1973). The active 
material could be described as a tris-glycine-chromium complex with 
associated ethanol,ammonia and water. The complex was most likely to 
be a binuclear complex and was, in solution, a positively charged 
complex ion. Tris-(amino acidato)chromium III complex reported by 
Oki et al (1976)dissociated in acid solution as did the active complex 
when attempting purification by paper chromatography in a butanol/ 
acetic acid solvent. The complex is not related to the simple tris-
glycinato chromium III monohydrate reported by Bryan et al (1971), 
although the visible absorption maxima were very similar to those reported 
by Oki and Otsuka (1976) in strong acid solution (Table 6.4). 
Absorption Maximum 
x(nm) x(nm) 
Oki et al (1976) 538 
	
400 
Reported complex 535 396 . 
TABLE 6.4 The absorption maximum of the active chromium 
glycine preparation reported in this thesis 
compared with the absorption of comparable 
tris-chromium glycine complexes reported by 
Oki et al (1976). 
The high solubility of the active complex contrasts with the 
limited solubility of the simple [Cr(gly) 3 ]H 20 and [Cr2(gly)4(01 -1)2P20 
(Bryan et a/ 1971). 
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The visible region solution spectrum shifts reported in this 
- thesis were larger than observations made by Krishnamoorthy et al (1980) 
for the interaction of chromium III solution complex ion with nucleosides. 
Anghileri (1971) reports the preparation of aspartic and asparagine 
complexes with 51chromium in aqueous solution for in vivo distribution 
studies. The reported cationic complexes were found to be products.of 
polymerization with mono and binuclear compounds being formed. Thus the 
formation of discrete complexes in aqueous solution can be seen to be 
difficult and the general consensus of opinion is that, with increasingly 
dilute solution and time, weak ligands will eventually interact with water 
molecules resulting in the formation of polymers. The storage of active 
material after lypholization overcame the problems of precipitation and 
deactivation in aqueous solution reported by Nath et al (1979). 
The preparation of Silio (1980) was found to be a cobalt III 
complex and strongly sorbed by cation exchange resin as was the chromium 
complex. The reported molecular weight of 1 500daltons compares closely 
with an estimated molecular weight of 1 048daltons for the active chromium 
complex and although the material was prepared with glutathione, no 
insulin mimicking activity was found, thus establishing GTE activity 
The complexes were thus similar with respect to size and overall charge. 
The fact that a cobalt preparation with nicotinamide rather than nicotinic 
acid was active is completely contrary to the requirements of Toepfer 
et al (1977) of an axial nicotinic acid arrangement with a chromium 
nucleus and the requirement of Mertz (1969) that the complex should be 
a chromium coordination complex. 
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6.5 CONCLUSION  
A chromium complex has been prepared without nicotinic acid 
or sulphydryl functional groups and found to be active. A cobalt 
complex prepared by Dr F. Silio has also been found to be active in the 
adipocyte assay. 
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CHAPTER SEVEN 
THE STRUCTURE OF YEAST GTF  
( 
7.1 INTRODUCTION  
The isolation of a biologically active, cationic fraction from 
whole yeast cell extract has been described in Chapter 5. The ninhydrin 
positive material produced a maximal stimulation of glucose oxidation 
with sub-optimal levels of insulin when tested in the adipocyte assay, 
and thus was considered to be*GTF since no activity was found in the 
absence of exogenous insulin. 
The characterization of the active material is described in 
this chapter. A wide range of instrumental facilities were used in 
order to elucidate the structure of the material which proved to be a 
difficult task because of its physical properties. Some indication of 
the polarity of the material and associated problems of sorption have 
already been discussed in Chapter 3. 
7.2 RESULTS  
7.2.1 Physical description  
Approximately 15mg of active material in two degrees of purity 
(2 e , 2") were isolated from a 2001 yeast culture grown in synthetic medium. 
The lypholized solids were white and similar in appearance to albumin. 
The solids were extremely water soluble and hygroscopic to such an 
extent as to preclude grinding with "nujol" to form a mull for IR 
spectroscopy. The material was also found to be totally insoluble in 
dimethyl sulphoxide (DMSO) thus obtaining exchangeable proton NMR spectra 
500 400 200 300 
pg of GTE 
0 100 
30 
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was not possible. The insolubility in DMSO highlights the high polarity 
of the material. 
7.2.2 Biological activity  
A dose response curve of % enhancement (increase over control, 
Chapter 4) of anaerobic glucose oxidation by yeast cells was prepared by 
accurate dilutions of the active material 2 e (Figure 7.1). 
FIGURE 7.1 le dose response curve for the active fraction 
2 as tested by the yeast assay described in 
Chapter 4. 
Although not outstanding in activity, there is a clear relationship 
between dose and % enhancement showing saturation at greater than 200pg/lml 
test volume. 
Fraction 2 e and 2" were tested for activity in the adipocyte 
assay by Ms J. Sherriff (MSc thesis, 1983) at a level of 50pg/1m1 test 
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volume. As has been indicated, the effect of the fraction was to increase 
the oxidation of glucose by adipocytes in the presence of 100 of insulin 
to equal the effect produced by 2000 of insulin. Duplicate experiments 
on the duplicate preparation confirmed the activity. No effect was 
found in the - absence of insulin thus ruling out the presence of insulin 
mimicking substances. 
7.2.3 Chemical analysis  
The chromium content of the active material was determined by 
CRA-AAS using the method described in Chapter 2 for yeast extract 
fractions. The chromium content was found to be 8 x 10 -4% and was 
regarded as being insignificant. 
Micro-chemical analysis of the material was performed by the 
Australian Micro-analytical Services (AMDL) who were supplied with 2mg 
of sample. The results were as follows: 
% carbon = 34.63 
% hydrogen = 13.86 
% nitrogen = 7.10 
% oxygen by difference = 44.41 
The ratio of carbon to nitrogen can be calculated to be 6 carbon:1 nitrogen 
in comparison with 6 carbon:2 nitrogen for lysine. 
7.2.4 Amino-acid analysis  
0.2mg of active material was acid hydrolysed in a 0.5ml 
"Reactivial", a conical vial with a teflon cap, by addition of 5y/ of 
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5N hydrochloric acid and heating for 18hrs at 110°C. Excess acid was 
removed by lypholization. The sample was diluted in the starting buffer 
(0.2N sodium citrate pH 6.28) for analysis by a programmed Dionex 
amino acid analyzer developed by J. Jordan of the Biochemistry Department. 
The column used was 4.6mm x 250mm packed with Aminex A-7 resin. The 
column temperature was 60°C and a ninhydrin detection system was used. 
Only one peak was observed eluting at the exact volume corresponding to 
lysine. 
Remaining hydrolyzed material was spotted onto paper for 
chromatography in the iso-propanol/ammonia solvent system described in 
Chapter 3. Unhydrolyzed material, lysine, poly-L-lysine (MW 4 000) and 
partially hydrolyzed poly-L-lysine (18hr, 80°C, 1N hydrochloric acid) were 
also applied to the paper prior to development. The material on the 
paper was visualized by Spraying with ninhydrin. All compounds developed 
without heating thus indicating the presence of an a-amino group. 
Rf 
L-lysine hydrochloride 0.33 
poly-L-lysine (MW 4 000) 0.01 
Sample 2 e 0.31 
TABLE 7.1 The Rf of poly-lyiine and the biologically 
active material 2 in iso-propanol/ 
ammonia solvent. 
The mildly acid hydrolyzed material yielded a series of 
compounds with Rf values from 0 to 0.31. The difference in Rf between 
lysine and the active material was small whereas the difference between 
poly-L-lysine was considerable thus indicating the active material was 
of considerably lower molecular weight. 
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7.2.5 Nuclear magnetic resonance  
Spectra were recorded using the 100M Hz Fourier Transform 
spectrometer at the National NMR Centre in Canberra. The instrument 
was operated by Dr Alan Jones and research assistant Ms B. Butler. 
Spectra were accumulated at 298°K unless otherwise specified. 
7.2.5.1 Proton NMR ( 1H)  
(i) The effect of pD and temperature 
The NMR proton spectrum of sample 2 e was found to pD dependent. 
The pD of the sample dissolved in D 20 was alkaline (-8). Spectra recorded 
in alkaline solution showed broad lines. Adjustment of pD using DC1 so 
that the sample was mildly acidic, resulted in a spectrum with defined 
spin-spin splitting multiplets. The line widths, when compared with 
those of L-lysine hydrochloride, were broadened (Figure 7.2). The 
E-protons were found to yield a quartet thus establishing the absence of 
hydroxy-lysine. A similar behaviour was observed in the spectrum of 
poly-L-lysine MW 50 000 (Sigma) in acid and alkaline solution. 
As hydrogen bonding was suspected to be the mechanism causing 
broadening at alkaline pD, spectra were obtained with the sample dissolved 
in urea, a hydrogen bond breaking solvent. The pD was varied from 5.0 up 
to 12.5. Increasing broadening of line widths with increasing p0 resulted 
as before, with the lines showing a decreasing chemical shift with 
increasing pD. If hydrogen bonding had been responsible for the 
broadening in alkaline solution, the presence of urea would have removed 
the effect. The conclusion drawn was that a strong zwitterionic 
structure was involved rather than hydrogen bonding. 
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(a) 
(b)  
(c)  
4.0 3.6 3.2 2.8 2.4 2.0 1.6 1.2ppm 
a 	 a 	6 	Y 
FIGURE 7.2 The 1 1-1 spectrum of 5mg of 2 e in (a) alkaline solution (pD 8) 
(b) acid solution (PD 5) and the spectrum of L-lysine in 
acid solution (c). 
FIGURE 7.3 The 41 spectrum of 5mg of 2 e in acid D 20 solution at 348°K. 
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Further evidence that the effect of line broadening was not 
due to hydrogen bonding was found in the spectra obtained at increased 
temperature. The probe temperature was increased to 348°K and the 
spectrum recorded. Line broadening and chemical shifts to higher values 
• resulted, returning to the original room temperature spectrum on cooling 
• (Figure 7.3),thus the effect was reversible. As breaking of hydrogen 
bonds occurs at higher temperature, the contrary would have been expected 
if hydrogen bonding was significant. 
(ii) Decoupling experiment 
Before evaluation of the proton spectrum, itwas necessary to 
establish that the protons observed were part of the same molecule to 
rule out the possibility of impurities. 
The 1 H spectrum was assigned based on the similarity to lysine 
thus the protons have been labelled as if they were lysine protons. 
Assignment Chemical Shift Spin-spin splitting J (Hz) 
a CH 3.69 doublet 6.2 
E CH 2 2.69 quartet 8.0 
? CH 2 1.83 singlet - 
a CH 2 1.83 sextet 8.0 
6 CH 2 1.74 octet 8.0 
y CH 2 1.42 octet 8.0 
TABLE 7.2 The proton spectrum of the active material 2 e . 
The spin-spin coupling constant (J) was similar for each multiplet 
indicating that all protons were of the same molecule. 
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DeCoupling was performed by irradiation at the frequency of 
each group of protons. The effect was observed on the remaining protons. 
(a) 998Hz (aCH) resulted in collapse of the f3CH 2 
region with no effect on the singlet at 1.83ppm. 
(b) 810Hz ( E CH 2 ) resulted in the collapse of the 
6CH 2 region. 
(c) 495Hz (CH 2 ) resulted in the collapse of the aCH 
and y and 6CH 2 region. 
(d) 380Hz (yCH2) resulted in changes in the f3CH 2 
and sCH 2 regions. 
Thus it can be seen that all protons except the singlet with a 
chemical shift of 1.83ppm are part of the same molecule. The line at 
1.83ppm was regarded as an impurity. 
(iii) The analysis of the proton spectrum 
As the spectral features of amino acids with ionizable side 
chains are pD dependent (Roberts and Jaradetzky 1970), comparative 
spectra of lysine, poly-lysine and the sample 2 e were obtained in acid 
conditions. As can be seen from Table 7.3, the chemical shifts compare 
more closely with lysine than poly-lysine with the proton integral also 
indicating lysine. 
Proton 
Chemical Shift (ppm) 
2
e 
proton integral Poly-lysine Lysine Sample 2
e 
a CH 4.31 3.74 3.70 1 
f3 CH 1.69 1.84 1.83 2 
y CH 1.45 1.47 1.40 2 
cS 	CH 1.71 1.68 2 
e CH 3.01 3.01 2.97 2 
TABLE 7.3 The comparison of H spectra of L-lysine hydrochloride, poly-
L-lysine (MW 4 000) and the biologically active material 2' 
in acidic D20 at 298°K. ' 
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7.2.5.2 13C NMR 
The effect of pD was found to be an important factor in 
obtaining a spectrum with a high signal to noise ratio. The sample (15mg) 
was dissolved in 0 20 and the pD adjusted to - 5. The spectrum was 
accumulated over a 64hr period with a lOsecond time delay. 
The chemical shifts of lysine, poly-L-lysine and the active 
material are compared in Table 7.4. 
Assignment 
Chemical Shift (ppm) 
Lysine Poly-lysine Sample 2 e , 2" 
C=0 174.7 174.6 175.7 
- 175.2 
a C 54.5 54.7 55.8 
55.4 
E C 40.5 40.2 40.4 
40.2 
(2. C 27.5 31.6 31.1 
S c 31.8 27.3 28.6 
27.6 
y C 23.1 23.2 24.0 
22.7 
TABLE 7.4 The u C spectrum of lysine, poly-DL-lysine 
(MW 5 000) and the active material in 
acidic 0 2 0. 
The apparent discrepancy in assignment between lysine and poly-
lysine was compared with literature (Wiithrich 1976, Smith et al 1973) - 
but was found to be correct thus posing problems in assigning the line 
at 31.1ppm in 2 e - is it a f3 or 5 carbon? 
The assignment of the carbon atoms fits lysine better than 
other amino acids but when compared to poly-lysine and lysine,.larger 
shifts are found for the carboxyl carbon, a carbon and y carbon and 
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difficulty in assigning the a carbon. The "paired" carbon atoms were 
originally thought to be due to the presence of D and L forms of lysine 
but was found to be incorrect as Table 7.4 demonstrates that poly-DL-
lysine did not show a similar spectrum to 2 e , -Thus, it must be concluded 
that two slightly different lysine polymer molecules are present, 
causing difficulty in the 'carbon integration. 
If an almost insignificant band at 182.4ppm is 
regarded as being the terminal carbon atom of a polypeptide, the ratio 
of the two different peptide banded carbon could be calculated from the 
integral to be 1 terminal C:1 13 C 175.7ppm:4 or 3 C 175.2ppm. If all 
were part of the same molecule, a very approximate molecular weight of 
800 daltons is implied but the two sets of lines would not be predicted. 
If the band at 182.4ppm is disregarded it may be that two small polymers 
of different size are present in the ratio of 1:3. 
7.2.6 Infra-red spectroscopy  
Infra-red spectra were obtained by J. Bignall of the Central 
Science Laboratory, University of Tasmania, using a Digilab Fourier 
Transform FTS-20E spectrometer. Samples of poly-L-lysine, L-lysine 
hydrochloride and the active preparation, 2e , were prepared as potassium 
bromide pellets. Spectra were accumulated from 100 scans with a 
resolution of 2 wavenumbers (cm-1 ). 
A strong band from 3 300 - 3 600cm -1 was observed for 
sample 2 e and poly-L-lysine. Both materials were hygroscopic so the 
band was attributed to water which absorbs in the 3 500cm -1 region. 
Poly-L-lysine (MW 4 000) was found to have a broad absorbance band below 
800cm-1 in comparison with lysine, due to the much greater length of 
the poly-lysine. The sample 2 e showed detail at less than 800cm-1 
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similar to lysine. Most significant differences were found in the 
1 650cm -1 (C=0) and N-H region which would involve peptide linkage 
oscillations. 
Assignment (cm-1 ) 
C=0 N-H 
symmetrical 
-NH3 + 
asymmetrical 
lysine 1 585 1 504 2 120 
poly-L-lysine 1 660 1 540 2 000 
sample 2 e 1 630 1 480 2 060 
TABLE 7.5 Comparison of the main absorbance bands of 
L-lysine hydrochloride, poly-L-lysine 
(MW 4 000) eand the biologically active 
material 2 . 
The sample 2 e can be seen to be intermediate between the lysine monomer 
and the 26-lysine polymer with the exception of the symmetrical -NH, 
bending band which is shifted further. 
7.2.7 UV-solution spectrum 
The solution spectrum was recorded using a Cary 219 
spectrophotometer (Varian). An aqueous solution of 1.33mg/lml of the 
active fraction was scanned from 300 to 200nm. A single symmetrical 
absorbance band at 260nm had an absorbance of 0.905 absorbance units. 
Strong absorbance was found at less than 230nm. If a molecular weight 
of 800daltons is assumed, the molar extinction coefficient can be 
calculated to be 6250 = 543 (lcm pathlength). No such band was observed 
for lysine or poly-L-lysine. 
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7.2.8 Mass spectrometry  
Following lack of success in obtaining a parent ion in the 
expected region of 800 mass units by ammonia chemical ionization mass 
spectroscopy (Central Science Laboratory, University of Tasmania), a 
sample was submitted to Dr I. Lewis of UG Analytical Ltd., Manchester, 
for fast atom bombardment (FAB source) mass spectroscopy. Unfortunately, 
he was unable to obtain a spectrum despite several attempts. The 
difficulty was not made apparent but may have been due to insolubility 
in the organic solvent used. 
7.2.9 The biological activity of poly-L-lysine  
As has been shown in Chapter 4, poly-L-lysine (MW 4 000) and 
poly-DL-lysine (MW 5 000) were found to be inhibitory in the yeast assay. 
As a smaller lysine fragment was required, the poly-L-lysine (MW 4 000) 
was mildly acid hydrolyzed in 1N HC1 for 18hrs at 80°C, similar to the 
hydrolysis of Tuman et al (1978). Six discrete compounds were found to 
be present by paper chromatography in the iso-propanol/ammonia solvent 
system. 
100pg of the acid hydrolysate was found to be active in the 
yeast assay, with a % enhancement of 19%. L-lysine hydrochloride was 
found to be inactive. Higher levels of the hydrolysate were inhibitory 
and would seem to be due to unhydrolyzed material. The adipocyte assay 
was not available due to the exhaustion of Teklad food and thus discon-
tinuation of the rat breeding programme. 
148 
7.3 DISCUSSION  
The active fraction 2 e was found to have physical and spectral 
similarities with a low molecular weight poly-lysine. The Merck Index 
(1968) describes poly-lysine as a transparent, film-like polymer, readily 
soluble in water and practically insoluble in usual organic solvents as 
was the case with the active material. Both the active material and 
poly-lysine were found to be hygroscopic. 
Acid hydrolysis of the sample 2 e yielded only lysine by 
amino acid analysis. As mass Spectroscopy did not give a result and gel 
filtration chromatography was not possible due to strong sorption 
(Chapter 3), the NMR spectra were to provide the majority of structural 
information, including estimated chain length. 
Initially, the extent of 13 C line broadening was thought to 
indicate a large molecular weight as has been demonstrated in the 
crosslinking of polystyrenes but this was discounted on the basis of 
paper chromatography. Poly-lysine, having a molecular weight of 4 000daltons, 
had a low Rf in the alkaline solvent system whereas 2 e had an Rf of 0.31. 
WUthrich (1976) reports that cyclic peptides exhibit line broadening, 
thus the possibility of a cyclic peptide linkage deserves closer examination. 
Smith et al (1973) have studied the 13 C chemical shifts of many amino 
acids in cyclic peptide hormones and find that the carboxyl carbon of 
lysine has an average chemical shift of 175.5ppm in cyclic peptides which 
compares closely with 175.7 and 175.2ppm in sample 2 e • Poly-lysine and 
lysine carboxyl carbon shifts were 174.6 and 174.7ppm. Thus, the line 
broadening seen in both the proton and 13 C spectra may be attributed to 
cyclic peptide linkage as can the larger chemical shifts for the carboxyl 
carbon atoms. 
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It has been indicated in Section 7.2.5.2 that two slightly 
different molecules are present in the proportion of 1 to 3. The slight 
differences in 
13
C shifts may arise from the presence of two ring sizes 
differing by 1 lysine unit. A possibility is the minimum of two lysine 
units, peptide linked to give a cyclic central unit, and a larger 
molecule of 4 lysine residues. The increased broadening with pD may 
result from the interaction of the protruding lysine chains as 
poly(lysine) 12 is reported to undergo a coil-helix transition at high 
pH (Smith et al 1973). 
The IR spectra would also appear to favour a cyclic structure 
as the absorbance bands associated with peptide formation were shifted 
to a greater extent than those of a linear poly-lysine. 
UV spectra indicated a weak absorbance band at 260nm which was 
difficult to account for as no aromatic structure was found in the NMR 
spectra which, if present, would have been obvious. Initially, it was 
thought that 6-amino-piperidine-2-carboxylic acid (a lysine like compound) 
may have absorbed in the 260nm region but, as L-pipecolinic acid was found 
to be transparent in that region, it seemed unlikely. A two lysine 
cyclic peptide may absorb in that region, however, it seems more likely 
that an impurity of a small amount of a strongly absorbing compound 
(e.g. nicotinamide) would have been responsible. 
The presence of saccharopine (E-N-L-glutar-2-yl-L-lysine), an 
intermediate in the biosynthesis of lysine by Sacch. cerevisiae (Jones 
et al 1965), was difficult to discount on the basis of spectral evidence, 
and if the micro-analytical result is considered, the ratio of 5 carbon 
atoms to 1 nitrogen correlates better than lysine. Saccharopine has been 
listed by the Merck Index (1968) as being sparingly soluble in water in 
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contrast with the ease of solution of the isolated active material. 
The micro-analysis would be expected to be in error in relation to oxygen 
and hydrogen analysis since a carefully desiccated sample was found to 
contain water by IR spectroscopy (Section 7.2.6). The micro-analysis 
carbon to nitrogen ratio still remain difficult to explain but, as the 
preparation had a higher degree of purity than commercially available 
poly-lysine, it may be that the analysis was in error due to the presence 
of water. 
7.4 CONCLUSION  
The NMR spectra strongly support the existence of a small cyclic 
lysine peptide. As partial hydrolysis fragments of poly-lysine were 
active in the yeast assay but to a lesser extent, it seems that lysine 
is the active principle of GTE. This finding contrasts with the historic 
structure of GTF, a chromium-nicotinamide-amino acid coordination complex 
described in Chapter 1.8.3. 
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CHAPTER EIGHT 
DISCUSSION  
The purification of GTE from brewers' yeast described -in this 
thesis resulted in decreasing chromium levels with increasing activity 
in the adipocyte assay, with the final active product containing a 
negligible chromium concentration (8 x 10 - '1). The divergence of chromium 
content from biological activity was not unexpected since the concentration 
of chromium in reported yeast fractions with activity in the - adipocyte 
assay was exceedingly low (Chapter 1), indicating some other factor may 
have been responsible for the biological activity. Toepfer et al (1977) 
had found that an increasing ratio of chromium to dry weight of yeast 
fraction resulting from purification procedures that did not result in 
the concentration of glucose tolerance factor activity as would be expected 
if chromium was important. The importance of nicotinic acid has also 
been questioned in reviewing the structure of GTE (Chapter 1) and it was 
not found in the final isolated product. The structure of GTE reported 
in Chapter 7 was that of a small, cyclic lysine peptide, a previously 
unreported structure in relation of glucose tolerance factor activity. 
The lysine peptide was •found to stimulate the action of a sub-optimal level 
of insulin on glucose oxidation, to that of a maximum effect. As no 
stimulation of glucose oxidation was found in the absence of exogenous 
insulin, the biological activity of the lysine peptide was deemed to be a 
true GTE effect by the criteria of Anderson et al (1978, 1979) and 
Kienle et al (1979). 
The active material was isolated from Sacch. carlsbergensis grown 
in a completely synthetic medium with no additions such as bacto-peptone 
.which may have been a source of GTE. Active material was isolated from 
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yeast grown in a chromium free medium but a higher yield of material was 
obtained when chromium (2.0ppm) was added to the culture (Chapter 5). 
The growth of yeast was found to be inhibited by chromium and was thus 
toxic in agreement with Kumpulainen et a/ (1978) and contrary to the 
findings of Burkeholder and Mertz (1966), thus the yeast used can be 
regarded as being chromium sensitive. 
Ono and Weng (1982) obtained ten mutant forms of Sacch. cerevisiae 
and genetically analyzed them finding all to be recessive. Among six 
mutations found in mutants with single mutations responsible for the 
chromium sensitivity, 6 loci were distinguished, one of them being 
identified as LYS 7, the gene previously known as the structure gene 
for homocitric dehydrase which was found to be involved in the detoxifi-
cation of chromium. It is proposed that the production of the lysine 
peptide may be associated with a detoxification mechanism that results 
in the production of higher levels of lysine. It may be that a chromium 
lysine complex is formed with the chromium initially bound to the 
E-NH 3 1- which has been reported by Brill (1977) to participate in metal 
binding and which has an intrinsic pK of 10.0. As most sample handling 
involved the use of ammonia (Toepfer et al 1977), it could well be that 
the chromium was lost to cation exchange resin while eluting with ammonia. 
• An amphoteric material was reported in Chapter 5 from_ which 
active material was derived after mild acid hydrolysis and which was 
more active in the yeast assay than the final product, the lysine peptide. 
It may be that the crude brown amphoteric material with associated 
chromium was the original GTF synthesized by the yeast, and that the 
active cationic material was a low molecular weight fragment of the 
original. In Chapter 5 (Table 5.2) it was demonstrated that crude 
anionic material from a synthetic medium culture was also active in 
the yeast assay and may have been equivalent to the chromium containing 
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anionic complexes of Kumpulainen et al (1978) and Votava et al (1973). 
No activity for such complexes was found in the adipocyte assay thus 
the different size and charge of the original compound would appear to 
have been responsible for the division of biological activity between 
the yeast and adipocyte assays. 
As has been reported in Chapter 6 of this thesis, a cobalt-
nicotinamide-glutathione preparation was also found to be active in the 
adipocyte assay but not in the yeast assay developed for screening of 
GTF containing fractions (Chapter 4). A chromium-glycine complex reported 
in Chapter 6 was found to be active in both assay systems but not to 
the extent of the cationic lysine peptide isolated from yeast. All three 
compounds were found to be basic and the cobalt complex was of similar 
molecular weight to the chromium complex. It may be that for adipocytes, 
the similarity of shape and charge of the complexes had resulted in a GTE 
effect. If the IR "fingerprint" spectrum of the chromium glycine 
preparation (Chapter 6) is compared with the lysine polymer (Chapter 7), 
many spectral similarities are seen in the 3 100cm -1 region, and the 
1 630cm-1 to 800cm-1 region which would otherwise be unexpected for two 
very different compounds. Thus it seems that chromium, with its low 
rate of ligand exchange, has a purely structural function. As the cobalt 
complex was not found to be active in the yeast assay, there is also the 
possibility that the mode of action may be different in adipocytes when 
compared with the lysine peptide. The mode of action of the cobalt GTF was 
thought to be the reoxidization of NADH which was necessary for the 
action of insulin at the pyruvate dehydrogenase level in contrast to the 
chromium complexes of Toepfer et al (1977) which were thought to inhibit 
pyruvate carboxylase (Silio, personal communication 1982, Silio 1975, 1977). 
No inhibition of pyruvate carboxylase has been found in this laboratory 
in yeast (Appleby and Holdsworth, to be published). 
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Three very different compounds were thus found to be active 
in the adipocyte assay. The adipocytes were isolated from rats which 
were not chromium deficient since the "low chromium" diet supplied by 
Teklad was found to contain 0.5 - 0.8pg/g Cr (Chapter 2) in comparison 
with the colony rat diet containing 0.81.g/g Cr. Both levels are in 
excess of the minimum dietary requirement for rats of 0.1ppm (Mertz and 
Anderson 1977), thus the rats were not chromium deficient yet GTF activity 
could only be demonstrated using tissue from the Teklad diet raised rats. 
It has been found that the rats fed the higher sugar Teklad diet had 
a lower growth rate than the colony rats and this has been attributed 
to the quality of available protein as the diet appeared to be adequate 
in all other respects including chromium (Sherriff, MSc thesis, 1983). 
The "low" chromium Teklad diet containing torula yeast as the only source 
of protein was similar to the diet first reported by Mertz and Schwarz 
(1955) in conjunction with the first indication of impaired glucose 
tolerance. 
It may be that the continual use of a high sugar diet was 
responsible for the observed effect in the isolated tissue rather than 
low quality protein. Schwarz and Mertz (1957) have reported impaired 
glucose tolerance in rats raised on a similar diet but with casein as the 
source of protein. Before further discussion of the effect of GTE, it is 
necessary to consider the yeast assay in relation to the adipocyte assay. 
An improved yeast assay is reported in Chapter 4 of this thesis. 
Yeasts have been used as the basis of a microbiological assay of 
vitamin B6 and its components (Toepfer and Polansky 1970). The possibility 
that a yeast vitamin may have promoted activity was ruled out by testing 
the complete vitamin mixture used to grow the yeast (Chapter 4). 
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The use of 140-glucose with substrate depleted yeast cells 
showed that GTE stimulates the anaerobic oxidation of glucose to yield 
stoichometric quantities of carbon dioxide and ethanol. The effect of 
GTE on adipocytes was also increased glycolysis but only in the presence 
of a small amount of insulin, thus a common effect would appear to exist 
in the different assay systems. Nicotinic acid (0.033mM) was reported 
to be active in the fat pad assay with the effect reduced considerably • 
when isolated adipocytes were used (Anderson et al 1978). Nicotinic acid 
and also adenosine have been reported to potentiate insulin stimulated 
glucose oxidation in fat cells via a decrease in c-AMP accumulation 
(Wieder and Fain 1975, Fain et al 1979). N6-methyl adenosine (100pM) 
was also found to stimulate glucose oxidation by Souness et al (1981), 
thus a wide variety of substances can produce a GTF effect in the adipocyte 
assay. None of the above substances were found to produce the maximal 
effect demonstrated with the isolated lysine peptide. 
The very basic material isolated can be likened to a group of 
hypoglycemic agents, the biguanides. They differ in the mechanism of 
action from the sulphonyl urea hypoglycemic agents which stimulate the 
secretion of insulin by the pancreas. In vitro, anaerobic glycolysis is 
increased by biguanides in the presence of small amounts of insulin 
resulting in an accumulation of lactate in mammalian cells which would 
correspond to an increase in ethanol production in yeast cells. In vivo, 
biguanides inhibit intestinal absorption of glucose. The biguanides do 
not act as readily in a normal patient compared with a diabetic, presumably 
because the increase in peripheral glucose utilization is compensated for 
by an increase in hepatic glucose output (Bowman 1980). Lower plasma 
levels in triglycerides and cholesterol have also resulted during treatment 
with biguanides. 
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FIGURE 8.1 The structure of two biguanide hypoglycemic agents used in the 
treatment of abnormal glucose tolerance in obese patients. 
If the action of pure cationic fractions isolated from brewers' 
yeast are likened to the effect of biguanides in vivo, the glucose 
tolerance of rats fed on the typical high sugar, "low" chromium diet 
would be expected to show blood glucose lowering on supplementation 
with yeast fractions. Thus a non-chromium containing glucose tolerance 
factor from yeast could be active in a glucose tolerance test. The glucose 
tolerance test is regarded as the ultimate specific test of glucose 
tolerance factor (Chapter 1) but one which is technically difficult to 
perform on rats (Sherriff, MSc thesis, 1983). 
The testing of synthetic complexes in vivo appears to have been 
confined to the intestinal absorption of complexes and, as has been 
indicated in Chapter 1, a high intestinal absorption does not correlate 
with activity in the adipocyte assay. Chromium tris-acetylacetonate has 
been reported to have a high intestinal absorption (Anderson et al 1974) 
but no activity in the adipocyte assay (Mertz 1969), a finding that has 
been confirmed in this thesis. Tuman et al (1978) were the only group 
found who compared the in vivo effect of synthetic complexes with yeast 
complexes by injecting mice with both preparations but without a chromium 
III control. A small decrease in plasma glucose was found with synthetic 
preparations. A large number of diverse synthetic preparations have 
been prepared with structures varying from the Ryridoxal nicotinic acid 
structure of Gonzalez-Vegera (1980. to a group of interesting porphyrin 
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chromium complexes prepared by Riley (1980) on the basis of their acid 
stability in the gut. Because of the lack of in vitro testing of the 
various compounds, it is not possible to draw any analogies between 
yeast GTE or the complex reported in this thesis. Once again, glucose 
tolerance tests would be the final measure of the value of such complexes 
as synthetic GTE. Using in vitro activity only may have shortcomings 
as the synthetic preparation of Toepfer et al (1977), found to be active 
in the fat pad assay, was not found to cross the placenta (Mertz and 
Anderson 1977), a specific requirement of Mertz (1969) for GTE activity. 
If a division is made in recent controlled studies between the 
effect of chromium supplementation and supplementation with high chromium 
brewers' yeast, two different effects can be postulated. Riales and Albrink 
(1981) found a slight improvement in glucose tolerance on supplementation 
with inorganic chromium but a more significant effect on the lowering of 
low density lipo-protein cholesterol. As one site of cholesterol 
synthesis is the liver (Harper et al 1977), it may be that the liver is 
a site of action of absorbed chromium. Evidence of the role of liver 
in chromium metabolism was found by Hamamoto et al (1980) who injected 
rabbits with 51chromium and then isolated a low molecular weight chromium 
complex from the livers by electrophoresis and by chromatography. 
Offenbacher et al (1980) studied the beneficial effect of a 
high chromium brewers' yeast with that of a low chromium yeast on diabetic 
and non diabetic groups of older Americans. The group receiving the 
high chromium yeast showed a decrease in blood glucose levels despite 
lowered or unchanged insulin levels suggesting enhanced insulin sensitivity. 
The response described is the same as reported for the biguanide hypo-
glycemic agents. The hypothesis that a hypoglycemic agent can be 
extracted from yeast in higher quantities in response to toxic levels of 
chromium is reinforced by the findings of Offenbacher et al (1980) who 
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also suggested that some factor other than chromium may be involved. 
Gill et al (1981) have conducted a similar experiment that supported 
the findings of Offenbacher et al (1980) but used high chromium yeast 
based cookies as a supplement in comparison with low chromium torula 
yeast cookies. The conclusion was that the high chromium yeast based 
cookie decreased the relative amount of insulin required to deal with 
a given glucose load. Thus, two effects may be distinguished, one of 
GTE activity and the other, a beneficial effect of chromium as a possible 
protective agent in coronary heart disease (Riales, 1979). 
As has already been indicated in Chapter 1, it has been stated 
by Anderson (1981) that the form of dietary chromium is not as important 
as has previously been postulated but that it is the total chromium intake. 
This casts some doubt on the worth of continuing research into the 
production . of chromium complexes which may have high intestinal absorption, 
since satisfactory supplementation in humans has been shown with 
chromium chloride (Jeejeebhoy 1977). Chromium has traditionally been 
regarded as a toxic element and studies by Okada et al (1981) indicate 
that chromium III stimulates RNA synthesis which may relate to the role of 
chromium in newborn human babies whose chromium content has been 
reported to be high, and also the carcinogenicity of chromium. As no 
reliable measure of chromium deficiency is available (Chapter 1), the 
question of supplementation with inorganic chromium should be approached 
with caution. 
An interesting area arising from this thesis could be the 
production of compounds with potential as hypoglycemic agents produced 
by yeast in presence of chromium. 
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